10-Q

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended May 31, 2023

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from _______ to _______

SEC File No. 001-37954

SHIFTPIXY, INC.

(Exact name of registrant as specified in its charter)

Wyoming	47-4211438
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
13450 W Sunrise Blvd, Suite 650, Sunrise FL	33323
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number: (888) 798-9100

N/A

(Former name, former address and former three months, if changed since last report)

Securities registered under Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.0001 per share	PIXY	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒     No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐     No ☒

 The number of shares of the registrant’s only class of common stock, $0.0001 par value was 12,177,191, as of July 14, 2023.

TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Financial Statements	3
	Condensed Consolidated Balance Sheets as of May 31, 2023 (Unaudited) and August 31, 2022	3
	Condensed Consolidation Statements of Operations for the Three and Nine Months ended May 31, 2023 and May 31, 2022 (Unaudited)	4
	Condensed Consolidated Statements of Stockholders’ Deficit for the Three and Nine Months ended May 31, 2023 and May 31, 2022 (Unaudited)	5
	Condensed Consolidated Statements of Cash Flows for the Nine Months ended May 31, 2023 and May 31, 2022 (Unaudited)	7
	Notes to the Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	36
Item 3.	Quantitative and Qualitative Disclosure about Market Risk	50
Item 4.	Controls and Procedures	50
PART II — OTHER INFORMATION
Item 1.	Legal Proceedings	51
Item 1A.	Risk Factors	51
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	51
Item 3.	Defaults Upon Senior Securities	51
Item 4.	Mine Safety Disclosures	51
Item 5.	Other Information	51
Item 6.	Exhibits	52
Signatures		53

2

Item 1. Condensed Consolidated Financial Statements

ShiftPixy, Inc. 

Condensed Consolidated Balance Sheets

	May 31, 2023			August 31, 2022
	(Unaudited)
ASSETS
Current assets
Cash	$	144,000		$	618,000
Accounts receivable, net of reserve of $10,000 and $0 as of May 31, 2023 and August 31, 2022 respectively		537,000			279,000
Unbilled accounts receivable		2,046,000			2,105,000
Prepaid expenses		256,000			696,000
Other current assets		271,000			187,000
Cash and marketable securities held in Trust Account (See Notes 2 and 4)		—			116,969,000
Total current assets		3,254,000			120,854,000
Fixed assets, net		2,665,000			2,769,000
Right-of-use operating lease		3,567,000			4,076,000
Deposits and other assets		1,098,000			919,000
Total assets	$	10,584,000		$	128,618,000
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities
Accounts payable and other accrued liabilities	$	18,342,000		$	17,121,000
Payroll related liabilities		24,379,000			16,055,000
Accrued workers’ compensation costs		425,000			568,000
Current liabilities of discontinued operations		1,765,000			1,362,000
Class A common shares of SPAC mandatory redeemable 0 shares and 11,500,000 shares as of May 31, 2023 and August 31, 2022 (See Notes 2 and 4)		—			116,969,000
Total current liabilities		44,911,000			152,075,000
Non-current liabilities
Operating lease liability, non-current		3,017,000			3,541,000
Accrued workers’ compensation costs		922,000			1,227,000
Non-current liabilities of discontinued operations		4,133,000			3,269,000
Total liabilities		52,983,000			160,112,000
Commitments and contingencies
Stockholders’ deficit
Preferred stock, 50,000,000 authorized shares; $0.0001 par value: 0 and 8,600,000 shares issued and outstanding as of May 31, 2023 and August 31, 2022.		—			1,000
Common stock, 750,000,000 authorized shares; $0.0001 par value; 10,110,524 and 513,349 shares issued as of May 31, 2023 and August 31, 2022		6,000			5,000
Additional paid-in capital		168,967,000			151,731,000
Accumulated deficit		(211,372,000	)		(192,725,000	)
Total ShiftPixy, Inc. Stockholders’ deficit		(42,399,000	)		(40,988,000	)
Non-controlling interest in consolidated subsidiary (See Note 4)		—			9,494,000
Total stockholders’ deficit		(42,399,000	)		(31,494,000	)
Total liabilities and stockholders’ deficit	$	10,584,000		$	128,618,000

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

ShiftPixy, Inc. 

Condensed Consolidated Statements of Operations 

(Unaudited)

	For the Three Months Ended						For the Nine Months Ended
	May 31, 2023			May 31, 2022			May 31, 2023			May 31, 2022
Revenues (See Note 2)	$	3,988,000		$	9,643,000		$	13,833,000		$	29,021,000
Cost of revenues		3,788,000			9,039,000			12,623,000			27,782,000
Gross profit		200,000			604,000			1,210,000			1,239,000
Operating expenses:
Salaries, wages, and payroll taxes		2,621,000			3,254,000			7,477,000			10,796,000
Professional fees		752,000			2,680,000			2,817,000			6,094,000
Software development		50,000			4,291,000			229,000			6,525,000
Depreciation and amortization		148,000			133,000			447,000			386,000
General and administrative		3,074,000			2,967,000			6,609,000			7,718,000
Total operating expenses		6,645,000			13,325,000			17,579,000			31,519,000
Operating loss		(6,445,000	)		(12,721,000	)		(16,369,000	)		(30,280,000	)
Other (expense) income:
Interest expense		(550,000	)		(1,000	)		(1,007,000	)		(2,000	)
Other income		—			27,000			536,000			43,000
SPAC offering costs		—			—			—			(515,000	)
Total other expense		(550,000	)		26,000			(471,000	)		(474,000	)
Net loss from continuing operations		(6,995,000	)		(12,695,000	)		(16,840,000	)		(30,754,000	)
Loss from discontinued operations, net of tax		(460,000	)		(132,000	)		(1,267,000	)		(283,000	)
Non-controlling interest		—			—			(540,000	)		—
Net loss attributable to ShiftPixy, Inc.		(7,455,000	)		(12,827,000	)		(18,647,000	)		(31,037,000	)
Preferred stock preferential dividend		—			—			(127,145,000	)		—
Deemed dividend from change in fair value from warrants modification		—			—			—			(7,731,000	)
Net loss attributable to common stockholders	$	(7,455,000	)	$	(12,827,000	)	$	(145,792,000	)	$	(38,768,000	)
Net loss per share attributable stockholders, basic and diluted
Continuing operations – basic and diluted	$	(0.70	)	$	(33.08	)	$	(14.84	)	$	(101.72	)
Discontinued operations – basic and diluted		(0.05	)		(0.34	)		(0.13	)		(0.75	)
Net loss per common share – basic and diluted	$	(0.75	)	$	(33.42	)	$	(14.97	)	$	(102.47	)
Weighted average common shares outstanding – basic and diluted		10,057,177			383,726			9,739,578			378,349

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

ShiftPixy, Inc. 

Condensed Consolidated Statement of Stockholders’ Deficit 

For the Nine Months Ended May 31, 2023

(Unaudited)

	Preferred Stock Issued						Common Stock Issued				Additional Paid-In			Accumulated			Total Stockholders’ Deficit			Noncontrolling			Total Stockholders’
	Shares			Amount			Shares		Amount		Capital			Deficit			ShiftPixy, Inc.			interest			Deficit
Balance, September 1, 2022		8,600,000		$	1,000			513,349	$	5,000	$	151,731,000		$	(192,725,000	)	$	(40,988,000	)	$	9,494,000		$	(31,494,000	)
Fair market value increase of preferred stock prior to reverse stock split		—			—			—		—		127,145,000			—			127,145,000			—		$	127,145,000
Preferential dividend of preferred stock		—			—			—		—		(127,145,000	)		—			(127,145,000	)		—		$	(127,145,000	)
Common stock issued on exercised prefunded warrants		—			—			124,204		—		1,000			—			1,000			—		$	1,000
Common stock issued for private placement, net of offering costs		—			—			416,667		—		4,387,000			—			4,387,000			—		$	4,387,000
Common stock issued on conversion of preferred shares		(8,600,000	)		(1,000	)		8,600,000		1,000		—			—			—			—		$	—
Stock-based compensation expense		—			—			—		—		735,000			—			735,000			—		$	735,000
Warrant modification expense		—			—			—		—		106,000			—			106,000			—		$	106,000
Additional shares issued due to reverse stock split		—			—			16,976		—		—			—			—			—		$	—
Net proceeds of ATM, net of offering expenses		—			—			439,328		—		1,973,000			—			1,973,000			—		$	1,973,000
Deconsolidation of VIE		—			—			—		—		10,034,000			—			10,034,000			(9,494,000	)	$	540,000
Net loss		—			—			—		—		—			(18,647,000	)		(18,647,000	)		—		$	(18,647,000	)
Balance, May 31, 2023		—		$	—			10,110,524	$	6,000	$	168,967,000		$	(211,372,000	)	$	(42,399,000	)	$	—		$	(42,399,000	)

ShiftPixy, Inc.

Condensed Consolidated Statement of Stockholders’ Deficit

For the Three Months Ended May 31, 2023

(Unaudited)

	Preferred Stock Issued				Common Stock Issued				Additional Paid-In		Accumulated			Total Stockholders’ Deficit			Noncontrolling		Total Shareholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			ShiftPixy, Inc.			interest		Deficit
Balance, March 1, 2023		—	$	—		9,976,536		6,000	$	168,193,000	$	(203,917,000	)	$	(35,718,000	)	$	9,494,000	$	(35,718,000	)
Proceeds of ATM, net of offering expenses		—		—		133,988		—		539,000		—		$	539,000			—	$	539,000
Stock-based compensation expense		—		—		—		—		235,000		—			235,000			—	$	235,000
Net loss		—		—		—		—		—		(7,455,000	)		(7,455,000	)		—	$	(7,455,000	)
Balance, May 31, 2023		—	$	—		10,110,524	$	6,000	$	168,967,000	$	(211,372,000	)	$	(42,399,000	)	$	—	$	(42,399,000	)

 accompanying notes are an integral part of these condensed consolidated financial statements.

5

ShiftPixy, Inc. 

Condensed Consolidated Statements of  Stockholders’ Deficit 

For the Nine Months Ended May 31, 2022

(Unaudited)

	Preferred Stock Issued				Common Stock Issued				Additional Paid-In			Accumulated			Total Stockholders’ Deficit			Noncontrolling			Total Stockholders’
	Shares		Amount		Shares		Amount		Capital			Deficit			ShiftPixy, Inc.			interest			Deficit
Balance, September 1, 2021		—	$	—		258,631	$	3,000	$	142,786,000		$	(149,338,000	)	$	(6,549,000	)	$	47,472,000		$	40,923,000
Cumulative effect adjustment for ASC 842 lease accounting adoption		—		—		—		—		—			608,000			608,000			—		$	608,000
Common stock issued for private placement, net of offering cost		—		—		28,500		—		4,183,000			—			4,183,000			—		$	4,183,000
Common stock issued on exercised warrants, net of offering costs		—		—		96,218		1,000		5,409,000			—			5,410,000			—		$	5,410,000
Prefunded warrants from private placement, net of offering costs		—		—		—		—		6,861,000			—			6,861,000			—		$	6,861,000
Stock-based compensation expense		—		—		—		—		1,069,000			—			1,069,000			—		$	1,069,000
Remeasurement of IHC temporary equity		—		—		—		—		(13,431,000	)		—			(13,431,000	)		—		$	(13,431,000	)
Withdrawal of SPAC registrations under Form S-1		—		—		—		—		—			—			—			(37,978,000	)	$	(37,978,000	)
Net loss		—		—		—		—		—			(31,037,000	)		(31,037,000	)		—		$	(31,037,000	)
Balance, May 31, 2022		—	$	—		383,349	$	4,000	$	146,877,000		$	(179,767,000	)	$	(32,886,000	)	$	9,494,000		$	(23,392,000	)

ShiftPixy, Inc.

Condensed Consolidated Statements of  Stockholders’ Deficit 

For the Three Months Ended May 31, 2022

(Unaudited)

	Preferred Stock Issued				Common Stock Issued				Additional Paid-In			Accumulated			Total Stockholders’ Deficit			Noncontrolling		Total Stockholders'
	Shares		Amount		Shares		Amount		Capital			Deficit			ShiftPixy, Inc.			interest		Deficit
Balance, March 1, 2022		—	$	—		336,616	$	3,000	$	146,716,000		$	(166,940,000	)	$	(20,221,000	)	$	9,494,000	$	(10,727,000	)
Common stock issued on exercised warrants, net of offering costs		—		—		46,733		1,000		—			—			1,000			—	$	1,000
Stock-based compensation expense		—		—		—		—		321,000			—			321,000		$	—	$	321,000
Remeasurement of IHC temporary equity		—		—		—		—		(160,000	)		—			(160,000	)		—	$	(160,000	)
Net loss		—		—		—		—		—			(12,827,000	)		(12,827,000	)	$	—	$	(12,827,000	)
Balance, May 31, 2022		—		—		383,349		4,000		146,877,000			(179,767,000	)		(32,886,000	)		9,494,000		(23,392,000	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

ShiftPixy, Inc.

Condensed Consolidated Statements of Cash Flows (Unaudited) 

	For the Nine Months Ended
	May 31, 2023			May 31, 2022
OPERATING ACTIVITIES
Net loss attributable to ShiftPixy, Inc stockholders	$	(18,647,000	)	$	(31,037,000	)
Loss from discontinued operations		(1,267,000	)		(283,000	)
Non-controlling interest		(540,000	)		—
Net loss from continuing operations		(16,840,000	)		(30,754,000	)
Adjustments to reconcile net loss to net cash used in operations
Depreciation and amortization		447,000			386,000
Provision for doubtful accounts		10,000			—
Stock-based compensation		735,000			1,069,000
Stock-based compensation – shares for services accrued to directors		169,000			—
Impaired asset expense		—			4,004,000
Warrant modification expense		106,000			—
Expensed SPAC offering cost		—			515,000
Amortization of operating lease		85,000			727,000
Changes in operating assets and liabilities:
Accounts receivable		(268,000	)		146,000
Unbilled accounts receivable		59,000			(729,000	)
Prepaid expenses and other current assets		356,000			(146,000	)
Deposits – workers’ compensation		—			541,000
Deposits and other assets		(79,000	)		—
Accounts payable and other accrued liabilities		952,000			4,573,000
Payroll related liabilities		8,324,000			6,583,000
Accrued workers’ compensation costs		(448,000	)		(295,000	)
Total adjustment		10,448,000			17,374,000
Net cash used in continuing operations		(6,392,000	)		(13,380,000	)
Net cash provided by discontinued operating activities		—			—
Net cash used in operations		(6,392,000	)		(13,380,000	)
INVESTING ACTIVITIES
Investment of IHC IPO proceeds into Trust Account		—			(116,765,000	)
Redemption of Trust Account		117,574,000			—
Investment in private company		(100,000	)
Purchase of fixed assets		(343,000	)		(500,000	)
Net cash provided by (used in) investing activities		117,131,000			(117,265,000	)
FINANCING ACTIVITIES
SPAC related offering costs paid		—			(3,663,000	)
Proceeds from initial public offering of IHC		—			116,725,000
Payment to IHC shareholders		(117,574,000	)		—
Proceeds from exercised warrants. Net of offering costs		1,000			5,410,000
Proceeds from private placement, net of offering costs		4,387,000			4,183,000
Proceeds from At-The-Market Offering, net of offering costs		1,973,000			—
Deferred offering costs					—
Proceeds from private placement prefunded warrants, net of offering costs		—			6,861,000
Net cash (used in) provided by financing activities		(111,213,000	)		129,516,000
Net increase in cash		(474,000	)		(1,129,000	)
Cash – beginning of period		618,000			1,199,000
Cash – end of period	$	144,000		$	70,000
Supplemental Disclosure of Cash Flows Information:
Cash paid for interest	$	102,000		$	2,000
Non-cash Investing and Financing Activities:
Deconsolidation of VIE	$	9,494,000		$	—
Elimination of deferred offering cost of abandoned SPAC’s initial public offering	$	—		$	37,978,000
Change in fair value due to warrant modification	$	—		$	13,728,000
Operating lease assets and liabilities s from adoption of ASC 842	$	—		$	8,970,000
Increase in marketable securities in trust account and Class A mandatory redeemable common shares	$	801,000		$	—
Transfer of preferred shares to common shares	$	1,000		$	—

The accompanying notes are an integral part of these financial statements.

7

ShiftPixy, Inc.

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Note 1: Nature of Operations

ShiftPixy, Inc. (the “Company”) was incorporated on June 3, 2015, in the State of Wyoming. The Company is a specialized Human Capital service provider that provides solutions for large, contingent, part-time workforce demands, primarily in the restaurant and hospitality service trades. The Company’s historic focus has been on the quick service restaurant industry in Southern California, but the Company has expanded into other geographic areas and industries that employ temporary or part-time labor sources, notably including the healthcare industry.

The Company functions as an employment administrative services (“EAS”) provider primarily through its wholly owned subsidiary, ReThink Human Capital Management, Inc. (“HCM”), as well as a staffing provider through another of its wholly owned subsidiaries, ShiftPixy Staffing, Inc. (“Staffing”). These subsidiaries provide a variety of services to our clients typically as a co-employer through HCM and a direct employer through Staffing, including the following: administrative services, payroll processing, human resources consulting, and workers’ compensation administration and coverage (as permitted and/or required by state law). The Company has built a human resources information systems (“HRIS”) platform to assist in customer acquisition that simplifies the onboarding of new clients into the Company’s closed proprietary operating and processing information system (the “ShiftPixy Ecosystem”). The Company expects this HRIS platform to facilitate additional value-added services in future reporting periods.

In January 2020, the Company sold the assets of Shift Human Capital Management Inc. (“SHCM”), a wholly owned subsidiary of the Company, pursuant to which the Company assigned the majority of the Company’s billable clients at the time of the sale to a third party for cash. The continuing impact of this transaction on the Company’s financial statements is described below in Note 3, Discontinued Operations.

Effective September 1, 2022, the Company filed articles of amendment to the Company’s articles of incorporation to effect a one-for-one hundred (1:100) reverse split of the Company’s issued and outstanding share of common stock. The reverse split became effective on NASDAQ, September 1, 2022. All share related numbers in this Report on Form 10-Q give effect to this reverse split.

Note 2: Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) applicable to interim reports of smaller reporting companies. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results of unaudited condensed operations for the three and nine months end May 31, 2023 are not necessarily indicative of the results that may be expected for the full year ending August 31, 2023.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2022 (“Fiscal 2022”), filed with the SEC on December 13, 2022, as amended by Forms 10-K/A, filed with the SEC on December 14, 2022, February 3, 2023 and February 9, 2023, respectively.

8

Principles of Consolidation

The unaudited condensed consolidated financial statements include the accounts of ShiftPixy, Inc., and its wholly owned subsidiaries. The unaudited condensed consolidated financial statements previously included the accounts of Industrial Human Capital, Inc. (“IHC”), which was a special purpose acquisition company, or “SPAC,” for which our wholly owned subsidiary, ShiftPixy Investments, Inc., served as the financial sponsor (as described below), and which SPAC was deemed to be controlled by us as a result of the Company’s 15% equity ownership stake, the overlap of three of our executive officers for a period of time as executive officers of IHC, and significant influence that the Company exercised over the funding and acquisition of new operations for an initial business combination (“IBC”). (See Note 2, Variable Interest Entity). All intercompany balances have been eliminated in consolidation. As of February 7, 2023, IHC was not a part of the Company’s operations, and consolidation. IHC was dissolved on November 14, 2022, and the Trustee released all the redemption funds from the Trust Account, See Note 4, to IHC shareholders on December 1, 2022, effectively liquidating the Trust. On February 7, 2023, three creditors of IHC filed an involuntary petition for liquidation under Chapter 7 against IHC in the US Bankruptcy Court for the Southern District of Florida. See Note 4, Pursuant to ASC 810-10-15, consolidation is precluded where control does not rest for a non-controlling interest in legal reorganization or bankruptcy. In addition, IHC did not meet the criteria of a Variable Interest Entity (VIE), see Note 4.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include:

· Continuation as a going concern; management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets and liquidation of all liabilities in the normal course of business

· Liability for legal contingencies

· Useful lives of property and equipment

· Deferred income taxes and related valuation allowance

· Projected development of workers’ compensation claims.

These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions are difficult to measure of value.

Management regularly reviews the key factors and assumptions to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such valuation, if deemed appropriate, those estimates are adjusted accordingly.

Liquidity, Capital Resources and Going Concern

Under the existing accounting guidance, management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the condensed consolidated financial statements are issued. This evaluation initially does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented as of the date the unaudited condensed consolidated financial statements are issued. When substantial doubt is determined to exist, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans; however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date the unaudited condensed consolidated financial statements are issued, and (2) it is probable that the plans, when implemented, may mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date the condensed consolidated financial statements are issued. Therefore, management has concluded that there is substantial doubt in the Company’s ability to continue as a going concern for the next twelve months.

9

As of May 31, 2023, the Company had cash of $0.1 million and a working capital deficit of $41.7 million. During the nine months ended May 31, 2023, the Company used approximately $6.7 million of cash from its continuing operations and incurred recurring losses, resulting in an accumulated deficit of $211.4 million. As of May 31, 2023, the Company is delinquent with respect to remitting payroll tax payments to the IRS. The Company has been in communication with the IRS regarding amounts owing in relation to Employee Retention Tax Credits (“ERTCs”) due. In addition, some clients have filed suits against the Company, demanding that the Company take action to file for additional ERTCs for certain tax periods. Until the matter is concluded, and the taxes are paid, the IRS could, subject to its standard processes and the Company’s right to respond, implement collection actions, including such actions as levying against Company bank accounts, to recover the amounts that it calculates to be due and owing.

Historically, the Company’s principal source of financing has come through the sale of the Company's common stock, including in certain instances, warrants and the issuance of convertible notes.

On January 31, 2023, the Company filed a registration statement on Form S-3 and related prospectus for the sale of up to $100 million of the Company’s equity securities via a “shelf” or "at-the-market” (“ATM”) sales mechanism over a three-year period. The registration statement also included a prospectus supplement providing for the sale of up to $8,187,827 of the Company’s shares of common stock, which the Company proposed to effect pursuant to an ATM Issuance Sales Agreement (“Sales Agreement”) executed with A.G.P./Alliance Global Partners (the “Agent” or “AGP”). Under the Sales Agreement, the Company’s shares of common stock could be sold from time to time and at various prices at the Company’s sole control, subject to the conditions and limitations in the Sales Agreement with AGP. The ATM was scheduled to expire on January 31, 2026. For the nine-months ended May 31, 2023, the Company received $2.4 million in gross proceeds ($2.0 million, net of costs) from the sale of 439,429 shares of the Company’s common stock. On May 22, 2023, the Company terminated the Sales Agreement and concluded the ATM. There is a limitation on the amount of funds that the Company can access under the baby shelf rules which is the value of a company’s public float if less than $75 million, The Company can only raise ⅓ of its float value over the previous 12-month period.

On July 12, 2023, the Company priced a “best efforts” public offering for the sale by the Company of an aggregate of 1,166,667 shares of common stock, 900,000 pre-funded warrants, and 2,066,667 common warrants. The public offering price was $1.50 per share and accompanying common warrant, or $1.4999 per pre-funded warrant and accompanying common warrant. The pre-funded warrants are exercisable immediately, may be exercised at any time until all of the pre-funded warrants are exercised in full, and have an exercise price of $0.0001.  The common warrants are exercisable immediately for a term of five years and have an exercise price of $1.50 per share. 1,100,000 shares, 900,000 pre-funded warrants and 2,000,000 common warrants under the offering were sold pursuant to a securities purchase agreement with an investor. A.G.P./Alliance Global Partners acted as placement agent for the offering and received a fee of 7% of the gross proceeds and reimbursement of $75,000 of expenses. The total estimated offering expenses were approximately $0.6millon and the net proceeds of approximately $2.5 million. The offering closed on July 14, 2023. Effective upon closing of the offering, the exercise price of an aggregate of 1,186,742 outstanding warrants the Company issued to an investor in 2020 and 2022 was reduced to $1.50 per share, subject to further adjustment as provided in the warrants, pursuant to a warrant amendment the Company entered into with the investor.

The Company’s plans and expectations for the next twelve months include raising additional capital to help fund expansion of the Company’s operations and strengthening of the Company’s sales force strategy by focusing on staffing services as the key driver to improve the Company’s margin and the continued support and functionality improvement of the Company’s information technology (“IT”) and HRIS platform. This expanded go-to-market strategy will focus on building a national account portfolio managed by a newly-formed regional team of senior sales executives singularly focused on sustained quarterly revenue growth and gross profit margin expansion. The Company expects to continue to invest in the Company’s HRIS platform, ShiftPixy Labs, and other growth initiatives, all of which have required and will continue to require significant cash expenditures.

The Company expects to raise capital from additional sales of its securities during this fiscal year either through registered public offerings or private placements, the proceeds of which the Company intends to use to fund its operations and growth initiatives. There can be no assurance that we will be able to sell securities on terms that the Company is seeking, or at all. Although management believes that its current cash position, along with its anticipated revenue growth and proceeds from future sales of its securities, when combined with prudent expense management, could alleviate substantial doubt, there is no assurance about its ability to continue as a going concern and to fund its operations for at least one year from the date these financials are available (even with the absence of any funded debt outstanding on its balance sheet). If these sources do not provide the capital necessary to fund the Company’s operations during the next twelve months, it may need to curtail certain aspects of its operations or expansion activities, consider the sale of additional assets, or consider other means of financing. The Company can give no assurance that it will be successful in implementing its business plan and obtaining financing on advantageous terms, or that any such additional financing will be available. If the Company is not successful in obtaining the necessary financing, we do not currently have the cash resources to meet our operating commitments for the next twelve months. Therefore, management has concluded that there is substantial doubt in the Company's ability to continue as a going concern for the next twelve months.

10

Reclassification

The Company reclassified certain expenses to conform to the current year's presentation.

Revenue and Direct Cost Recognition

The Company’s revenues are primarily disaggregated into fees for providing staffing solutions and EAS/HCM services. The Company enters into contracts with its clients for Staffing or EAS based on a stated rate and price in the contract. Contracts generally have a term of 12 months, however, are cancellable at any time by either party with 30 days’ written notice. The performance obligations in the agreements are generally combined into one performance obligation, as they are considered a series of distinct services, and are satisfied over time because the client simultaneously receives and consumes the benefits provided as the Company performs the services. Payments for the Company’s services are typically made in advance of, or at the time that the services are provided. The Company does not have significant financing components or significant payment terms for its customers and consequently has no material credit losses. The Company uses the output method based on a stated rate and price over the payroll processed to recognize revenue, as the value to the client of the goods or services transferred to date appropriately depicts the Company’s performance towards complete satisfaction of the performance obligation.

Staffing Solutions

The Company records gross billings as revenues for its staffing solutions clients. The Company is primarily responsible for fulfilling the staffing solutions services and has discretion in establishing price. The Company includes the payroll costs in revenues with a corresponding increase to cost of revenues for payroll costs associated with these services. As a result, we are the principal in this arrangement for revenue recognition purposes.

EAS Solutions / HCM

EAS solutions revenue is primarily derived from the Company’s gross billings, which are based on (i) the payroll cost of the Company’s worksite employees (“WSEs”) and (ii) a mark-up computed as a percentage of payroll costs for payroll taxes and workers’ compensation premiums.

Gross billings are invoiced to each EAS client concurrently with each periodic payroll of the Company’s WSEs, which coincides with the services provided and which is typically a fixed percentage of the payroll processed. Revenues, which exclude the payroll cost component of gross billings and therefore consist solely of markup, are recognized ratably over the payroll period as WSEs perform their services at the client worksite. Although the Company assumes responsibility for processing and remitting payroll and payroll related obligations, it does not assume employment-related responsibilities such as determining the amount of the payroll and related payroll obligations. As a result, the Company records revenue on a “net” basis in this arrangement for revenue recognition purposes. Revenues that have been recognized but not invoice are included in unbilled accounts receivable on the Company’s condensed consolidated balance sheets were $2.0 million and $2.1 million, as of May 31, 2023 and August 31, 2022, respectively.

11

Consistent with the Company’s revenue recognition policy for EAS clients, direct costs do not include the payroll cost of its WSEs. The cost of revenue associated with the Company’s revenue generating activities is primarily comprised of all other costs related to its WSEs, such as the employer portion of payroll-related taxes, employee benefit plan premiums and workers’ compensation insurance costs.

The fees collected from the worksite employers for benefits (i.e. zero-margin benefits pass-through), workers’ compensation and state unemployment taxes are presented in revenues and the associated costs of benefits, workers’ compensation and state unemployment taxes are included in operating expenses for EAS clients, as the Company does retain risk and acts as a principal with respect to this aspect of the arrangement. With respect to these fees, the Company is primarily responsible for fulfilling the service and has discretion in establishing price.

Disaggregation of Revenue

The Company’s primary revenue streams include HCM and staffing services. The Company’s disaggregated revenues for the nine months ended May 31, and May 31, 2022, respectively, were as follows:

	For the Three Months Ended				For the Nine Months Ended
Revenue (in thousands):	May 31, 2023		May 31, 2022		May 31, 2023		May 31, 2022
HCM1	$	111	$	1,734	$	1,521	$	4,052
Staffing		3,877		7,909		12,312		24,969

¹ HCM revenue is presented net, $8.3 million and $30.7 million gross billings less WSE payroll costs of $8.2 million and $29.2 million for the three and nine months ended May 31, 2023, respectively. Gross billings were $13.9 million and $39.4 million less WSE payroll costs of 12.2 million and $35.3 million for the three and nine months ended May 31, 2022, respectively.

For the three and nine months ended May 31, 2023 and May 31, 2022, respectively, the following geographical regions represented more than 10% of total revenues:

	For the Three Months Ended						For the Nine Months Ended
Region:	May 31, 2023			May 31, 2022			May 31, 2023			May 31, 2022
California		33.1	%		49.0	%		42.5	%		52.2	%
Washington		15.5	%		14.9	%		12.8	%		13.7	%
New Mexico		12.9	%		7.6	%		11.9	%		7.4	%

Incremental Cost of Obtaining a Contract

Pursuant to the “practical expedients” provided under Accounting Standards Update “ASC” No 2014-09, the Company expenses sales commissions when incurred because the terms of its contracts are cancellable by either party upon 30 day’' notice. These costs are recorded in commissions in the Company’s unaudited condensed consolidated statements of operations.

12

Segment Reporting

Prior to August 31, 2021, the Company operated as one reportable segment under Accounting Standards Codification “ASC” 280, Segment Reporting. The chief operating decision maker regularly reviews the financial information of the Company at a consolidated level in deciding how to allocate resources and in assessing performance. Reporting and monitoring activities on a segment basis will allow the chief operating decision maker to evaluate operating performance more effectively. However, the Company is working on its systems to properly allocate to its business segments. However, the CEO is actively involved in the day to day business and is aware of the overall segment information.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased as cash equivalents. The Company had no cash equivalent as of May 31, 2023 and August 31, 2022.

Marketable Securities Held in Trust Account

As of August 31, 2022, substantially all of the assets held in the Trust Account were invested in U.S. Treasury securities with maturities of 180 days or less. These funds are restricted for use and may only be used for purposes of completing an initial business combination ("IB") or redemption of the public common shares of IHC. On December 1, 2022, the Company distributed $117.6 million to the shareholders of IHC. There were no assets held in the Trust Account as of May 31, 2023.

Concentration of Credit Risk

The Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal. As of May 31, 2023 and August 31, 2022, there was $0.0 million and $0.6 million, respectively, of cash on deposit in excess of the amounts insured by the FDIC.

The following represents clients who have ten percent of total accounts receivable as of May 31, 2023 and August 31, 2022, respectively.

	As of
	May 31, 2023			August 31, 2022
Clients:	(Unaudited)
Client 1		57.8	%	—		%
Client 2		21.4	%		41.9	%
Client 3		9.6	%		13.7	%
Client 4		6.3	%		21.9	%
Client 5	—		%		20.7	%

Fixed Assets

Fixed assets are recorded at cost, less accumulated depreciation and amortization. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When fixed assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Leasehold improvements are amortized over the shorter of the useful life or the initial lease term.

Fixed assets are recorded at cost and are depreciated over the estimated useful lives of the related assets using the straight-line method. The estimated useful lives of property and equipment for purposes of computing depreciation are as follows:

Equipment:	5 years
Furniture & Fixtures:	5 – 7 years
Leasehold improvements	Shorter of useful life or the remaining lease term, typically 5 years

13

Depreciation and amortization expense for the three months ended May 31, 2023 and May 31, 2022 was $0.1 million and $0.1 million, respectively, and included on the unaudited condensed consolidated statements of operations. Depreciation and amortization expense for the nine months ended May 31, 2023 and May 31, 2022 was $0.4 million and $0.4 million, respectively.

Computer Software Development

Software development costs relate primarily to software coding, systems interfaces and testing of the Company’s proprietary employer information systems and are accounted for in accordance with Accounting Standards Codification “ASC” 350-40, Internal Use Software.

Internal software development costs are capitalized from the time the internal use software is considered probable of completion until the software is ready for use. Business analysis, system evaluation and software maintenance costs are expensed as incurred. The capitalized computer software development costs are reported under the section fixed assets, net in the consolidated balance sheets and are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company determined that there was no material capitalized internal software development costs for the nine months ended May 31, 2023 and August 31, 2022. All capitalized software recorded was purchased from third party vendors. Capitalized software development costs are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company incurred research and development costs of $0.2 million and $0.7 million for the three and nine months ended May 31, 2023, respectively. During the three and nine months ended May 31, 2022, the Company incurred research and development costs of approximately $1.1 million and $5 million, respectively. All costs were related to internally developed or externally contracted software and related technology for the Company’s HRIS platform and related mobile application.

Lease Recognition

The Financial Accounting Standards Board "FASB" established Topic 842, Leases, by issuing ASU No. 2016-02 “ASC” 842, which required lessees to recognize leases on the balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The standard established a right-of-use asset model (“ROU”) that required a lessee to recognize an ROU operating lease asset and lease liability on the condensed balance sheets for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the unaudited condensed consolidated statement of operations.

Impairment and Disposal of Long-Lived Assets

The Company periodically evaluates its long-lived assets for impairment in accordance with ASC 360-10, Property, Plant, and Equipment. ASC 360-10 requires that an impairment loss be recognized for assets to be disposed of or held-for-use when the carrying amount of an asset is deemed not to be recoverable. If events or circumstances were to indicate that any of the Company’s long-lived assets might be impaired, the Company would assess recoverability based on the estimated undiscounted future cash flows to be generated from the applicable asset. In addition, the Company may record an impairment loss to the extent that the carrying value of the asset exceeds the fair value of the asset. Fair value is generally determined using an estimate of discounted future net cash flows from operating activities or upon disposal of the asset. The Company assessed impairment for the periods presented and no impairment charges were deemed necessary.

14

Workers’ Compensation

Everest Program

Until July 2018, a portion of the Company’s workers’ compensation risk was covered by a retrospective rated policy through Everest National Insurance Company, which calculates the final policy premium based on the Company’s loss experience during the term of the policy and the stipulated formula set forth in the policy. The Company funded the policy based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. During the policy term and thereafter, periodic adjustments may involve either a return of previously paid premiums or a payment of additional premiums by the Company or a combination of both. If the Company’s losses under that policy exceed the expected losses under that policy, then the Company could receive a demand for additional premium payments. The Company became engaged in litigation regarding such a demand for additional premium payments; however, the Company has entered into a settlement agreement with Everest and Gallagher Bassett, concluding the litigation. See Note 9, Contingencies, Everest Litigation, below and Note 10 subsequent events. The Company has accrued for this settlement as of May 31, 2023.

Sunz Program

From July 2018 through February 28, 2021, the Company’s workers’ compensation program for its WSEs was provided primarily through an arrangement with United Wisconsin Insurance Company and administered by Sunz Insurance Solutions, LLC (“Sunz”). Under this program, the Company has financial responsibility for the first $0.5 million of claims per occurrence. The Company provides and maintains a loss fund that is earmarked to pay claims and claims related expenses. The workers’ compensation insurance carrier establishes monthly funding requirements comprised of premium costs and funds to be set aside for payment of future claims (“claim loss funds”). The level of claim loss funds is primarily based upon anticipated WSE payroll levels and expected workers’ compensation loss rates, as determined by the insurance carrier. Monies funded into the program for incurred claims expected to be paid within one year were recorded as Deposit - workers’ compensation, a short-term asset, while the remainder of claim funds were included in Deposit - workers’ compensation, a long-term asset in our condensed consolidated balance sheets. The Company is currently engaged in litigation regarding demands by Sunz for additional claims loss funds, which we believe to be without merit, as discussed at Note 9, Contingencies, Sunz Litigation, below.

Under the Everest and Sunz programs, the Company utilized a third party to estimate its loss development rate, which was based primarily upon the nature of WSEs’ job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates.

There were no workers compensation deposits related to these programs as of May 31, 2023, and as of August 31, 2022, respectively.

Current Program

Effective March 1, 2021, the Company migrated its clients to a guaranteed cost program. Under this program, the Company’s financial responsibility is limited to the cost of the workers’ compensation premium. The Company funds the workers’ compensation premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. Any final adjustments to the premiums are based on the final audited exposure multiplied by the applicable rates, classifications, experience modifications and any other associated rating criteria.

With regard to the prior programs, which continue until fully concluded, the Company’s estimate of incurred claim costs expected to be paid within one year is included in short-term liabilities, while its estimate of incurred claim costs expected to be paid beyond one year is included in long-term liabilities on its consolidated balance sheets. As of May 31, 2023 and August 31, 2022, the Company had short term accrued workers’ compensation costs of $0.4 million and $0.6 million, and long-term accrued workers’ compensation costs of $0.9 million and $1.2 million, respectively.

The Company retained workers’ compensation asset reserves and workers’ compensation related liabilities for former WSEs of clients transferred to Shiftable HR Acquisition, LLC, a wholly owned subsidiary of Vensure Employer Services, Inc. (“Vensure”), in connection with the Vensure Asset Sale described in Note 3, Discontinued Operations, below. As of May 31, 2023, the retained workers’ compensation assets and liabilities are presented as a discontinued operation net asset or liability. As of May 31, 2023 and August 31, 2022, the Company had $1.8 million and $1.4 million in short-term liabilities, and $4.1 million and $3.3 million in long-term liabilities, respectively. The Company had no related worker's compensation assets as of May 31, 2023 and as of August 31, 2022, respectively.

15

Because the Company bears the financial responsibility for claims up to the level noted above, such claims, which are the primary component of its workers’ compensation costs, are recorded in the period incurred. Workers’ compensation insurance includes ongoing health care and indemnity coverage whereby claims are paid over numerous years following the date of injury. Accordingly, the accrual of related incurred costs in each reporting period includes estimates, which take into account the ongoing development of claims and therefore require a significant level of judgment. In estimating ultimate loss rates, the Company utilizes historical loss experience, exposure data, and actuarial judgment, together with a range of inputs that are primarily based upon the WSE’s job responsibilities, their location, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. For each reporting period, changes in the actuarial assumptions resulting from changes in actual claims experience and other trends are incorporated into the Company’s workers’ compensation claims cost estimates. The estimated incurred claims are based upon: (i) the level of claims processed during each quarter; (ii) estimated completion rates based upon recent claim development patterns under the plan; and (iii) the number of participants in the plan.

The Company has had very limited and immaterial COVID-19 related claims between March 2020 through the date of this Quarterly Report, although there is a possibility of additional workers’ compensation claims being made by furloughed WSEs as a result of the employment downturn caused by the pandemic. On May 4, 2020, the State of California indicated that workers who become ill with COVID-19 would have a potential claim against workers’ compensation insurance for their illnesses. There is a possibility that additional workers’ compensation claims could be made by employees required to work by their employers during the COVID-19 pandemic, which could have a material impact on the Company's workers’ compensation liability estimates. While the Company has not seen significant additional expenses as a result of any such potential claims to date, which would include claims for reporting periods after May 31, 2023, we continue to monitor closely all workers’ compensation claims made in relation to the COVID-19 pandemic.

Fair Value of Financial Instruments

Accounting Standard Codification "ASC" 820, Fair Value Measurement, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practical to estimate fair value. ASC 820 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of May 31, 2023 and August 31, 2022, the carrying value of certain financial instruments (cash, accounts receivable and payable) approximated fair value due to the short-term nature of the instruments. Notes Receivable is valued at the Company's estimate of expected collections value as described below, See Note 3, Discontinued Operations.

The Company measures fair value under a framework that utilizes a hierarchy prioritizing the inputs to relevant valuation techniques. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used in measuring fair value are:

· Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

· Level 2: Inputs to the valuation methodology include

· Quoted prices for similar assets or liabilities in active markets

· Quoted prices for identical or similar assets or liabilities in inactive markets

· Inputs other than quoted prices that are observable for the asset or liability

· Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and

· If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability

· Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement

16

Funds held in Trust Account represent U.S. treasury bills that was restricted for use and may only be used for purposes of completing an IBC or redemption of the public shares of common stock of the SPACs as set forth in their respective trust agreements. The funds held in trust are included within Level 1 of the fair value hierarchy and included in cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheets. The Trustee distributed all the funds in the Trust Account to the shareholders of IHC on December 1, 2022.

When the Company changes its valuation inputs for measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it could be required to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these transfers at the end of the reporting period that the transfers occur. The development and determination of the unobservable inputs for Level 3 fair value measurements and the fair value calculations are the responsibility of the Company’s chief financial officer and are approved by the chief executive officer. There were no transfers out of Level 3 for the nine months ended May 31, 2023 and August 31, 2022.

Advertising Costs

The Company expenses all advertising as incurred. Advertising expense for the three months ended May 31, 2023 and May 31, 2022 was $0.8 million and $0.4 million, respectively. Advertising expense for the nine months end May 31, 2023 and May 31, 2022 was $2.0 million and $1.4 million, respectively.

Income Taxes

The Company accounts for income taxes pursuant to ASC 740, Income Taxes. Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. A full valuation allowance was recorded as of May 31, 2023 and August 31, 2022, respectively,

Income (Loss) Per Share

Basic net income or net (loss) per common share is computed by dividing net income or net (loss) attributable to common shareholders by the weighted-average number of shares of common stock outstanding during the reporting period. Common stock outstanding for purposes of net income or net (loss) per share calculations include options, warrants, shares of common stock to be issued to directors for services provided and Preferred Option. Diluted net income or and net (loss) per share is computed similar to basic income or net (loss) per share except that the denominator is increased to include additional common stock equivalents available upon exercise of stock options, warrants, shares of common stock to be issued to directors for services provided and Preferred Option using the treasury stock method. Dilutive common stock equivalents include the dilutive effect of in-the-money stock equivalents, which are calculated based on the average share price for each period using the treasury stock method, excluding any common stock equivalents if their effect would be anti-dilutive. In periods in which a net loss has been incurred, all potentially dilutive common stock shares are considered anti-dilutive and thus are excluded from the calculation. Securities that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, are:

	Three Months Ended				Nine Months Ended
	May 31, 2023		May 31, 2022		May 31, 2023		May 31, 2022
Options (See Note 5)		10,003		15,498		10,003		15,498
Warrants (See Note 5)		1,252,749		224,402		1,252,749		224,402
Shares of common stock to be issued to directors for services provided, (See Note 7)		59,040		—		59,040		—
Preferred Option (Note 5)		37,570		—		37,570		—
Total potentially dilutive shares		1,359,362		239,900		1,359,362		239,900

17

For the table above, “Options” represent all options granted under the Company’s 2017 Stock Option/Stock Issuance Plan (the "Plan"), as described in Note 5, Stock Based Compensation, below.

Stock-Based Compensation

The Company has one stock-based compensation plan under which the Company may issue awards, as described in Note 5, Stock Based Compensation, below. The Company accounts for the Plan under the recognition and measurement principles of ASC 718, Compensation-Stock Compensation, which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the unaudited condensed consolidated statements of operations at their fair values.

The grant date fair value is determined using the Black-Scholes-Merton (“Black-Scholes”) pricing model. For all employee stock options, the Company recognizes expense on an accelerated basis over the employee’s requisite service period (generally the vesting period of the equity grant).

The Company’s option pricing model requires the input of highly subjective assumptions, including the expected stock price volatility and expected term. The expected volatility is based on the historical volatility of the Company’s common stock since the Company's initial public offering. Any changes in these highly subjective assumptions significantly impact stock-based compensation expense.

The Company elects to account for forfeitures as they occur. As such, compensation cost previously recognized for an unvested award that is forfeited because of the failure to satisfy a service condition is revised in the period of forfeiture.

The methods and assumptions used in the determination of the fair value of stock-based awards are consistent with those described in the Company's Annual Report on Form 10-K for the year ending August 31, 2022, filed with the SEC on December 13, 2022, and the amendments thereto on Forms 10-K/A filed with the SEC on December 14, 2022, February 3, 2023 and February 9, 2023, respectively, which include a detailed description of the Company's stock-based compensation awards, including information related to vesting terms, service and performance conditions, payout percentages, and process for estimating the fair value of stock options granted.

Recently Adopted Accounting Standards

In June 2016, the Financial Accounting Standards Board "FASB" issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This standard requires an impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces multiple existing impairment models in current. GAAP, which generally requires a loss to be incurred before it is recognized. The new standard applies to trade receivables arising from revenue transactions such as contract assets and accounts receivable. Under ASC 606, revenue is recognized when, among other criteria, it is probable that an entity will collect the consideration it is entitled to when goods or services are transferred to a customer. When trade receivables are recorded, they become subject to the CECL model and estimates of expected credit losses on trade receivables over their contractual life will be required to be recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. For the three months ended May 31, 2023, the Company adopted this guidance, and it was not material to the results of operations.

18

Variable Interest Entity

The Company has been involved in the formation of various entities considered to be Variable Interest Entities (“VIEs”). The Company evaluates the consolidation of these entities as required pursuant to ASC Topic 810 relating to the consolidation of VIEs. These VIEs are SPACs.

The Company’s determination of whether it is the primary beneficiary of a VIE is based in part on an assessment of whether or not the Company and its related parties are exposed to the majority of the risks and rewards of the entity. Typically, the Company is entitled to substantially all or a portion of the economics of these VIEs. The Company is the primary beneficiary of the VIE entities.

Through November 30, 2022, only one of the four SPAC companies existed, See Note 4 Special Purpose Acquisition Company Sponsorship that has more information regarding the remaining SPAC company. There are no SPAC companies as of February 7, 2022.

In connection with the IPO in October 2021, the Company purchased, through its wholly owned subsidiary, ShiftPixy Investments, Inc. ("Investments" or the "Sponsor"), 4,639,102 private placement warrants ("Placement Warrants") at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102, and the Company currently own 2,110,000 Founder Shares of IHC common stock, representing approximately 15% of the issued and outstanding common stock of IHC. Before the closing of the IPO, the Sponsor transferred 15,000 Founder Shares to IHC's independent directors, reducing its shareholdings from 2,125,000 to 2,110,000. Each Placement Warrant was identical to the warrants sold in the IPO, except as described in the IPO registration statement and prospectus. Following the completion of IHC's IPO, the Company determined that IHC was a VIE in which the Company had a variable interest because IHC did not have enough equity at risk to finance its activities without additional subordinated financial support. The Company had also determined that IHC's public stockholders did not have substantive rights, and their equity interest constitutes temporary equity, outside of permanent equity, in accordance with ASC 480-10-S99-3A, at such time. As such, the Company concluded that they were the primary beneficiary of IHC as a VIE, as the Company had the right to receive benefits or the obligation to absorb losses of the entity, as well as the power to direct a majority of the activities that significantly impact IHC's economic performance. Since the Company was the primary beneficiary, IHC to be consolidated into the Company's unaudited condensed consolidated financial through February 7, 2023. See Note 4, for the dissolution of IHC and entire amount from the Trust Account to IHC shareholders on December 1, 2022. As of December, 1, 2021, the Company determined that IHC was not a VIE. The Company did not have the power to direct the operations of IHC since IHC was dissolved on November 14, 2022 and the assets of the Trust Account was distributed to its shareholders on December 1, 2022. The Company lost its voting rights, and there is no possibility of recouping its investment. As a result, the Company determined that IHC will not be consolidated into the unaudited condensed financial statements as of December 1, 2022 See Note 4 regarding three of IHC creditors forcing them into bankruptcy. As a result of the deconsolidation of the VIE on February 7, 2023, the Company recorded the elimination of $9.4 million of the non-controlling interest to additional paid-in capital as it was originally recorded. The net liabilities of IHC were $0.6 million as of February 7, 2023 that resulted in the Company recorded $0.6 million to other income and $0.5 million to non-controlling or, 85% of its non- ownership interest in IHC.

Subject to Possible Redemption

The Company previously accounts for its common stock holdings in its sponsored SPACs (which were consolidated in the Company's unaudited condensed consolidated financial statements) through February 7, 2023, which was previously subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of common stock were classified as a current liability since the shares were redeemed as of August 31, 2022. Each sponsored SPAC's shares of common stock feature certain redemption rights that are considered to be outside of the SPAC's control and subject to occurrence of uncertain future events. However, since the common stock subject to redemption were paid to IHC shareholders on December 1. 2022, the fair market value as of August 31, 2022 was classified as a current liability. The Company has recorded increases or decreases in the carrying amount of the redeemable common stock are affected by charges against additional paid in-capital and accumulated deficit.

19

Note 3: Discontinued Operations

On January 3, 2020, the Company entered into an asset purchase agreement with Shiftable HR Acquisition, LLC, a wholly owned subsidiary of Vensure, pursuant which was the assigned client contracts was significant to its revenues for the three months ended November 30, 2019, including 100% of the Company's existing PEO business. In connection with this transaction, the Company had a Note Receivable to be paid over four years.

For Fiscal 2020, the Company estimated the value of the Note Receivable at fair value as discussed in Note 2, Summary of Significant Accounting Policies, above. The Company recorded the Note Receivable based on the Company's estimate of expected collections which, in turn, was based on additional information obtained through discussions with Vensure and evaluation of the Company's records. On March 12, 2021, the Company received correspondence from Vensure proposing approximately $10.7 million of working capital adjustments under the terms of the Vensure Asset Sale agreement which, if accepted, would have had the effect of eliminating any sums owed to the Company under the Note Receivable. As indicated in the reconciliation table below, the Company has recorded $2.6 million of working capital adjustments, subject to final review and acceptance, and has provided for an additional reserve of $2.9 million for potential claims. By letter dated April 6, 2021, the Company disputed Vensure’s proposed adjustments and maintains that the amount Vensure owes the Company pursuant to the Note Receivable is as much as $9.5 million. The Company assessed the collectability of this note receivable during the reporting of its Fiscal Year End as of August 31, 2022, and determined that it was probable that all contractually required payments will not be collected and recorded a reserve on collectability of approximately $4 million. The disputes between the Company and Vensure regarding working capital adjustments under the Vensure Asset Sale agreement are currently the subject of litigation pending in the Delaware Chancery Court, as discussed at Note 9, Contingencies, Vensure Litigation, below.

The following reconciliation of the gross proceeds to the net proceeds from the Vensure Asset Sale is presented in the condensed consolidated balance sheets as of May 31, 2023 and August 31, 2022.

	As of
	May 31, 2023 (Unaudited)			August 31, 2022
Gross proceeds	$	19,166,000		$	19,166,000
Cash received at closing – asset sale		(9,500,000	)		(9,500,000	)
Cash received at closing – working capital		(166,000	)		(166,000	)
Gross note receivable	$	9,500,000		$	9,500,000
Less:  Transaction reconciliation – estimated working capital adjustments		(2,604,000	)		(2,604,000	)
Adjusted Note Receivable		6,896,000			6,896,000
Reserve for estimated potential claims		(2,892,000	)		(2,892,000	)
Reserve for potential collectability concerns	$	(4,004,000	)	$	(4,004,000	)
Long-term note receivable, estimated net realizable value	$	—		$	—

As of May 31, 2023 and August 31, 2022, as discussed above, the note receivables asset has been impaired to adjust the net realizable value of the long-term note receivable to zero and zero, respectively.

20

The Vensure Asset Sale generated a gain of $15.6 million for during the fiscal year end August 31, 2020. The Company expected a minimal tax impact from the Vensure Asset Sale as it utilized its net operating losses accumulated since inception to offset the gain resulting from discontinued operations tax provision with a corresponding offset to the valuation allowance.

The Vensure Asset Sale met the criteria of discontinued operations set forth in ASC 205 and as such the Company has reclassified its discontinued operations for all periods presented and has excluded the results of its discontinued operations from continuing operations for all periods presented.

The terms of the Vensure Asset Sale call for adjustments to the Note Receivable either for: (i) working capital adjustments or (ii) in the event that the gross wages of the business transferred is less than the required amount.

(i) Working capital adjustments: Through May 31, 2023,, the Company has identified $2.6 million of likely working capital adjustments, including $88,000 related to lower net assets transferred at closing, and $2.5 million of cash remitted to the Company’s bank accounts, net of cash remitted to Vensure’s bank accounts. Under the terms of the Vensure Asset Sale, a reconciliation of the working capital was to have been completed by April 15, 2020. Due to operational difficulties and quarantined staff caused by the outbreak of COVID-19, Vensure requested a postponement of the working capital reconciliation that was due in Fiscal 2020. Although Vensure provided the Company with its working capital reconciliation on March 12, 2021, it failed to provide adequate documentation to support its calculations. Accordingly, the working capital adjustment recorded as of May 31, 2023, represents the Company’s estimate of the reconciliation adjustment by using Vensure’s claims and the limited supporting information Vensure provided as a starting point, and then making adjustments for amounts in dispute based upon the Company's internal records and best estimates. There is no assurance that the working capital change identified as of May 31, 2023 , represents the final working capital adjustment.

(ii) Gross billings adjustment: Under the terms of the Vensure Asset Sale, the proceeds of the transaction are reduced if the actual gross wages of customers transferred for Calendar 2020 are less than 90% of those customers’ Calendar 2019 gross wages. The Company has prepared an estimate of the Calendar 2020 gross wages based on a combination of factors including reports of actual transferred client billings in early Calendar 2020, actual gross wages of continuing customers of the Company, publicly available unemployment reports for the Southern California markets and the relevant COVID-19 impacts on employment levels, and other information. Based on the information available, the Company estimated that it would receive additional consideration below the required threshold and reduced the contingent consideration by $1.4 million. Vensure has not identified any such adjustments to date. Based on the information available, the Company reclassified the previously recorded gross wages claim to a general potential claims reserve for Fiscal 2021. No additional adjustments were made during the three and nine months ended May 31, 2023 and May 31, 2022.

21

The carrying amounts of the classes of assets and liabilities from the Vensure Asset Sale included in discontinued operations are as follows:

	As of
	May 31, 2023			August 31, 2022
	(Unaudited)
Deposits – workers’ compensation		—			—
Total current assets		—			—
Deposits – workers’ compensation		—			—
Total assets	$	—		$	—
Accrued workers’ compensation cost		1,765,000			1,362,000
Total current liabilities		1,765,000			1,362,000
Accrued workers’ compensation cost		4,133,000			3,269,000
Total liabilities		5,898,000			4,631,000
Net liability	$	(5,898,000	)	$	(4,631,000	)

Reported results for the discontinued operations by period were as follows:

	For the Three Months Ended						For the Nine Months Ended
	May 31, 2023			May 31, 2022			May 31, 2023			May 31, 2022
Revenues	$	—		$	—		$	—		$	—
Cost of revenues		460,000			132,000			1,267,000			283,000
Gross profit (loss)		(460,000	)		(132,000	)		(1,267,000	)		(283,000	)
Total operating expenses		—			—			—			—
Loss from discontinued operations	$	(460,000	)	$	(132,000	)	$	(1,267,000	)	$	(283,000	)

Note 4: Special Purpose Acquisition Company ("SPAC") Sponsorship

IHC closed on its IPO effective October 2021, and its net proceeds of $116.7 million, the funds were placed in a trust account (the “Trust Account”), and was invested in U.S. government securities. The Company owned approximately 15% of its issued and outstanding stock. Furthermore, we anticipated that IHC would operate as a separately managed, publicly traded entity following the completion of its IPO. The operations of IHC have been consolidated in the accompanying unaudited condensed financial statements through November 30, 2022.

22

On October 14, 2022, the stockholders of IHC approved the proposed action to file an amended and restated certificate of incorporation to extend the date by which the Company has to consummate a Business Combination from October 22, 2022, to April 22, 2023, or a such earlier date as determined by the board of directors. The Company accordingly filed the Amendment with the Secretary of State of Delaware. In connection with the meeting, however, shareholders holding 11,251,347 Public Shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account, leaving 248,653 of the Company’s remaining Public Shares outstanding and the Trust Account substantially below the $5 million minimum net tangible asset amount required by IHC's Amended and Restated Certificate of Incorporation to be available upon consummation of such Business Combination. IHC's efforts to secure the decisions of some shareholders to reverse their redemptions were unsuccessful, and IHC accordingly declined to fund the extension, cancelled the Amendment as filed with the Secretary of State of Delaware, and proceeded to cease operations, dissolve and unwind. The board of directors of IHC accordingly adopted resolutions to liquidate, dissolve and unwind the entity. IHC was dissolved on November 14, 2022, and the Trustee released all the redemption funds from the Trust Account to IHC shareholders on December 1, 2022, effectively liquidating the Trust. The Class A common shares subject to redemption were, however, classified as a current liability as of August 31, 2022 and through November 30, 2022. In view of the actions taken in November and December of 2022, the Company has concluded that as of February 7, 2023, the operations of IHC shall not be included in the Company's consolidation as IHC did not meet the criteria of a VIE. A net liability of $0.6 million was recorded to other income, and $0.5 million was recorded for the non-controlling interest, applicable to the 85% interest that the Company did not own of IHC.

On February 7, 2023, three creditors of IHC filed an involuntary petition for liquidation under Chapter 7 against IHC in the US Bankruptcy Court for the Southern District of Florida. The matter is proceeding, and the Company and its subsidiary, ShiftPixy Investments, Inc., are listed as two significant creditors of IHC. However, there can be no assurance that either the Company or ShiftPixy Investments, Inc. will recover any of the amounts owed to them by IHC from the bankruptcy estate.

Note 5: Stockholders’ Deficit

Preferred Stock

In September 2016, the founding shareholders of the Company were granted options to acquire preferred stock of the Company (the “Preferred Options”). The number of Preferred Options granted was based upon the number of shares held at the time of the grant. These Preferred Options are nontransferable and forfeited upon the sale of the related founding shares of common stock held by the option holder. Upon the occurrence of certain specified events, such founding shareholders can exercise each Preferred Option to purchase one share of preferred stock of the Company at an exercise price of $0.0001 per share. The preferred stock underlying the Preferred Options does not include any rights to dividends or preference upon liquidation of the Company and is convertible into shares of the Company’s common stock on a one-for-one basis. Upon consummation of the Vensure Asset Sale in January 2020, a total of 24,634,560 Preferred Options became exercisable and exchangeable into an equal number of shares of the Company's common stock.

On June 4, 2020, Scott W. Absher, the Company’s Chief Executive Officer, exercised 12,500,000 Preferred Options to purchase 12,500,000 shares of the Company's preferred stock for an aggregate purchase price of $1,250 per share, Immediately following the exercise of the Preferred Options, Mr. Absher elected to convert the 12,500,000 shares of preferred stock into 12,500,000 shares of common stock, which were subject to a 24-month lock-up period during which such shares could not be traded. Between July 20, 2020 and November 30, 2020, an additional 294,490 Preferred Options were exercised and converted into 294,490 shares of common stock, which are freely tradable.

On October 22, 2021, the Company’s board of directors canceled 11,790,000 Preferred Options previously issued to its co-founder, J. Stephen Holmes. As noted in Note 9, Contingencies, the trustee of the bankruptcy estate of Mr. Holmes is now asserting rights to these preferred options. Were the trustee to be successful in its claim, the Company would be obligated to issue up to 12,500,000 restricted shares of the Company's common stock to the trustee, which issuance would materially dilute the share ownership of the existing shareholders and could cause a material decline in the price per share of the Company's common stock. A total of 37,570 Preferred Options, in excess of the options claimed by the trustee of the bankruptcy estate of Mr. Holmes and issued pursuant to the September 2016 grant and triggered by the Vensure Asset Sale remain unexercised. The Preferred Options expire on December 31, 2023.

23

The number of Preferred Options, and the number of shares of preferred stock issuable upon exercise of such options, is based upon the number of shares of common stock held by the option holders at the time the Preferred Options were issued in September 2016. Accordingly, in order to confirm the original intent of the granting of up to 25,000,000 Preferred Options to Mr. Absher, it has always been the Company’s intent to adopt a second grant of an additional 12,500,000 Preferred Options to Mr. Absher, whereby each option permits the holder to acquire one share of the Company’s preferred stock for $0.0001 per share. On August 13, 2021, consistent with this intent, the Company granted 12,500,000 Preferred Options to Mr. Absher to purchase shares of Preferred Stock, par value $0.0001 for consideration of $0.0001 per share. Each Preferred Option is exercisable for a period of twenty-four months upon (i) the acquisition of a Controlling Interest (as defined below) in the Company by any single shareholder or group of shareholders acting in concert (other than Mr. Absher), or (ii) the announcement of (x) any proposed merger, consolidation, or business combination in which the Company’s Common Stock is changed or exchanged, or (y) any sale or distribution of at least 50% of the Company’s assets or earning power, other than through a reincorporation. Each share of Preferred Stock is convertible into Common Stock on a one-for-one basis. “Controlling Interest” means the ownership or control of outstanding voting shares of the Company sufficient to enable the acquiring person, directly or indirectly and individually or in concert with others, to exercise one-fifth or more of all the voting power of the Company in the election of directors or any other business matter on which shareholders have the right to vote under the Wyoming Business Corporation Act.

On July 14, 2022, the Board of the Company approved the issuance to the Company’s founder and principal shareholder, Scott Absher, of 12,500,000 shares of the Company’s Preferred Class A Stock ("Preferred Shares"), par value $0.0001 per share, in exchange for (a) the surrender by Mr. Absher of his options to acquire 12,500,000 Preferred Shares, which Preferred Options provide for exercise upon certain triggering events as described above, and as detailed in the Company's prior filings, and (b) the tender of payment by Mr. Absher of the sum of $5,000, representing four times the par value for such Preferred Shares. The Company evaluated the Preferred Shares on the same date using Level 2 inputs based on the closing market price of the Company’s common stock. The resulting allocated common share price was then discounted for a lack of marketability of shares, which yielded a fair value of $0.2322 per preferred share. The Company used the following assumptions to value the expense related to the Preferred Shares: (i) life of 10 years; (ii) risk free rate of 3.1%; (iii) volatility of 125.7%; (iv) exercise price of $0.0001 per share; and (v) a fair value of $0.3 per share of the Company’s common stock. These were recorded as compensation expense in the general and administrative expenses during the fiscal year August 31, 2022.

On August 12, 2022, the Company entered into an agreement with Mr. Absher whereby he waived claims to certain unpaid compensation due to him through July 31, 2022, totaling $0.82 million, in exchange for an option to receive 4,100,000 shares of the Company's Preferred Class A Stock. The Company evaluated the Preferred Shares on the same date using Level 2 inputs based on the closing market price of the Company’s common stock. The resulting allocated common share price was then discounted for a lack of marketability of shares, which yielded a fair value of $0.2025 per Preferred Share. The Company used the following assumptions to value the expense related to the Preferred Shares: (i) life of 10 years; (ii) risk free rate of 3.0%; (iii) volatility of 125.7%; (iv) exercise price of $0.0001 per share; and (v) a fair value of $0.23 per share of the Company’s common stock. Pursuant to Rule 144, these 4,100,000, when converted into shares of common stock, are subject to a six-month holding period during which they may not be sold in the marketplace. All of the 8,600,000 preferred shares were converted into common stock on September 1, 2022, after the Company's reverse stock split had taken effect. As of November 30, 2022, there were no preferred shares options or preferred shares outstanding. As a result of this transaction, the Company recorded a preferential dividend of $127.1 million based upon the incremental value of the stock that was held prior to the reverse stock split and the date of preferred stock conversion to common stock. In addition, this had no effect on stockholders' deficit.

Prior to the shareholder vote to approve the reverse stock split, the Company on August 2, 2022, amended its Articles of Incorporation to state that only the common stock is affected if the reverse stock split is effectuated with no intention to affect the preferred stock of the company. The reverse stock split was subsequently approved by the shareholders, and effectively the terms and conditions of the preferred stock were “deemed modified” and treated as an extinguishment (in accordance with ASC 470-50 and ASC 260-10-S99-2 for the disproportionate value received (the carrying value compared to the fair value received).

On September 1, 2022, Mr. Absher converted 8,600,000 Preferred Shares to 8,600,000 shares of the Company’s common stock. Pursuant to Rule 144, these 8,600,000 shares of common stock are subject to a six-month holding period during which they may not be sold in the marketplace. All of the 8,600,000 preferred shares were converted into common shares on September 1, 2022, after the Company's reverse stock split had taken effect. Accordingly, no preferred shares are issued and outstanding as of May 31, 2023. As noted in Note 9 Contingencies, however, the trustee of the bankruptcy estate of Mr. Holmes is now asserting rights to preferred options and has attempted to convert preferred options into shares of preferred stock.

24

Common Stock and Warrants

As reported in our 8-K filed on September 23, 2022, on September 20, 2022, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a large institutional investor (the “Purchaser”) pursuant to which the Company sold to the Purchaser an aggregate of 416,667 shares (the “Shares”) of its common stock together with warrants (the “Warrants”) to purchase up to 833,334 shares of common stock (collectively, the “Offering”). Each share of common stock and two accompanying Warrants were sold together at a combined offering price of $12.00. The Warrants are exercisable for a period of seven years commencing upon issuance at an exercise price of $12.00, subject to adjustment. The private placement closed on September 23, 2022. The net proceeds to the Company from the Offering were $4,378,000.

In connection with the Purchase Agreement, the Company and the Purchaser entered into Amendment No. 1 to Warrants (the “Warrant Amendment”). Pursuant to the Warrant Amendment, the exercise price of (i) 25,233 warrants issued on September 3, 2021, and (ii) 98,969 warrants issued on January 28, 2022, was reduced to $0.01. As a result of the change in exercise price, the Company recorded an expense of $106,000. The incremental change in the fair market values was based upon the Black- Scholes option pricing model with the following inputs. The risk free interest of 3.7%, expected volatility of 149.4%, dividend yield of 0% and expected term of 6.7 to 6.8 years.

A.G.P./Alliance Global Partners (the “Placement Agent” or "AGP") acted as the exclusive placement agent in connection with the Offering pursuant to the terms of a Placement Agent Agreement, dated September 20, 2022, between the Company and the Placement Agent (the “Placement Agent Agreement”). Pursuant to the Placement Agent Agreement, the Company paid the Placement Agent a fee equal to 7.0% of the aggregate gross proceeds from the Offering. In addition to the cash fee, the Company issued to the Placement Agent warrants to purchase up to 20,833 shares of common stock (5% of the number of shares sold in the Offering (the “Placement Agent Warrants”). The Placement Agent Warrants are exercisable for a period commencing six months from issuance, will expire four years from the effectiveness of a registration statement for the resale of the underlying shares, and have an initial exercise price of $13.20 per share.

On January 31, 2023, the Company filed a S-3 registration statement on Form S-3 for $100 million for the sale of up to $100 million of equity securities over a three year period. The SEC declared the S-3 effective on February 2, 2023. There is a limitation on the amount of funds that the Company can access under the baby shelf rules which is the value of a company’s public float if less than $75 million, The Company can only raise ⅓ of its float value over the previous 12-month period.

On January 31, 2023, the Company entered into an ATM Issuance Sales Agreement which was a part of the registration statement on Form S-3 and prospectus supplement. The at the market offering was for up to $8.2 million in shares of its common stock, could be sold from time to time and at various prices at the Company’s sole control, subject to the conditions and limitations in the sales agreement with AGP. For the three and nine months ended May 31, 2023, the Company received net proceeds of $0.5 million and $2.0 million from the sale of 133,988 and 439,328 shares of the Company’s common stock, respectivily. On May 22, 2023, the Company terminated the ATM.

On May 17, 2021, the Company issued warrants to purchase up to an aggregate of 49,484 shares of our common stock, with an exercise price of $242.50 (the "Existing Warrants"). The Existing Warrants were immediately exercisable and expire on June 15, 2026. On January 26, 2022, we entered into a Warrant Exercise Agreement ("the Exercise Agreement") with the holder of the Existing Warrants (the "Exercising Holder"). Pursuant to the Exercise Agreement, the Exercising Holder and the Company agreed that, subject to any applicable beneficial ownership limitations, the Exercising Holder would cash exercise up to 49,484 of its Existing Warrants (the "Investor Warrants") into shares of our common stock underlying such Existing Warrants (the "Exercised Shares"). To induce the Exercising Holder to exercise the Investor Warrants, the Exercise Agreement (i) amended the Investor Warrants to reduce their exercise price per share to $120.00 and (ii) provided for the issuance of a new warrant to purchase up to approximately 98,969 shares of our common stock (the “January 2022 Common Warrant”), with such January 2022 Common Warrant being issued on the basis of two January 2022 Common Warrant shares for each share of the Existing Warrant that was exercised for cash. The January 2022 Common Warrant is exercisable commencing on July 28, 2022, terminates on July 28, 2027, and has an exercise price per share of $155.00. The Exercise Agreement generated aggregate proceeds to the Company of approximately $5.9 million, prior to the deduction of $0.5 million of costs consisting of placement agent commissions and offering expenses payable by the Company. As a result of the warrant modification, which reduced the exercise price of the Existing Warrants, as well as the issuance of the January 2022 Common Warrants, the Company recorded approximately (i) $0.64 million for the increased fair value of the modified warrants; and (ii) $12.6 million as the fair value of the January 2022 Common Warrants on the date of issuance. We recorded approximately $5.5 million as issuance costs that offset the $5.5 million of additional paid-in capital the received for the cash exercise of the existing Warrants at the reduced exercise price, while the remaining $7.7 million was recorded as a deemed dividend on the unaudited condensed consolidated statements of operations, resulting in a reduction of income available to common shareholders in our basic earnings per share calculation.

25

During the three months ended May 31, 2022, certain prefunded warrant holders exercised their right to purchase 4,673,321 shares of the Company’s Common Stock at an exercise price of $0.0001 totaling $467, all of which was received by the Company in May 2022.

The following table summarizes the changes in the Company’s common stock and prefunded warrants for the period ended May 31, 2023.

	Number of shares			Weighted average remaining life (years)		Weighted average exercise price
Warrants outstanding, August 31, 2022		522,786			7.2		47.99
Issued		854,166			6.3		12.02
Exercised		(124,203	)		—		—
Warrants outstanding and exercisable, May 31, 2023		1,252,749			6.4	$	35.68

The following table summarizes the Company’s warrants outstanding as of May 31, 2023:

	Warrants Outstanding		Weighted Average Life of Outstanding Warrants (In years)		Exercise price
September 2022 Common Warrants (Note 10)		833,334		6.3	$	12.00
September 2022 Underwriter Warrants		20,833		3.9		13.20
July 2022 Common Warrants (Note 10)		348,408		7.1		26.00
Sep 2021Underwriter Warrants		3,762		5.9		175.00
May 2021Underwriter Warrants		2,474		3.0		243.00
October 2020 Common Warrants (1)		23,000		2.4		330.00
October 2020 Underwriter Warrants		2,000		2.4		330.00
May 2020 Common Warrants		12,776		2.0		540.00
May 2020 Underwriter Warrants		1,111		2.0		540.00
March 2020 Exchange Warrants		4,237		2.3		1,017.00
Amended March 2019 Warrants		663		0.8		4,000.00
March 2019 Services Warrants		34		0.8		7,000.00
June 2018 Warrants		63		0.5		9,960.00
June 2018 Services Warrants		54		0.5		9,960.00
		1,252,749		6.4	$	35.68

(1)     See Note 10 Subsequent Events as 5,000 of the 23,000 warrants had change in the exercise price to $1.50 per share.

26

Note 6: Stock Based Compensation

Employee Stock Option Plan Increase

In March 2017, the Company adopted its 2017 Stock Option/Stock Issuance Plan (the “Plan”). The Plan provides incentives to eligible employees, officers, directors and consultants in the form of incentive stock options (“ISOs”), non-qualified stock options (“NQs”) (each of which is exercisable into shares of common stock) (collectively, “Options”), or shares of common stock (“Share Grants”). On March 31, 2021, the Shareholders approved an increase in the number of shares of common stock issuable under the Plan from 2,500 to 30,000. On March 6, 2023, the shareholders approved an increase in the number of shares of common stock issuable under the Plan from 30,000 to 750,000. As of May 31, 2023, there are 749,997 shares available under the Plan.

For all options to purchase common stock granted prior to July 1, 2020, each option has a term of service vesting provision over a period of time as follows: 25% vest after a 12-month service period following the award, with the balance vesting in equal monthly installments over the succeeding 36 months. Options granted on or after July 1, 2020 typically vest over four years, with 25% of the grant vesting one year from the grant date, and the remainder in equal quarterly installments over the succeeding 12 quarters. All options granted to purchase common stock have a ten year term.

Stock grants are issued at fair value, considered to be the market price on the grant date. The fair value of option awards is estimated on the grant date using the Black-Scholes stock option pricing model.

Following its adoption of ASU 2016-9, the Company elected to account for forfeitures under the Plan as they occur. Any compensation cost previously recognized for an unvested award that is forfeited because of a failure to satisfy a service condition is reversed in the period of the forfeiture.

Stock-based compensation expense was $0.2 million and $0.7 million for the three and nine months ended May 31, 2023, respectively. Stock-based compensation was approximately $0.3 million and $1.1 million of compensation expense for the three and nine months ended May 31, 2022, respectively.

The following table summarizes option activity for the nine months ended May 31, 2023.

	Options Outstanding and Exercisable
	Number of Options			Weighted Average Remaining Contractual Life		Weighted Average Exercise Price
				(In years)
Balance outstanding as of August 31, 2022		11,753			8.1	$	733.00
Forfeited		(1,750	)		8.3		2.70
Balance outstanding expected to be exercisable as of May 31, 2023		10,003			7.2	$	813.70

27

As of May 31, 2023, the total unrecognized deferred share-based compensation expected to be recognized over the remaining weighted average vesting periods of 1.5 years for outstanding grants was $918,000. There was no intrinsic value for outstanding as of May 31, 2023.

The following table summarizes the vested options for the nine months ended May 31, 2023.

Options Vested	Number of Options			Weighted Remaining Contractual Life		Weighted Average Exercise Price
				(In years)
Balance, August 31, 2022		5,269			8.1	$	1,146
Vested		2,290			7.7		442
Forfeited		(716	)		8.1		293
Balance, May 31, 2023	6,843				7.4	$	998

The following table summarizes information of all stock options outstanding as of May 31, 2023:

	Options Outstanding						Options Vested
Exercise Prices	Number of Options Exercisable		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number of Options		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price
			(In Years)						(In Years)
$50.00 - 1,000.00		9,641		7.6	$	453	6,483			7.1	$	466
$1,001.00 - $4,000.00		20		6.3		1,895		19		6.0		1,896
$4,001.00 - $8,000.00		121		6.1		5,121		120		5.1		5,120
$8,001.00 - $12,000.00		101		5.2		10,298		101		4.1		10,298
$12,001.00 - $16,000.00		109		4.4		15,584		109		4.0		15,584
$16,001.00 - $39,160.00		11		4.4		39,160		11		4.0		39,160
		10,003		7.6	$	814	6,843			7.4	$	998

Note 7: Related Parties and Certain Directors and Officers

Director Compensation

Scott Absher

On October 22, 2021, our Board approved raising Mr. Absher’s annual salary to $1M, effective January 1, 2022, and also approved the payment of a $0.5 million bonus to Mr. Absher, 50% of which was payable upon Board approval, and the remainder of which was payable on January 1, 2022. As of August 31, 2022, Mr. Absher received payment of 50% of his bonus, or $0.3 million, in March 2022. Furthermore, as discussed in Note 5, Stockholders' Deficit on August 12, 2022, the Company entered into an agreement with Mr. Absher whereby he waived claims to certain unpaid compensation due to him through July 31, 2022, totaling $0.8 million, in exchange for an option to receive $4.1 million Company Preferred Shares. The agreement settled, the deferred payment of his incremental base salary, his outstanding personal time off or PTO as of July 31, 2022, and the remaining 50% of his approved bonus. As of January 1, 2023, Mr. Absher's salary was adjusted back to the level applicable prior to the time of the adjustment effective January 1, 2022. Mr. Absher salary for the three months and nine months ended May 31, 2023 was $0.2 million and $0.6 million, respectively. Mr. Absher salary for the three months and nine months ended May 31, 2022 was $0.4 million and $0.8 million, respectively. Accrued salary as of May 31, 2023 and August 31, 2022 was $0.3 million and $0.8 million, respectively.

28

Amanda Murphy

On February 10, 2020, Amanda Murphy was appointed to our Board. Ms. Murphy was our Director of Operations at the time of her appointment. Ms. Murphy received salary compensation of $0.3 million for Fiscal 2022, respectively. On October 22, 2021, our Board approved the promotion of Ms. Murphy to the position of Chief Operating Officer, as well as an increase in her annual salary to $0.5 million, all of which were effective January 1, 2022. As of August 31, 2022, Ms. Murphy has deferred payment related to her salary increase of approximately $0.2 million. The deferred payment salary is recorded in the accrued liabilities on the condensed consolidated balance sheets. As of January 1, 2023, Ms. Murphy's salary was adjusted back to the level applicable prior to the time of the adjustment effective January 1, 2022. Ms. Murphy salary for the three months and nine months ended May 31, 2023 was $66,000 and $0.5 million, respectively. MS Murphy salary for the three months and nine months ended May 31, 2022 was $66,000 and $0.2 million, respectively. Accrued salary as of May 31, 2023 was $0.3 million.

J. Stephen Holmes

J. Stephen Holmes formerly served as a non-employee sales manager, advisor to and significant shareholder of the Company. The Company incurred $0.8 million in professional fees for services provided by Mr. Holmes during Fiscal 2021. On October 22, 2021, the Company severed all ties with Mr. Holmes, effective immediately, and cancelled Preferred Options that had previously been issued to him but had not been exercised. As a result of these actions, the Company no longer has any financial obligation to Mr. Holmes, and believes that he is no longer a significant shareholder of the Company, see Note 5, Stockholders’ Deficit and Note 9, Contingencies.

Related Persons to Scott Absher

Mark Absher, the brother of Scott Absher, was hired by the Company as Deputy General Counsel – Special Projects, for an annual salary of $0.2 million. Mr. Absher's compensation for the three and nine month period ending May 31, 2023, was $60,000 and $0.2 million, respectively. His compensation for the three and nine month period ending May 31, 2022, was $60,000 and $0.1 million, respectively.

David May, a member of our business development team, is the son-in-law of Mr. Absher. Mr. May's compensation for the three month and nine month period ending May 31, 2023, was $38,000 and $0.1 million, respectively. His compensation for the three and nine month period ending May 31, 2022, was $43,000 and $0.1 million, respectively.

Phil Eastvold, the Executive Producer of ShiftPixy Productions, Inc., is the son-in-law of Mr. Absher. Mr. Eastvold received compensation of approximately $56,000 and $0.2 million for the three and nine months ended May 31, 2023, respectively. His compensation remained the same for the three and nine month period ending May 31, 2022.

Jason Absher, a member of the Company's business development team, is the nephew of Scott Absher and the son of Mark Absher. Mr. Absher's compensation for the three month period and nine month period ending May 31, 2023, was $30,000 and $90,000 respectively, His compensation for the three month period and nine month period ending May 31, 2022 remained the same.

Connie Absher, (the spouse of Scott Absher), Elizabeth Eastvold, (the daughter of Scott and Connie Absher and spouse of Mr. Eastvold), and Hannah Woods, (the daughter of Scott and Connie Absher), are also employed by the Company. These individuals, as a group, received compensation for the three and nine month period ending May 31, 2023, of $56,000 and $0.2 million, respectively. Compensation as a group for these individuals for the three month period and nine month period ending May 31, 2022 was $53,000 and $0.2 million, respectively.

29

The Company has accrued stock-based compensation related to shares of common stock to be issued for services provided by three directors. Stock-based compensation expense for the three months ended May 31, 2023 and May 31, 2022 was $0.2 million and $0.3 million, respectively. Stock-based compensation expense for the nine months ended May 31, 2023 and 2022 was $0.7 million and $1.1 million, respectively. The Company has agreements with three directors to receive shares of common stock was valued at $0.1 million per year. No shares of common stock have been issued as of August 31, 2022 and May 31, 2023, respectively. As of May 31, 2023, there are 59,040 shares of common stock to be issued to directors.

As of May 31, 2023 and August 30, 2022, the Company has accrued $0.7 million and $0.6 million, respectively for stock-compensation related to shares to be issued for services to certain directors.

Note 8: Commitments

Operating Leases & License Agreements

Effective August 13, 2020, the Company entered into a non-cancelable seven-year lease for office space located in Miami, Florida, to house its principal executive offices commencing October 2020, and continuing through September 2027. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. The monthly rent expense under this lease is approximately $57,000. The Company has not made payments under the lease agreement since June 2022, see Note 9 Contingencies related to the legal case with the litigation with the landlord, Courvoisier Centre.

On October 1, 2020, the Company entered into a non-cancelable 64-month lease for industrial space located in Miami, Florida, to house ghost kitchens, production facilities, and certain marketing and technical functions, including those associated with ShiftPixy Labs. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. The monthly rent expense under this lease is approximately $35,000.

On June 7, 2021, the Company entered into a non-cancelable sublease agreement with Verifone, Inc. to sublease premises consisting of approximately 8,000 square feet of office space located in Miami, Florida, that the Company anticipates using for its sales and operations workforce. The lease has a term of three years expiring on May 31, 2024. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the sublease. Monthly rent expense under this lease is approximately $27,000.

On June 21, 2021, the Company entered into a non-cancelable 77-month lease for premises for office space located in Sunrise, Florida, that the Company anticipates using primarily to house its operations personnel and other elements of its workforce. The Company lease had possession date of August 1, 2022. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the lease. Monthly rent expense under this lease is approximately $27,000.

On May 2, 2022, the Company entered into a non-cancelable 60-month operating lease, as constituted in an amendment to a prior lease, commencing on July 1, 2022, for office space in Irvine, California, which the Company anticipates using primarily for its IT, operations personnel, and other elements of its workforce. The base rent is paid monthly and escalates annually according to a schedule outlined in the lease. The monthly rent expense under this lease is approximately $24,000. As an incentive, the landlord provided a rent abatement of 50% of the monthly rent for the first four months, with a right of recapture in the event of default.

On August 31, 2022, the Company decided to formally abandon the leases for its offices in the Courvoisier Center, including a sublease on the second floor with Verifone. The determination was based on its inability to utilize the premises as they were under extensive construction renovation by the landlord, resulting in a significant negative impact on the Company’s ability to conduct business and the health and well-being of the Company’s employees and guests. The Company formally notified the landlord of its intention to vacate the premises and has not been legally released from the Company's primary obligations under the leases. The Company received a formal complaint from the landlord, and the matter is in litigation. The Company intends to vigorously defend the lawsuit and counterclaim for relocation costs, see Note 9, Contingencies. As a result of the abandonment, the Company evaluated the ROU assets for impairment as of August 31, 2022, and recorded an impairment charge of $3.9 million, within the impairment loss line item for the year ended. Furthermore, the Company released the corresponding lease liability and evaluated the need for a loss contingency in accordance with ASC 450, recording a contingent liability of $3.8 million, included within accrued expenses of the consolidated balance sheets as of May 31, 2023 and August 31, 2022, respectively.

30

The components of lease expense are as follows:

	Three Months  Ended May 31, 2023		Nine Months Ended May 31,  2023
Operating Lease Cost	$	260,000	$	824,000

Future minimum lease and licensing payments under non-cancelable operating leases as of May 31, 2023, are as follows:

	Minimum lease commitments
2024	$	1,047,000
2025		1,081,000
2026		928,000
2027		694,000
2028		403,000
Thereafter		225,000
Total minimum payments		4,378,000
Less: present value discount		508,000
Lease liability		3,870,000
Weighted-average remaining lease term - operating leases (months)		49
Weighted-average discount rate		5.54	%

The current portion of the operating lease liability is included within our accounts payable and other accrued liabilities in our condensed consolidated balance sheets.

Special Purpose Acquisition Company Sponsorship

On April 29, 2021, the Company announced its sponsorship, through a wholly owned subsidiary, of four SPAC IPOs. The Company purchased founder shares in each SPAC (the "Founder Shares"), through its wholly owned subsidiary, for an aggregate purchase price of $25,000 per SPAC. The number of Founder Shares issued was determined based on the expectation that such Founder Shares would represent 15% of the outstanding shares of each SPAC after its IPO (excluding the private placement warrants described below and their underlying securities).

The registration statement and prospectus covering the IPO of IHC, was declared effective by the SEC on October 19, 2021, and IHC units (the “IHC Units”), consisting of one share of common stock and an accompanying warrant to purchase one share of IHC common stock, began trading on the NYSE on October 20, 2021. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million. In connection with the IHC IPO, the Company purchased, through its wholly owned subsidiary, 4,639,102 placement warrants at a price of $1.00 per warrant, for an aggregate purchase price of $4.6 million. Each private placement warrant was exercisable to purchase one whole share of common stock in IHC at $11.50 per share. Inasmuch as IHC was dissolved on November 14, 2022, and the Trust released all the redemption funds to shareholders on December 1, 2022, effectively liquidating the Trust Account, (See Note 4: Special Purpose Acquisition Company ("SPAC") Sponsorship), the private placement warrants have been deemed worthless.

The investment amounts set forth above do not include loans that the Company's subsidiary, ShiftPixy Investments, Inc., has extended to IHC in an amount not to exceed $0.5 million, in its role as sponsor. Nor do they include sums advanced by the Company to IHC to enable it to conduct its activities. As of May 31, 2023, the Company had advanced, through its wholly owned subsidiary, an aggregate of approximately $0.9 million to the SPACs for payment of various expenses in connection with the SPAC IPOs, principally consisting of SEC registration, legal and auditing fees. The Company previously disclosed that it anticipates that the SPAC will repay these advanced expenses from when its IBC is completed. As of May 31, 2023, the Company had an outstanding balance of $0.7 million from advances, which are considered uncollectible with the dissolution of IHC.

31

Note 9: Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will be resolved only when one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

During the ordinary course of business, the Company is subject to various claims and litigation. Management believes that after consulting legal counsel the outcome of such claims or litigation will not have a material adverse effect on the Company’s financial position, results of operations or cash flow. Some of the matters are detailed below.

Splond Litigation

On April 8, 2019, claimant, Corey Splond, filed a class action lawsuit, on behalf of himself and other similarly situated individuals in the Eighth Judicial District Court for the State of Nevada, Clark County, naming the Company and its client as defendants, and alleging violations of certain wage and hour laws. The Company denies any liability. Discovery is proceeding in the case, and no trial date has been set. Even if the plaintiff ultimately prevails, the potential damages recoverable will depend substantially upon whether the Court determines in the future that this lawsuit may appropriately be maintained as a class action. Further, in the event that the Court ultimately enters a judgment in favor of the plaintiff, the Company believes that it would be contractually entitled to be indemnified by its client against at least a portion of any damage award.

Everest Litigation

On December 18, 2020, the Company was served with a Complaint filed in the United States District Court for the Central District of California by its former workers’ compensation insurance carrier, Everest National Insurance Company. The Complaint asserts claims for breach of contract, alleging that the Company owes certain premium payments to plaintiff under a retrospective rated policy, and seeks damages of approximately $0.6 million, which demand has since increased to approximately $1.6 million. On February 5, 2021, the Company filed an Answer to Plaintiff’s Complaint denying its claims for relief, and also filed a cross-claim against the third party claims administrator, Gallagher Bassett Services, Inc., for claims sounding in breach of contract and negligence based upon its administration of claims arising under the policy. By order dated April 7, 2021, the Court dismissed the Company’s complaint against Gallagher Bassett without prejudice to re-filing in another forum. On May 17, 2021, the Company refiled its complaint against Gallagher Basset in the Circuit Court of Cook County, Illinois. Everest subsequently filed a complaint against Gallagher Bassett in New Jersey. Discovery proceeded in the cases, and the California Court set a trial date in the Everest case of August 8, 2023, while no trial date has been set in either of the related Illinois or New Jersey cases, which are in preliminary stages. Mediation in the matter was conducted on December 14, 2022, and the matter was kept open until further notice as the parties endeavored to settle the case. As noted below in Note 10: Subsequent Events, on or about June 28, 2023, the Company entered into a confidential settlement agreement with Everest National Insurance Company and Gallagher Bassett, resolving the litigation amongst the parties. The Company accrued for the settlement as of May 31, 2023.

Sunz Litigation

On March 19, 2021, the Company was served with a Complaint filed in the Circuit Court for the 11th Judicial Circuit, Manatee County, Florida, by its former workers’ compensation insurance carrier, Sunz Insurance Solutions, LLC. The Complaint asserts claims for breach of contract, alleging that the Company owes payments for loss reserve funds totaling approximately $10 million, which represents approximately 200% of the amount of incurred and unpaid claims. The Company denies plaintiff’s allegations and is defending the lawsuit vigorously. On May 12, 2021, the Company filed a motion to dismiss the complaint, and Sunz filed an amended complaint in response. Discovery is proceeding in the matter and no trial date has been set. On June 21, 2022, the Court granted Plaintiff’s partial motion for summary judgment, holding that Defendant is liable under the contract, but further finding that the amount of damages, if any, to which Plaintiff is entitled should be determined at trial. We believe that partial summary judgment was improvidently granted, and therefore appealed the Court’s Order by filing a petition for writ of certiorari with the Court of Appeal, which appeal is now pending. On or about November 14, 2022, a court granted Sunz’ motion for summary judgment on a contractual issue—holding that the Company waived claims regarding Sunz’ management of claims to the extent that the Company did not complain about such management within 6 months of the alleged mismanagement of the claims. This ruling may limit the scope of the Company’s counterclaim. Trial in the case has been set for February 2024.

32

Vensure Litigation

On September 7, 2021, Shiftable HR Acquisition, LLC, a wholly owned subsidiary of Vensure, filed a complaint against the Company in the Court of Chancery of the State of Delaware asserting claims arising from the Asset Purchase Agreement (the “APA”) governing the Vensure Asset Sale described above. The APA provided for Vensure to purchase, through its wholly owned subsidiary, certain of the Company’s assets for total consideration of $19 million in cash, with $9.5 million to be paid at closing, and the remainder to be paid in 48 equal monthly installments (the “Installment Sum”). The Installment Sum was subject to certain adjustments to account for various post-closing payments made by the parties, and the APA provided for the following procedure to determine the final amount of the Installment Sum: (i) Within 90 days of the effective date, Vensure was required to provide the Company with a “Proposed Closing Statement”, which must detail any adjustments; (ii) Within 30 days of its receipt of Vensure’s Proposed Closing Statement, the Company had the right to challenge any of the proposed adjustments contained therein; and (iii) If the Company disputed Vensure’s Proposed Closing Statement, a 30-day period ensued for the parties to attempt to resolve the dispute, with the Company entitled to examine “such Books and Records of [Vensure] as relate to the specific items of dispute.”

Vensure resisted the Company’s repeated efforts to obtain the Proposed Closing Statement for over one year after the closing of the transaction. Finally, on March 12, 2021, under threat of legal action by the Company, Vensure provided its Proposed Closing Statement, in which it contended for the first time that it owes nothing to the Company, and that the Company actually owes Vensure the sum of $1.5 million. By letter dated April 6, 2021, the Company provided Vensure with its objections to the Proposed Closing Statement, which included Vensure’s gross overstatement of payments it purportedly made on the Company’s behalf, as well as its bad faith actions in obstructing the Company’s efforts to make these payments.

From April 2021 through August 2021, Vensure and the Company engaged in the “30-day negotiation period” referred to above, which was extended multiple times at Vensure’s request to provide Vensure an opportunity to provide evidence supporting its assertions. Over the course of these negotiations, Vensure withdrew its claim for approximately $1.5 million from the Company, and acknowledged that Vensure owed ShiftPixy some portion of the Installment Fund. Nevertheless, in early September 2021, without warning and contrary to the dispute resolution provisions of the APA, Vensure filed suit against the Company in Delaware Chancery Court for breach of contract and declaratory judgment, seeking unspecified damages. The Company vigorously disputes and denies each of Vensure’s claims. Accordingly, on November 4, 2021, the Company filed its Answer and Counterclaim to Vensure’s Complaint, in which it not only denied Vensure’s claims, but also asserted counterclaims for breach of contract and tortious interference with contract. The counterclaim seeks damages from Vensure totaling approximately $9.5 million – the full amount due under the APA - plus an award of attorneys’ fees and expenses. The case is proceeding, and no trial date has been set.

Courvoisier Centre Litigation

On August 24, 2022, the landlord of our headquarters offices, Courvoisier Centre, LLC, filed a complaint against the Company in the Eleventh Judicial Circuit Court (Miami-Dade County, Florida) alleging breach of the lease. The Company vacated the offices and ceased payments under the lease in July of 2022, after repeatedly complaining to the landlord regarding the impact of its extensive renovations of the campus and building in which the Company's offices were situated, citing substantial impairments to the Company's ability to conduct business as well as concerns regarding the health and well-being of the Company’s employees and guests, and the Landlord’s inability and refusal to provide any adequate relief. On or about October 10, 2022, the Company filed our answer to the complaint and the Company's counterclaim. The Company intends to vigorously defend the lawsuit and seek recovery for its costs of relocation.

33

Certified Tire Litigation

On June 29, 2020, the Company was served with a complaint filed by its former client, Certified Tire, in the Superior Court of the State of California, Orange County, naming the Company, two of its officers, and one of its former subsidiaries as defendants. The Complaint asserts multiple causes of action, all of which stem from the former client’s claim that the Company is obligated to reimburse it for sums it paid in settlement of a separate lawsuit brought by one of its employees pursuant to Private Attorney General Act or PAGA. This underlying lawsuit alleged the Company's former client was responsible for multiple violations of the California Labor Code. The Company and the officers named as defendants deny the former client’s allegations, and the Company is defending the lawsuit vigorously based primarily on the Company's belief that the alleged violations that gave rise to the underlying lawsuit were the responsibility of Certified Tire and not the Company. Trial in the matter has been set for September 5, 2023. The Company’s dispositive motion for summary judgment was denied by the court because of its determination that factual disputes exist.

In Re John Stephen Holmes Bankruptcy Litigation

On November 8, 2022, the Chapter 7 trustee of the bankruptcy estate of John Stephen Holmes filed an action against the Company, asserting that the cancellation by the Company of Mr. Holmes' 11,790,000 preferred options on October 22, 2021, violated the automatic stay applicable to Mr. Holmes' Chapter 7 proceedings. After the Company filed a motion to dismiss the trustee's complaint, the trustee endeavored to exercise an option (for 12,500,000 preferred shares) that had been issued in the early stages of the Company but that was later superseded by a modified option that did not provide for convertibility of the preferred shares to common stock and which modified option was in effect at the time that Mr. Holmes filed for bankruptcy. The trustee insists that it has a right to exercise the option for 12,500,000 preferred shares and convert the shares to common stock, notwithstanding (a) the fact that the preferred shares were not convertible to common stock at the time Mr. Holmes filed his bankruptcy petition, (b) the lapse of more than 3 years' time during which the trustee failed to take any action in relation to the option, (c) the connection of the option to Mr. Holmes, who now competes with and is believed to have taken clients from the Company, (d) the intervening 1-for-100 reverse stock split and extensive corporate governance actions, and (e) the negative impact that the issuance of up to 12,500,000 shares would have on the Company and its shareholders. Were the trustee to be successful in its claim, the Company would be obligated to issue up to 12,500,000 restricted shares of the Company's common stock to the trustee, which issuance would materially dilute the share ownership of the existing shareholders and could cause a material decline in the price per share of the Company's common stock. The Company has asserted a number of defenses and intends to vigorously defend itself against the claim.

Employee Retention Tax Credit (“ERTCs”) Claims

The Company has filed various ERTCs claims with the IRS on behalf of its clients that have otherwise failed to obtain the related benefits afforded to them pursuant to the filing of Form 7200—the time for the filing of which has expired. To date, the Company has received ERTCs amounting to $1,152,000, and based on pending claims submissions, it expects to receive an additional $2,985,000, for a total of $4,137,000 in ERTCs submitted to date. In addition, the Company anticipates filing additional ERTCs claims as clients continue to request that the Company complete the submission thereof to the IRS. Because of the Company’s currently existing payroll tax liability, the Company presently receives ERTCs from the IRS in the form of a credit to the Company’s outstanding payroll tax liability. The Company is not presently able to remit the ERTCs to its clients and plans to offer its clients restricted shares of the Company’s common stock in payment of the ERTCs applicable to such clients. If a client rejects the payment of its respective ERTCs in the form of the restricted shares of the Company’s common stock as proposed by ShiftPixy, such client may seek to enforce its rights to recover its ERTCs by filing lawsuits against the Company.

34

Note 10: Subsequent Events

On June 5, 2023, the Company received a letter (the “Nasdaq Letter”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), which notifies the Company that it does not presently comply with Nasdaq’s Listing Rule 5550(b)(2), which requires that the Company maintain a Market Value of Listed Securities (“MVLS”) of $35 million, and that the Company does not otherwise satisfy the requirements of Listing Rules 5550(b)(1) or 5550(b)(3). The Staff calculates MVLS based upon the most recent Total Shares Outstanding (TSO), multiplied by the closing bid price. The Nasdaq Letter does not have any immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market, and the Company has 180 calendar days from the date of the Nasdaq Letter (the “Compliance Period”) to regain compliance. If at any time during the Compliance Period the Company’s MVLS closes at $35 million or more for a minimum of ten (10) consecutive business days, Nasdaq will provide the Company with written confirmation of compliance, and this matter will be closed. If the Company does not achieve compliance within the Compliance Period, it will receive written notice from Nasdaq that its securities are subject to delisting, which is a determination that the Company could appeal to the Nasdaq Hearings Panel.

On or about June 28, 2023, the Company entered into a confidential settlement agreement with Everest National Insurance Company and Gallagher Bassett, resolving the litigation amongst the parties, see Note 9: Contingencies. The Company has accrued for this settlement as of May 31, 2023.

On July 12, 2023, the Company priced a “best efforts” public offering for the sale by the Company of an aggregate of 1,166,667 shares of common stock, 900,000 pre-funded warrants, and 2,066,667 common warrants. The public offering price was $1.50 per share and accompanying common warrant, or $1.4999 per pre-funded warrant and accompanying common warrant. The pre-funded warrants are exercisable immediately, may be exercised at any time until all of the pre-funded warrants are exercised in full, and have an exercise price of $0.0001.  The common warrants are exercisable immediately for a term of five years and have an exercise price of $1.50 per share. 1,100,000 shares, 900,000 pre-funded warrants and 2,000,000 common warrants under the offering were sold pursuant to a securities purchase agreement with an investor. A.G.P./Alliance Global Partners acted as placement agent for the offering and received a fee of 7% of the gross proceeds and reimbursement of $75,000 of expenses. The total estimated offering expenses were approximately $0.6millon and net proceeds of approximately $2.5 million. The offering closed on July 14, 2023. Effective upon closing of the offering, the exercise price of outstanding warrants the Company issued to an investor in 2020 and 2022 was reduced to $1.50 per share, subject to further adjustment as provided in the warrants, pursuant to a warrant amendment the Company entered into with the investor. The change in the exercise price will result in a non-cash warrant modification expense for the three months ended August 31, 2023.

Management has evaluated events that have occurred subsequent to the date of these financial statements and has determined that, other than those listed below, no such reportable subsequent events exist through the date the financial statements were issued in accordance with ASC Topic 855, "Subsequent Events."

35

PART I — FINANCIAL INFORMATION

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes, and other financial information included in this Quarterly Report, as well as the information contained in our Annual Report on Form 10-K and Forms 10-K/A for the fiscal year ended August 31, 2022 (“Fiscal 2022”), filed with the SEC on December 13, 2022, December 14, 2022, February 3, 2023 and February 9, 2023, respectively.

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS AND INFORMATION

This Quarterly Report, the other reports, statements, and information that we have previously filed or that we may subsequently file with the SEC, and public announcements that we have previously made or may subsequently make, contain “forward-looking statements” within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995, which statements involve substantial risks and uncertainties. Unless the context is otherwise, the forward-looking statements included or incorporated by reference in this Quarterly Report and those reports, statements, information and announcements address activities, events or developments that we expect or anticipate will or may occur in the future. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements contained in this Quarterly Report include, but are not limited to, statements about:

· our future financial performance, including our revenue, costs of revenue and operating expenses;

· our ability to achieve and grow profitability;

· the sufficiency of our cash, cash equivalents and investments to meet our liquidity needs;

· our predictions about industry and market trends;

· our ability to expand successfully internationally;

· our ability to manage effectively our growth and future expenses, including our growth and expenses associated with our sponsorship of various special purpose acquisition companies;

· our estimated total addressable market;

· our ability to maintain, protect and enhance our intellectual property;

· our ability to comply with modified or new laws and regulations applying to our business;

· the attraction and retention of qualified employees and key personnel;

· the effect that the novel coronavirus disease (“COVID-19”) or other public health issues could have on our business, financial condition and the economy in general;

· our ability to be successful in defending litigation brought against us; and

· our ability to continue to meet the listing requirements of Nasdaq.

We caution you that the forward-looking statements highlighted above do not encompass all of the forward-looking statements made in this Quarterly Report.

36

We have based the forward-looking statements contained in this Quarterly Report primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section entitled “Risk Factors” in this report and in our Annual Report on Form 10-K and Forms 10-K/A for Fiscal 2022, filed with the SEC on December 13, 2022, December 14, 2022, February 3, 2023 and February 9, 2023, respectively, which are expressly incorporated herein by reference, and elsewhere in this Quarterly Report. Moreover, the Company operates in a very competitive and challenging environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report. We cannot assure you that the results, events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

The forward-looking statements made in this Quarterly Report relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made herein to reflect events or circumstances after the date of this Quarterly Report or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, other strategic transactions or investments we may make or enter into.

The risks and uncertainties the Company currently face are not the only ones we will face. New factors emerge from time to time, and it is not possible for us to predict which will arise. There may be additional risks not presently known to us or that that the Company currently believe are immaterial to our business. In addition, the Company cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Our business, operating results, liquidity and financial condition could be materially affected in an adverse manner as a result of these risks.

The industry and market data contained in this Quarterly Report are based either on our management’s own estimates or, where indicated, independent industry publications, reports by governmental agencies or market research firms or other published independent sources and, in each case, are believed by our management to be reasonable estimates. However, industry and market data are subject to change and cannot always be verified with complete certainty due to limits on the availability and reliability of raw data, the voluntary nature of the data gathering process and other limitations and uncertainties inherent in any statistical survey of market shares. The Company has not independently verified market and industry data from third-party sources. In addition, consumption patterns and customer preferences can and do change. As a result, you should be aware that market share, ranking and other similar data set forth herein, and estimates and beliefs based on such data, may not be verifiable or reliable.

The ShiftPixy logo and other trademarks or service marks of ShiftPixy, Inc. appearing in this Quarterly Report on Form 10-Q are the property of ShiftPixy, Inc. This Form 10-Q also includes trademarks, trade names and service marks that are the property of other organizations. Solely for convenience, trademarks and trade names referred to in this Form 10-Q appear without the ® and ™ symbols, but those references are not intended to indicate, in any way, that the Company will not assert, to the fullest extent under applicable law, our rights, or that the applicable owner will not assert its rights, to these trademarks and trade names.

Overview

Our current business, and the primary source of our revenues to date, has been providing human resources, employment compliance, employment related insurance, payroll, and operational employment services solutions for our business clients using a comprehensive HRIS platform under a human capital fee-based business model. The Company has developed a comprehensive human resources information system or "HRIS" platform designed to provide real-time, agile business intelligence information for our clients as well as an employment marketplace designed to match client opportunities with a large workforce under a digital umbrella. Our market focus is to use this traditional approach, coupled with developed technology, to address underserved markets containing predominately lower wage employees with high turnover, beginning with light industrial, services, and food and hospitality markets. The Company provides human resources, employment compliance, insurance-related, payroll, and operational employment services solutions for our clients and shift work or gig opportunities for worksite employees (WSEs or shifters). As consideration for providing these services, the Company receive administrative or processing fees, typically as a percentage of a client’s gross payroll, process and file payroll taxes and payroll tax returns, provide workers’ compensation insurance, and provide employee benefits. Our losses were driven primarily by substantial investments in our technology platform, our SPAC sponsorships and our ShiftPixy Labs growth initiative, as well as by necessary upgrades to our back-office operations to facilitate servicing a large WSE base under a traditional staffing model.

37

For most of the fiscal year ending August 31, 2022, and continuing through the nine months ended May 31, 2023, the Company's primary focus was on clients in the restaurant and hospitality industries, (market segments typically characterized by high employee turnover and low pay rates), and healthcare industries typically employing specialized personnel that command higher pay rates. The Company believes that these industries are better served by our HRIS platform and related mobile application, which provide payroll and human resources tracking for our clients, and which we believe result in lower operating costs, improved customer experience and revenue growth acceleration. California continued to be our largest market during the three-months ended May 31, 2023, accounting for approximately 33.1% of our gross billings. Washington and New Mexico represented our other significant markets during the three-months ended May 31, 2023, representing approximately 28.4% of our total gross billings. For the nine-months ended May 31, 2023, California represented 42.5% of our gross billings with Washington and New Mexico accounting for approximately 24.7% of our gross billings. Our other locations did not contribute revenue to a material degree. All of our clients enter into client services agreements ("CSAs") with us or one of our wholly owned subsidiaries.

The Company's business focus during the fiscal year ending August 31, 2022, and continuing into the quarter ending May 31, 2023, was to complete our HRIS platform and to expand that platform to position the Company for rapid billings growth as well as to expand our product offerings to increase our monetization of our payroll billings. Now we believe that our HRIS platform is at completion stage and our IT development cost has started to stabilize with a significant cost reduction year over year, we are focused in the maintenance and minor functionality improvements to keep our technology at a top level of excellence in functionality. To that end, we identified and began to execute on various growth strategies, and expect that our execution of these strategies, if successful, will yield significant customer growth driven by widespread adoption of our technology offerings, which we believe represents a substantial value proposition to our clients as a valuable source of agile human capital business intelligence.

The Company's revenues consisted of: (i) staffing solutions revenues equal to gross billings for staffing solutions clients; and (ii) EAS solutions revenues which consist of administrative fees calculated as a percentage of gross payroll processed, payroll taxes due on WSEs billed to the client and remitted to the taxation authority, and workers’ compensation premiums billed to the client for which we facilitate coverage for our clients. Our costs of revenues for EAS solutions revenues consist of the accrued and paid payroll taxes and our costs to provide the workers’ compensation coverage and administration related services, including premiums and loss reserves. For staffing solutions revenues, our cost of revenues also included the gross payroll paid to staffing solutions employees. A significant portion of our liabilities is for our projected workers’ compensation claims attributable to prior programs, carried as liabilities. We provided a self-funded workers’ compensation policy up to $500K and purchased reinsurance for claims in excess of that limit through February 28, 2021, after which we changed to a direct cost premium only workers’ compensation program.

We believe that our customer value proposition is to provide a combination of overall net cost savings to our clients, for which they are willing to pay increased administrative fees, as follows:

· Payroll tax compliance and management services;

· Governmental HR compliance services, such as compliance with the Affordable Care Act (“ACA”);

· Reduced client workers’ compensation premiums or enhanced coverage; and

· Access to an employee pool of potential applicants to reduce turnover costs.

We have invested heavily in a robust, cloud-based HRIS platform (the ShiftPixy “Ecosystem”) in order to:

· Reduce WSE management costs;

· Automate new WSE and client onboarding; and

· Provide value-added services for our business clients resulting in additional revenue streams to the Company.

Our cloud-based HRIS platform captures, holds, and processes HR and payroll information for clients and WSEs through an easy-to-use customized front-end interface coupled with a secure, remotely hosted database. The HRIS platform can be accessed by either a desktop computer or an easy to use smartphone application designed with legally binding HR workflows in mind. Once fully implemented, we expect to reduce the time, expense, and error rate for on-boarding WSEs into our ecosystem. This allows our HRIS platform to serve as a “gig” marketplace for WSEs and clients and for client businesses to better manage their human capital needs.

38

We see our technology platform as a key competitive advantage and differentiator to our competitors and one that will allow us to expand our human capital business beyond our current focus of low-wage employees and healthcare workers. We believe that providing this baseline business, coupled with a technology solution to address additional concerns such as employee scheduling and turnover, will provide a unique, cost effective solution to the HR compliance, staffing, and scheduling problems that these businesses face. We are completing additional features that we expect to generate additional revenue streams, enhance and expand our product offering, increase our client customer and WSE counts, and increase our revenues and profit per existing WSE.

Off-Balance Sheet Arrangements

During the periods presented, we did not have, nor do we currently have, any off-balance sheet arrangements as defined in the rules and regulations of the SEC.

Critical Accounting Estimates and Policies

A critical accounting policy and related estimates are both important to the portrayal of a company’s financial condition and results of operations and requires management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Refer to the Company's Annual Report for a complete listing of the critical accounting estimates. Below summarizes a few significant accounting policies for your reference.

Our unaudited condensed consolidated financial statements are presented in accordance with U.S. GAAP, and all applicable U.S. GAAP accounting standards effective as of May 31, 2023 have been taken into consideration in preparing the unaudited consolidated financial statements. The preparation of unaudited consolidated financial statements requires estimates and assumptions that affect the reported amounts of assets, liabilities, expenses and related disclosures. Some of those estimates are subjective and complex, and, consequently, actual results could differ from those estimates. The following accounting policies and estimates have been highlighted as significant because changes to certain judgments and assumptions inherent in these policies could affect our unaudited consolidated financial statements:

· Assumption as a going concern; management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets and liquidation of all liabilities in the normal course of business;

· Liability for legal contingencies;

· Useful lives of property and equipment;

· Deferred income taxes and related valuation allowance;

· Projected development of workers’ compensation claims.

Growth Initiatives

Through November, 20, 2022, the Company concluded activities associated with our SPAC-related growth initiative, and we continued to execute on our other primary growth initiative, which is designed to leverage our technology solution, knowledge, and expertise to provide for significant future revenue growth for the human capital management services we provide to our clients. Further, we have emphasized sales growth in the staffing division of our business, which has historically tended to present less risk and greater margin than the HCM division of our business. Our R&D work under our SPAC project has opened additional market opportunities into which we intend to leverage our technology.

Transformative Sales Growth Strategy

ShiftPixy's agile business development plan for organic growth has always been focused on building scalable long-term revenue creation with a goal to become the market leader in U.S. contingent labor through increasingly diverse service offerings. Our new market opportunities open doors for us with Fortune 1000 companies to rethink human capital, ShiftPixy’s novel technology and proprietary sourcing tools are designed to disrupt not only traditional thinking about staffing, but also provide a cure to toxic employee turnover and thus provide labor cost certainty.

39

This new and compelling go-to-market strategy is prepared to leverage the recently expanded staffing platform on the ShiftPixy Human Resources Information System (“HRIS”) that offers clients an industry-leading digital and mobile technology to handle the duties and demands of human capital management at significant scale. An enhanced value proposition will offer clients automation, acceleration, liberation, and some indemnification, which we believe will drive growth and deliver value to stakeholders while also increasing our market share. Successful execution of this sales growth plan will leave ShiftPixy strategically positioned for secular growth in the $123 billion temporary and contract employment staffing market in the U.S.

The Company’s transformative sales growth strategy will capitalize on several economic developments in attractive vertical markets including retail, skilled trades, logistics, manufacturing, healthcare, and hospitality. A sustained surge in e-commerce is driving the need for supply chain expansions that require additional warehouses and the labor necessary to expedite delivery and returns. Likewise, a re-focus on domestic manufacturing capacity expansion for critical technology and an acute labor supply gap is anticipated to spur demand for ShiftPixy’s contingent and flexible skilled labor pool. Additional tailwinds supporting our growth strategy include positive demographic trends as the labor market prioritizes flexibility, control, and access to job opportunities anywhere and anytime.

ShiftPixy’s business development plan offers immediate solutions to critical workflow challenges for human capital acquisition, talent management, labor force retention, worker supply chain disruptions, and runaway hiring costs. ShiftPixy’s continuous improvement of its client and candidate experience elevates engagement and satisfaction for neglected contingent and temporary workers. The completion of the Company’s current sales growth strategy is expected by management to create one of the largest employers in the U.S. and build the fastest growing flexible labor force to meet the demands of a fast-changing human capital market while ushering significant enterprise value creation and recurring revenue growth for our shareholders.

ShiftPixy Labs

On July 29, 2020, we announced the launch of ShiftPixy Labs, which includes the development of ghost kitchens in conjunction with our wholly owned subsidiary, ShiftPixy Labs, Inc. Through this initiative, we intend to bring various food delivery concepts to market that will combine with our HRIS platform to create an easily replicated, comprehensive food preparation and delivery solution. The initial phase of this initiative is being implemented in our dedicated kitchen facility located in close proximity to our Miami headquarters, which we are already showcasing through the distribution of video programming on social media produced and distributed by our wholly owned subsidiary, ShiftPixy Productions, Inc. If successful, we intend to replicate this initiative in similarly constructed facilities throughout the United States and in selected international locations. We also intend to provide similar services via mobile kitchen concepts, all of which will be heavily reliant on our HRIS platform and which we believe will capitalize on trends observed during the COVID-19 pandemic toward providing customers with a higher quality prepared food delivery product that is more responsive to their needs.

The idea of ShiftPixy Labs originated from discussions with our restaurant clients, combined with our observations of industry trends that appear to have accelerated during the pandemic. Beginning in calendar 2020, we recognized a significant uptick in the use of mobile applications to order take-out food either for individual pickup or third-party delivery, which grew even more dramatically as the pandemic took hold. Not surprisingly, the establishment of fulfillment kitchens for third party delivery also spread rapidly during this time period, initially among national fast food franchise chains but then among smaller quick service restaurants or "QSR".

We believe that the restaurant industry is in the midst of a food fulfillment paradigm shift that will ultimately result in the widespread use of “ghost kitchens” in a shared environment. Similar to shared office work locations, a shared kitchen can provide significant cost efficiencies and savings compared to the cost of operating multiple retail restaurant locations. Coupled with ShiftPixy’s technology stack, which includes order delivery and dispatch, we believe that the ghost kitchen solutions that emerge from ShiftPixy Labs will provide a robust and effective delivery order fulfillment option for our clients.

40

We have also observed the growing impact of social media platforms over the past five years, a trend which has accelerated through the pandemic. As this trend has gained steam, many social media influencers have successfully capitalized on their popularity by establishing new business concepts in a variety of industries, including within the QSR space. Some of these QSRs are identified as “virtual” restaurants with delivery-only service fulfilled by centralized ghost kitchens. We intend to capitalize on this trend by creating an extensive social media presence for ShiftPixy Labs.

Many restaurant entrepreneurs have also become successful during the pandemic by moving outside through the use of mobile food trucks, which can be used as a launching point for restaurants and ultimately expanded to traditional indoor dining locations. We have researched this phenomenon and, coupled with our experience in the restaurant industry, believe a significant business opportunity exists to assist with the fulfillment of new restaurant ideas and rapidly expand those ideas across a broad geographic footprint utilizing centralized ghost kitchen fulfillment centers. Again, we believe that ShiftPixy Labs will provide solutions that will facilitate the rapid growth of these new businesses, through a combination of centralized ghost kitchens and an available pool of human capital resources provided through our HRIS platform, as well as though other business assistance provided by our management team.

During Fiscal 2021, we established an industrial facility in Miami that we expect to be fully completed and operational during Fiscal 2023. During Fiscal 2022, we equipped this facility with ten standardized kitchen stations in both single and double kitchen configurations built within standard cargo container shells and ordered a food truck for mobile operation. We expect this facility, upon completion, to function as a state-of-the-art ghost kitchen space that will be used to incubate restaurant ideas through collaboration and partnerships with local innovative chefs, resulting in sound businesses that provide recurring revenue to us in a variety of ways, both through direct sales and utilization of the ShiftPixy Ecosystem, our HRIS platform, and other human capital services that we provide. To the extent that this business model is successful and can be replicated in other locations, it has the potential to contribute significant revenue to us in the future.

We may also take equity stakes in various branded restaurants that we develop and operate with our partners through ShiftPixy Labs. Such ownership interests will be held to the extent that it is consistent with our continued existence as an operating company, and to the extent that we believe such ownership interests have the potential to create significant value for our shareholders.

The Company anticipates that it will spin off Labs and have them as a client to use our HRIS platform providing the access to fulfill their workforce needs.

Workers’ Compensation Insurance

During Fiscal 2021, the Company made a strategic decision to change its approach to securing workers’ compensation coverage for our clients. This was primarily due to rapidly increasing loss development factors stemming in part from the COVID-19 pandemic. The combination of increased claims from WSEs, the inability of WSEs to obtain employment quickly and return to work after injury claims and increasing loss development factor rates from our insurance and reinsurance carriers resulted in significantly larger potential loss exposures, claims payments, and additional expense accruals. Starting on January 1, 2021, we began to migrate our clients to our new direct cost program, which we believe significantly limits our claims exposure. Effective March 1, 2021, all of our clients had migrated to the direct cost program.

For the three and nine months ended May 31, 2023 and May 31, 2022, primarily all the recorded in the discounted operations as disclosed in the accompany unaudited condensed statements of operations. The claims estimate increases relating to loss reserves activity for the legacy Sunz and Everest programs. These claims estimates are the subject of ongoing litigation with our former workers’ compensation insurance providers, Sunz and Everest, as described in Note 9, Contingencies, above. We are currently re-evaluating our workers’ compensation liability estimates under our legacy Sunz and Everest programs.

Following the close of the period ended May 31, 2023, the Everest matter was liquidated.  See Note 9, Contingencies, Everest Litigation and Sunz Litigation, and Note 10 Subsequent Events.

Vensure Asset Sale Note Receivable Reconciliation

On January 3, 2020, the Company entered into an asset purchase agreement with Shiftable HR Acquisition, LLC, a wholly owned subsidiary of Vensure, pursuant which the assignment of client contracts significantly impacted the Company’s quarterly revenue as of November 30, 2019, including 100% of the Company's existing PEO business. In connection with this transaction, the Company had a Note Receivable to be paid over four years. In the Company's third quarter of Fiscal 2022 we recorded an asset impairment to adjust the net realizable value of the long-term note receivable to zero. As of May 31, 2023, Vensure and the Company were engaged in litigation regarding the amount owed to the Company pursuant to the Note Receivable, as described in Note 9, Contingencies.

41

Results of Operations

The following table summarizes the condensed consolidated results of our operations for the three and nine months ended May 31, 2023 and May 31, 2022.

	For the Three Months Ended						For the Nine months ended
	May 31, 2023			May 31, 2022			May 31, 2023			May 31, 2022
Revenues (See Note 2)	$	3,988,000		$	9,643,000		$	13,833,000		$	29,021,000
Cost of revenues		3,788,000			9,039,000			12,623,000			27,782,000
Gross profit		200,000			604,000			1,210,000			1,239,000
Operating expenses:
Salaries, wages, and payroll taxes		2,621,000			3,254,000			7,477,000			10,796,000
Professional fees		752,000			2,680,000			2,817,000			6,094,000
Software development		50,000			4,291,000			229,000			6,525,000
Depreciation and amortization		148,000			133,000			447,000			386,000
General and administrative		3,074,000			2,967,000			6,609,000			7,718,000
Total operating expenses		6,645,000			13,325,000			17,579,000			31,519,000
Operating loss		(6,445,000	)		(12,721,000	)		(16,369,000	)		(30,280,000	)
Other (expense) income:
Interest expense		(550,000	)		(1,000	)		(1,007,000	)		(2,000	)
Other income		—			27,000			536,000			43,000
SPAC offering costs		—			—			—			(515,000	)
Total other expense		(550,000	)		26,000			(471,000	)		(474,000	)
Net loss from continuing operations		(6,995,000	)		(12,695,000	)		(16,840,000	)		(30,754,000	)
Loss from discontinued operations, net of tax		(460,000	)		(132,000	)		(1,267,000	)		(283,000	)
Non-controlling interest		—			—			(540,000	)		—
Net loss attributable to Shift Pixy, Inc.	$	(7,455,000	)	$	(12,827,000	)	$	(18,647,000	)	$	(31,037,000	)
Preferred stock preferential dividend and deemed dividend from changes in fair value from warrant modification		—			—			(127,145,000	)		—
Deemed dividend from change in fair value from warrants modification		—		$	—		$	—		$	(7,731,000	)
Net loss attributable to common shareholders	$	(7,455,000	)	$	(12,827,000	)	$	(145,792,000	)	$	(38,768,000	)
Net loss per share, basic and diluted
Continuing operations - basic and diluted	$	(0.70	)	$	(33.08	)	$	(14.84	)	$	(101.72	)
Discontinued operations - basic and diluted		(0.05	)		(0.34	)		(0.13	)		(0.75	)
Net loss per common share – basic and diluted	$	(0.75	)	$	(33.42	)	$	(14.97	)	$	(102.47	)
Weighted average common shares outstanding – basic and diluted		10,057,177			383,726			9,739,578			378,349

42

We report our revenues as gross billings, net of related direct labor costs for the Company's EAS/HCM clients and revenues without reduction of labor costs for staffing services clients.

The following table presents certain information related to the gross profit components in thousands, (unaudited):

	For the Three Months Ended						For the Nine months ended
	May 31, 2023			May 31, 2022			May 31, 2023			May 31, 2022
Gross Billings for HCM	$	8,335		$	13,924		$	30,696		$	39,356
Gross Wages for HCM		(8,224	)		(12,190	)		(29,175	)		(35,304	)
Total Net Revenue for HCM		111			1,734			1,521			4,052
Revenue for Staffing		3,877			7,909			12,312			24,969
Total Net Revenues (in thousands)	$	3,988		$	9,643		$	13,833		$	29,021
Increase (Decrease), Quarter over Quarter (in thousands)		(5,655	)		7,500			(15,188	)		14,600
Percentage Increase (Decrease), Quarter over Quarter		(58.6	)%		375.0	%		(52.3	)%		101.4	%
Cost of Revenues (in thousands)	$	3,788		$	9,039		$	12,623		$	27,782
Increase (Decrease), Quarter over Quarter (in thousands)		(5,251	)		(9,000	)		(15,159	)		13,800
Percentage Increase (Decrease), Quarter over Quarter		(58.1	)%		(9.1	)%		(54.6	)%		98.6	%
Gross Profit (in thousands)	$	200		$	604		$	1,210		$	1,239
Increase (Decrease), Quarter over Quarter (in thousands)		(404	)		1,000			(29	)		800
Percentage Increase (Decrease), Quarter over Quarter		(66.9	)%		(250.0	)%		(2.3	)%		200	%
Gross Profit Percentage		5.0	%		6.3	%		8.7	%		4.1	%

Three months ended May 31, 2023 as compared to the three months ended May 31, 2022

Net revenues for the HCM services exclude the payroll cost component of gross billings. With respect to staffing services, employer payroll taxes, employee benefit programs, and workers’ compensation insurance, we believe that we are the primary obligor, and we have latitude in establishing price, selecting suppliers, and determining the service specifications. As such, the billings for those components are included as revenue. Revenues are recognized ratably over the payroll period as WSEs perform their services at the client worksite. See also non-GAAP Financial Measures below.

Net Revenues decreased approximately $5.7 million from $9.6 million to $4.0 million and for the three months ended May 31, 2023. This decrease is related to the loss of clients during the end of Fiscal 2022 due to executives who focused their time on the SPAC which its impact is fully reflected in the second quarter of Fiscal 2023. The Company expected clients from the SPAC transaction.

Cost of Revenues includes the Company's costs associated with employer taxes, workers’ compensation insurance premiums, and the gross wages paid for our staffing clients. Cost of revenues for the three months ended May 31, 2023, decreased by $5.3 million to $3.8 million from $9.0 million for the three months ended May 31, 2022. This decrease is related to the loss of clients during the end of Fiscal 2022, for which its impact is fully reflected in the second quarter of Fiscal 2023.

43

Gross Profit for the three months ended May 31, 2023 was $0.2 million compared to a gross profit of $0.6 million or 5.0.% for the three months ended May 31, 2022. The decrease correlates with the decrease in gross wages due to the loss of clients previously mentioned and the mix of clients for the change in gross profit percentage.

Operating expenses decreased for the three months ended May 31, 2023, by $6.7 million, compared to the three months ended May 31, 2022. The components of operating expenses change for such periods are as follows:

Salaries, wages and payroll taxes decreased for the three months ended May 31, 2023, by approximately $0.6 million, as compared to the three months ended May 31, 2022. The decrease is directly related to the reduction in employees during the Fiscal 2022, including C-suite salary employees. The Company experience a reduction of approximately 14 employees when compared period over period or a reduction from 82 employees as of May 31, 2022 to 68 corporate employees as of May 31, 2023.

Professional fees consist of legal fees, accounting and public company costs, board fees, and consulting fees. professional fees for the three months ended May 31, 2023, decreased by $1.9 million, compared to three months ended May 31, 2022. The decrease is directly related to the ceased operations of our sponsored SPAC for which the Company is no longer incurring expenses. In addition, the company experienced a decrease in legal fees of $0.5 million.

Software development consists of costs associated with research and development outsourced to third parties. Software development costs decreased by $4.2 million for the three months ended May 31, 2023, respectively, compared to the three months May 31, 2022. The decrease is related to the reduction of external IT consultants as the application was essentially completed during the second half of Fiscal 2022. In addition, the company recorded a $4.0 million charge related to an impairment of a software asset. This transaction is related to a legal dispute noted in our legal support documentation.

General and administrative expenses consist of office rent and related overhead, software licenses, insurance, penalties, stock- based compensation, travel and entertainment, and other general business expenses. General and administrative expenses for the three months ended May 31, 2023, increased by $0.2 million, compared to the three months ended May 31, 2022. The increase is related to reduced short-term leases, travel & entertainment, insurance and miscellaneous expense being offset in part by a $1.0 million increase in expense from penalties related to payroll obligations owed to the Internal Revenue Service "IRS" and state taxing authorities.

Other income for the three months ended May 31, 2023 was zero compared to $0.03 million for the three months ended May 31, 2022. The decrease is due to the elimination of the IHC SPAC.

44

Interest expense primarily consist of the Company's obligation to the IRS and state tax authorities based upon its unpaid payroll liabilities. . Interest expense for the three months ended May 31, 2023 was $0.6 million compared to May 31, 2022.

Nine months ended May 31, 2023 as compared to nine months ended May 31, 2022

Net Revenues decreased $15.2 million from $29.0 million to $13.8 million for the nine months ended May 31, 2023. this decrease is predominantly due to the decrease in net wages related to the loss of a few clients during the end of Fiscal 2022, for which its impact is fully reflected in the nine months ended May 31, 2023.

Cost of Revenues includes the Company's costs associated with employer taxes, workers’ compensation insurance premiums, and the gross wages paid for our staffing clients. Cost of revenues for the nine months ended May 31, 2023, decreased by $15.0 million to $12.8 million from $27.8 million for the nine months ended May 31, 2022. The decrease correlates with the decrease in our gross wages.

Gross Profit was $1.1 million or 7.5% for the nine months ended May 31, 2023 as compared to a gross profit of $1.2 million or 4.1% for the nine months May 31, 2022 due to lower gross wages for the nine months ended May 31, 2023 and the mix of clients for the change in gross profit.

Salaries, wages and payroll taxes decreased for the nine months ended May 31, 2023, by approximately $3.3 million, as compared to May 31, 2022. The decrease is primarily attributable to the significant reduction in employee head count through all departments.

Professional fees consist of legal fees, accounting and public company costs, board fees, and consulting fees. Professional fees for the nine months ended May 31, 2023, decreased by $3.3 million, compared to May 31, 2022. The decrease is directly related to the ceased operations of our sponsored SPAC for which the Company is no longer incurring expenses.

Software development consists of costs associated with research and development outsourced to third parties. Software development costs decreased by $6.3 million, for the nine months ended , respectively, compared to the nine months May 31, 2022. The decrease is related to a reduction in the number of external IT consultants as the application was substantially completed during the second half of Fiscal 2022. In addition, the company recorded an impairment related to a Software asset of $4.0 million in Q3 2022. This impairment is related to a legal dispute discussed within our legal support documentation.

General and administrative expenses consist of office rent and related overhead, software licenses, insurance, penalties, stock- based compensation, travel and entertainment, and other general business expenses. General and administrative expenses for the nine months ended May 31, 2023, decreased by $0.7 million, compared to May 31, 2022. Increased expenses in FYE 2023 for penalties related to outstanding payroll tax liabilities owed to the IRS and states taxing for approximately $1.4 million, offset expense reductions in insurance, rent, other short-term leases and miscellaneous expense.

Other income for the nine months ended May 31, 2023 was $0.1 million compared to $0.04 million for the nine months ended May 31, 2022. The increase is related to the deconsolidation of IHC along with a small balance related to the company credit card award program.

Interest expense primarily consist of the Company's obligation to the IRS and state tax authorities based upon its unpaid payroll liabilities. Interest expense for the nine months ended May 31, 2023 was $1.0 million as compared to the nine months ended May 31, 2022 which was $2,000.

45

Cash Flows

The following table summarizes our sources and uses of cash for the periods presented:

	For the Nine Months Ended
	May 31, 2023			May 31, 2022
Net cash used in operations activities	$	(6,392,000	)	$	(13,380,000	)
Net cash provided by (used in) investing activities		117,131,000			(117,265,000	)
Net cash (used in) provided by financing activities		(111,213,000	)		129,516,000
Net increase in cash		(474,000	)		(1,129,000	)
Cash - beginning of period		618,000			1,199,000
Cash - end of period	$	144,000		$	70,000

Operating Activities

Cash used in operations for the nine months ended May 31, 2023 was $6.5 million, primarily consisting of a net loss from continuing operations of $18.6 million, a decrease in accounts receivable and workers compensation payable of $0.8 million, offset by accounts payable and accrued expenses of $1.0 million, decrease in accounts receivable of $0.5 million, a decrease in workers compensation of $0.4 million offset by an increase in payroll related liabilities of $8.3 million, an increase in non-cash expenses of $1.5 million and impairment loss of $4.0 million.

Cash used in operations of ShiftPixy, Inc for the nine months ended May 31, 2022 was $10.3 million primarily consisting of the net loss of $18.1 million, a decrease in workers compensation of $0.5 million, a decrease in prepaid and other current assets of $0.6 million, offset by an increase in payroll related liabilities of $3.3 million, an increase in accounts payable and accrued expenses of $3.1 million, an increase in non-cash expenses of $1.0 million.

Investing Activities

Net cash provided by investing activities for the nine months ended May 31, 2023, was $117.1 million from the redemption of IHC Trust Account of $117.2 million and from the purchase of fixed asset of $0.3 million. Net cash used investing activities for the nine months ended May 31, 2022, was $129.5 million which was from an investment of $116.7 million from the proceeds of the initial public offering into the IHC Trust Account, proceeds from a private placement of and for the purchase fixed assets of $0.5 million.

Financing Activities

Net cash used in financing activities for the nine months ended May 31, 2023, was $111.2 million which was from the net proceeds of $4.4 million related to a private placement, $2.0 million from the net proceeds of an ATM offering and $117.6 million payment to IHC shareholders. Net cash provided by financing activities for the nine months ended May 31, 2022 was $129.5 million, primarily from the net proceeds of $116.7 million for an initial public offering of IHC, $11.0 million from the net proceeds from two private placements, $5.4 million net proceeds from common stock issued on exercised warrants and payment of $3.5 million of SPAC related offering cost.

Liquidity and Capital Resources

As of May 31, 2023, the Company had cash of $0.1 million and a working capital deficit of $41.7 million. During the nine months ended May 31, 2023, the Company used approximately $16.5 million of cash from its continuing operations and incurred recurring losses, resulting in an accumulated deficit of $211.4 million. As of May 31, 2023, the Company is delinquent with respect to remitting payroll tax payments to the IRS. The Company has been in communication with the IRS regarding amounts owing in relation to Employee Retention Credits due. In addition, some clients have filed suits against the Company, demanding that the Company take action to file for additional Employee Retention Credits for certain tax periods. Until the matter is concluded, and the taxes are paid, the IRS could, subject to its standard processes and the Company’s rights to respond, implement collection actions, including such actions as levying against Company bank accounts, to recover the amounts that it calculates to be due and owing.

46

Historically, the Company's principal source of financing has come through the sale of the Company's common stock, including in certain instances, warrants and issuance of convertible notes.

On May 23, 2023, the Company filed a registration statement on Form S-1, providing for the sale of shares of the Company's common stock on a firm commitment basis, underwritten by Titan Partners Group LLC, a division of American Capital Partners, LLC ("Titan"). On June 7, 2023, the Company filed an amendment to the registration statement, on Form S-1/A, providing for the sale of 4,566,210 shares of our common stock, par value $0.0001 per share at an assumed public offering price of $2.19 per share, pursuant to an underwriting agreement with Titan. The commitment was not consummated by Titan, and on June 30, 2023, the Company filed an amendment to the registration statement, on Form S-1/A, providing for the sale on a best efforts basis of up to $10.0 million of shares of our common stock, par value $0.0001 per share, together with common warrants to purchase up to 4,926,108 shares of common stock, pursuant to a Placement Agent Agreement with AGP.

On January 31, 2023, the Company filed a registration statement on Form S-3 and related prospectus for the sale of up to $100 million of the Company's equity securities via a "shelf" or "at-the-market" ("ATM") sales mechanism over a three-year period. The registration statement also included a prospectus supplement providing for the sale of up to $8,187,827 of the Company's shares of common stock, which the Company proposed to effect pursuant to an ATM Issuance Sales Agreement ("Sales Agreement") executed with A.G.P./Alliance Global Partners (the “Agent” or "AGP"). Under the Sales Agreement, the Company's shares of common stock could be sold from time to time and at various prices at the Company’s sole control, subject to the conditions and limitations in the Sales Agreement with AGP. The ATM was scheduled to expire on January 31, 2026. For the nine-months ended May 31, 2023, the Company received $2.4 million in gross proceeds ($2.0 million, net of costs) from the sale of 439,429 shares of the Company’s common stock. On May 22, 2023, the Company terminated the Sales Agreement and concluded the ATM. There is a limitation on the amount of funds that the Company can access under the baby shelf rules which is the value of a company’s public float if less than $75 million, The Company can only raise ⅓ of its float value over the previous 12-month period.

The recurring losses, negative working capital and cash used in the Company’s operations are indicators of substantial doubt as to the Company’s ability to continue as a going concern for at least one year from issuance of these financial statements. For a discussion of our liquidity and capital resources, see Note 2, Liquidity and Capital Resources to the accompanying financial statements.

The recurring losses, negative working capital and cash used in the Company’s operations are indicators of substantial doubt as to the Company’s ability to continue as a going concern for at least one year from issuance of these financial statements. The Company's plans and expectations for the next twelve months include raising additional capital to help fund expansion of our operations and strengthening of the Company's sales force strategy by focusing on staffing services as the Company's key driver to improve the Company's margin and the continued support and functionality improvement of the Company's information technology (“IT”) and HRIS platform. This expanded go-to-market strategy will focus on building a national account portfolio managed by a newly formed regional team of senior sales executives singularly focused on sustained quarterly revenue growth and gross profit margin expansion. We expect to continue to invest in the Company's HRIS platform, ShiftPixy Labs, and other growth initiatives, all of which have required and will continue to require significant cash expenditures.

The Company also expects its ShiftPixy Labs growth initiative to generate cash flow once launched, by functioning as an incubator of food service and restaurant concepts through collaboration and partnerships with local innovative chefs. If successful, the Company believes that this initiative will produce businesses that provide recurring revenue through direct sales, as well as through utilization of the ShiftPixy Ecosystem, HRIS platform, and other human capital services that the Company provides. To the extent that this business model is successful and can be replicated in other locations, the Company believes that it has the potential to contribute significant revenue to ShiftPixy in the future. The Company may also take equity stakes in various branded restaurants that it develops and operates with its partners through ShiftPixy Labs. Such ownership interests will be held to the extent that it is consistent with the Company’s continued existence as an operating company, and to the extent that the Company believes such ownership interests have the potential to create value for its shareholders.

47

The Company expects to raise capital from additional sales of its securities during this fiscal year either through its ATM, registered public offerings or private placements, the proceeds of which the Company intends to use to fund its operations and growth initiatives. There can be no assurance that we will meet the requirements to be able to sell securities on terms that the Company is seeking. Management believes that its current cash position, along with its anticipated revenue growth and proceeds from future sales of its securities, when combined with prudent expense management, could alleviate substantial doubt about its ability to continue as a going concern and to fund its operations for at least one year from the date these financials are available (especially when considering the absence of any funded debt outstanding on its balance sheet). If these sources do not provide the capital necessary to fund the Company’s operations during the next twelve months, it may need to curtail certain aspects of its operations or expansion activities, consider the sale of additional assets, or consider other means of financing. The Company can give no assurance that it will be successful in implementing its business plan and obtaining financing on advantageous terms, or that any such additional financing will be available. If the Company is not successful in obtaining the necessary financing, we do not currently have the cash resources to meet our operating commitments for the next twelve months. These unaudited condensed consolidated financial statements do not include any adjustments for this uncertainty. Therefore, management has concluded that Company that there is substantial doubt its ability to continue as a going concern for the next twelve months.

As noted in the accompany condensed financial statements, Note 4: Special Purpose Acquisition Company ("SPAC") Sponsorship, on February 7, 2023, three creditors of IHC filed an involuntary petition for liquidation under Chapter 7 against IHC in the US Bankruptcy Court for the Southern District of Florida. The matter is proceeding, and the Company and its subsidiary, ShiftPixy Investments, Inc., are anticipated to be listed as two of the largest creditors of IHC. However, there can be no assurance that either the Company or ShiftPixy Investments, Inc. will recover any of the amounts owed to them by IHC from the bankruptcy estate. ShiftPixy, Inc. is the largest creditor of IHC, having periodically advanced a total of approximately $2 million in cash to IHC to enable it to fund its ongoing prospective target engagement, evaluation and negotiation activities. Following the dissolution of IHC, in January of 2023, the dissolved IHC issued approximately $0.6 million to ShiftPixy, Inc., in partial satisfaction of amounts advanced by ShiftPixy, Inc. to IHC, including the return to ShiftPixy, Inc. of a recently received refund of approximately $0.5 million in premiums applicable to the cancellation of directors and officer insurance policies attributable to four of the SPACs sponsored by ShiftPixy Investments, Inc. Although the public shareholders of IHC received in excess of $117.6 million in redemption of their capital contributions to IHC, the bankruptcy trustee could elect to pursue the amount received by the Company from IHC, if it can demonstrate that the payment was preferential and made outside of the ordinary course of business of IHC.

Non-GAAP Financial Measures

In addition to financial measures presented in accordance with GAAP, we monitor other non-GAAP measures that we use to manage our business, make planning decisions and allocate resources. These key financial measures provide an additional view of our operational performance over the long term and provide useful information that we use to maintain and grow our business. The presentation of these non-GAAP financial measures is used to enhance the understanding of certain aspects of our financial performance. They are not meant to be considered in isolation, superior to, or as a substitute for the directly comparable financial measures presented in accordance with GAAP.

Our revenue recognition policy differs for our EAS/HCM and staffing clients and is dependent on the respective CSA applicable to each client. During Fiscal 2021, some of our EAS clients migrated to a staffing CSA. Our policy is to report revenues as gross billings, net of related direct labor costs, for our EAS/HCM clients, and revenues without reduction for labor costs for staffing clients. For the three months ended May 31, 2023, our gross billings from HCM and staffing services totaled approximately $8.3 million and $3.0 million (total of $12.1 million), representing 68% and 32% of our gross revenue, respectively. For the nine months ended May 31, 2023, our gross billings from HCM and staffing services totaled approximately $30.7 million and $11.8 million (total of $42.5 million), representing 72% and 28% of our gross revenue, respectively. For the three and nine months ended May 31, 2022, our gross billings from HCM and staffing services totaled approximately $13.9 million and $8.7 million (total of $22.6 million) and $39.4 million and $25.8 million (total of $65.2 million), respectively.

Gross billings represent billings to our business clients and include WSE gross wages, employer payroll taxes, and workers’ compensation premiums as well as administrative fees for our value-added services and other charges for workforce management support. Gross billings for our HCM services are a non-GAAP measurement that we believe to represent a key revenue-based operating metric, along with number of WSEs and number of clients. Active WSEs are defined as employees on our HRIS platform that have provided services for at least one of our clients for any reported period. Our primary profitability metrics are gross profit, and our primary driver of gross profit is administrative fees.

48

Reconciliation of GAAP to Non-GAAP Measure

Gross Billings to Net Revenues

The following table presents a reconciliation of our Gross Billings (unaudited) to Revenues:

	For the Three Months Ended May 31,						For the Nine Months Ended May 31,
($ in thousands)	2023			2022			2023			2022
Gross Billings	$	12,144		$	22,628		$	42,524		$	65,198
Less: Adjustment to Gross Billings		(8,156	)		(12,985	)	$	(28,691	)	$	(36,177	)
Revenues	$	3,988		$	9,643		$	13,833		$	29,021

The following table provides the key revenue and our primary gross profit driver used by management (unaudited).

	For the Three Months Ended May 31,						For the Nine Months Ended
	2023			2022			2023			2022
Administrative Fees (in thousands)	$	433		$	461		$	1,065		$	1,404
Increase (Decrease), Quarter over Quarter (in thousands)	$	(28	)		100		$	(340	)	$	313
Percentage Increase (Decrease), Quarter over Quarter		(6.1	)%		15.8	%		(24.2	)%		28.7	%
Administrative Fee % of Gross Billings		4.2	%		2.0	%		2.9	%		2.2	%
Average WSEs		1,600			3,000			2,000			3,000
Average Gross Billings per Average WSE	$	7,590		$	7,543		$	21,300		$	21,733

Average Active WSEs totaled approximately 1,600, decreased for the three months ended May 31, 2023, as compared to 3,000 WSEs for three months ending May 31, 2022 due to the decrease in net revenue was due to loss of clients. Average Active WSEs totaled approximately 2,000, decreased for the nine months ended May 31, 2023 as compared to 3,000 WSEs for nine months ending May 31, 2022 was due the decrease in net revenue was due to loss of clients.

Material Commitments

We do not have any contractual obligations for ongoing capital expenditures at this time. The Company purchased fixed assets and software necessary to conduct its operations on an as needed basis.

Contingencies

For a discussion of contingencies, see Note 9, Contingencies, to the Notes to the condensed consolidated financial statements in “Part I, Item 1. condensed consolidated financial statements” of this Quarterly Report.

New and Recently Adopted Accounting Standards

For a listing of our new and recently adopted accounting standards, see Note 2, Summary of Significant Accounting Policies, to the Notes to the condensed consolidated financial statements in “Part I, Item 1. condensed consolidated financial statements” of this Quarterly Report.

49

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not required for smaller reporting companies.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer (Principal Executive Officer) and the Chief Financial Officer (Principal Financial Officer), to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, the Company recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

The Company conducted an evaluation under the supervision and with the participation of management, including the Principal Executive Officer and Principal Financial Officer, of the effectiveness of its disclosure controls and procedures as of May 31, 2023, as defined in Rule 13a -15(e) and Rule 15d -15(e) under the Exchange Act. This evaluation was carried out under supervision and with the participation of our Chief Executive Officer and Chief Financial Officer. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of May 31, 2023, our disclosure controls and procedures were not effective due to material weaknesses in internal control over financial reporting related to the lack of adequate accounting and finance personnel, as further discussed in our Annual Report on Form 10-K for the year ended August 31, 2022, as amended by Forms 10-K/A, and which the Company determined continued to exist as of May 31, 2023.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the three months ended May 31, 2023, that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

50

PART II — OTHER INFORMATION

Item 1. Legal Proceedings.

The Company is a party to various legal actions, in addition to the contingencies noted above in Note 9: Contingencies to the accompanying financial statements, arising in the ordinary course of business which, in the opinion of the Company, are not material in that management either expects that the Company will be successful on the merits of the pending cases or that any liabilities resulting from such cases will be immaterial or substantially covered by insurance. While it is impossible to estimate with certainty the ultimate legal and financial liability with respect to these actions, management believes that the aggregate amount of such liabilities will not be material to the results of operations, financial position or cash flows of the Company. There have been no material developments to the litigation disclosed in our Annual Report on Form 10-K and Forms 10-K/A for the fiscal year ended August 31, 2022 (“Fiscal 2022”), filed with the SEC on December 13, 2022, December 14, 2022, February 3, 2023 and February 9, 2023, respectively, except as noted in Note 9: Contingencies to the accompanying financial statements.

Item 1A. Risk Factors.

You should carefully review and consider the information regarding certain factors that could materially affect our business, financial condition or future results set forth under Part I, Item 1A, Risk Factors, contained in our Annual Report on Form 10-K and Form 10-K/A for Fiscal 2022, as filed with the SEC on December 13, 2022, December 14, 2022, February 3, 2023 and February 9, 2023, respectively, which are expressly incorporated herein by reference. There have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K and Forms 10-K/A for Fiscal 2022, filed with the SEC on December 13, 2022, December 14, 2022, February 3, 2023 and February 9, 2023, respectively.

In addition, we note that our President, CEO and director, Scott W. Absher, currently owns approximately 85.1% of the issued and outstanding shares of the Company’s common stock; accordingly, he may be deemed to control the Company as a result of his voting power and otherwise has significant influence over the voting matters of the shareholders of the Company’s common stock, including but not limited to the power to elect directors and approve other actions that require stockholder approval. Notwithstanding Mr. Absher's share ownership percentage, no action has been taken to seek the Controlled Company Exemption available under Nasdaq Listing Rule 5615(c)(2). If the Company were to seek Controlled Company status, (a) we would not be required to comply with certain governance requirements set forth in the listing standards, including requiring a majority of independent Directors on our Board, the determination of the compensation of our executive officers solely by independent Directors, and the recommendation of nominees for Director solely by independent Directors, and (b) as a result, the Company’s stockholders would not have certain of the same protections as a stockholder of other publicly-traded companies, and the market price of the Company’s common stock could be adversely affected. The concentration of ownership with respect to the Company’s common stock also results in there being a limited trading volume, which may make it more difficult for stockholders to sell their shares and increase the price volatility of the Company’s common stock.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Not applicable.

51

Item 6. Exhibits.

(a) Exhibits.

Exhibit No.	Document Description
31.1	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
31.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.
32.1*	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.
32.2*	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.

101*	Inline XBRL Document set for the financial statements and accompanying notes in Part I, Item 1, of this Quarterly Report on Form 10-Q.
104*	Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.

* Furnished herewith.

52

 SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ShiftPixy, Inc., a Wyoming corporation
DATE: July 17, 2023	By:	/s/ Scott W. Absher
		Scott W. Absher
		Principal Executive Officer
DATE: July 17, 2023	By:	/s/ Douglas Beck
		Douglas Beck
		Principal Financial Officer

53

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Scott W. Absher, certify that:

1.	I have reviewed this report on Form 10-Q of ShiftPixy, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
	a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c)	evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d)	disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):
	a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
	b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

	ShiftPixy, Inc.,
DATE: July 17, 2023	By:	/s/ Scott W. Absher
		Scott W. Absher
		Principal Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Douglas Beck, certify that:

1.	I have reviewed this report on Form 10-Q of ShiftPixy, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
	a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c)	evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d)	disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):
	a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
	b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

DATE: July 17, 2023	By:	/s/ Douglas Beck
		Douglas Beck
		Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that the Quarterly Report on Form 10-Q for the period ended May 31, 2023, of ShiftPixy, Inc. (the "Company") fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	ShiftPixy, Inc.,
DATE: July 17, 2023	By:	/s/ Scott W. Absher
		Scott W. Absher
		Principal Executive Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to ShiftPixy, Inc., and will be retained by ShiftPixy, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that the Quarterly Report on Form 10-Q for the period May 31, 2023, of ShiftPixy, Inc. (the "Company") fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

DATE: July 17, 2023	By:	/s/ Douglas Beck
		Douglas Beck
		Chief Financial Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to ShiftPixy, Inc. and will be retained by ShiftPixy, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - shares	9 Months Ended
	May 31, 2023	Jul. 14, 2023
Cover [Abstract]
Entity Registrant Name	SHIFTPIXY, INC.
Entity Central Index Key	0001675634
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--08-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	May 31, 2023
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		12,177,191
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-37954
Entity Incorporation State Country Code	WY
Entity Tax Identification Number	47-4211438
Entity Address Address Line 1	13450 W Sunrise Blvd
Entity Address Address Line 2	Suite 650
Entity Address City Or Town	Sunrise
Entity Address State Or Province	FL
Entity Address Postal Zip Code	33323
City Area Code	888
Local Phone Number	798-9100
Security 12b Title	Common Stock, par value $0.0001 per share
Trading Symbol	PIXY
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes

XML

Condensed Consolidated Balance Sheets - USD ($)	May 31, 2023	Aug. 31, 2022
Current assets
Cash	$ 144,000	$ 618,000
Accounts receivable, net of reserve of $10,000 and $0 as of May 31, 2023 and August 31, 2022 respectively	537,000	279,000
Unbilled accounts receivable	2,046,000	2,105,000
Prepaid expenses	256,000	696,000
Other current assets	271,000	187,000
Cash and marketable securities held in Trust Account (See Notes 2 and 4)	0	116,969,000
Total current assets	3,254,000	120,854,000
Fixed assets, net	2,665,000	2,769,000
Right-of-use operating lease	3,567,000	4,076,000
Deposits and other assets	1,098,000	919,000
Total assets	10,584,000	128,618,000
Current liabilities
Accounts payable and other accrued liabilities	18,342,000	17,121,000
Payroll related liabilities	24,379,000	16,055,000
Accrued workers' compensation costs	425,000	568,000
Current liabilities of discontinued operations	1,765,000	1,362,000
Class A common shares of SPAC mandatory redeemable 0 shares and 11,500,000 shares as of May 31, 2023 and August 31, 2022 (See Notes 2 and 4)	0	116,969,000
Total current liabilities	44,911,000	152,075,000
Non-current liabilities
Operating lease liability, non-current	3,017,000	3,541,000
Accrued workers' compensation costs	922,000	1,227,000
Non-current liabilities of discontinued operations	4,133,000	3,269,000
Total liabilities	52,983,000	160,112,000
Stockholders' deficit
Preferred stock, 50,000,000 authorized shares; $0.0001 par value: 0 and 8,600,000 shares issued and outstanding as of May 31, 2023 and August 31, 2022.	0	1,000
Common stock, 750,000,000 authorized shares; $0.0001 par value; 10,110,524 and 513,349 shares issued as of May 31, 2023 and August 31, 2022	6,000	5,000
Additional paid-in capital	168,967,000	151,731,000
Accumulated deficit	(211,372,000)	(192,725,000)
Total ShiftPixy, Inc. Stockholders' deficit	(42,399,000)	(40,988,000)
Non-controlling interest in consolidated subsidiary (See Note 4)	0	9,494,000
Total Stockholders' deficit	(42,399,000)	(31,494,000)
Total liabilities and Stockholders' deficit	$ 10,584,000	$ 128,618,000

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	May 31, 2023	Aug. 31, 2022
Condensed Consolidated Balance Sheets
Accounts receivable, net of reserve	$ 10,000	$ 0
Class A common shares of SPAC mandatory redeemable (in shares)	0	11,500,000
Stockholders' deficit
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares issued (in shares)	0	8,600,000
Preferred stock, shares outstanding (in shares)	0	8,600,000
Common stock, shares authorized (in shares)	750,000,000	750,000,000
Common stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares issued (in shares)	10,110,524	513,349

XML

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022
Condensed Consolidated Statements of Operations (Unaudited)
Revenues (See Note 2)	$ 3,988,000	$ 9,643,000	$ 13,833,000	$ 29,021,000
Cost of revenues	3,788,000	9,039,000	12,623,000	27,782,000
Gross profit	200,000	604,000	1,210,000	1,239,000
Operating expenses:
Salaries, wages, and payroll taxes	2,621,000	3,254,000	7,477,000	10,796,000
Professional fees	752,000	2,680,000	2,817,000	6,094,000
Software development	50,000	4,291,000	229,000	6,525,000
Depreciation and amortization	148,000	133,000	447,000	386,000
General and administrative	3,074,000	2,967,000	6,609,000	7,718,000
Total operating expenses	6,645,000	13,325,000	17,579,000	31,519,000
Operating loss	(6,445,000)	(12,721,000)	(16,369,000)	(30,280,000)
Other (expense) income:
Interest expense	(550,000)	(1,000)	(1,007,000)	(2,000)
Other income	0	27,000	536,000	43,000
SPAC offering costs	0	0	0	(515,000)
Total other expense	(550,000)	26,000	(471,000)	(474,000)
Net loss from continuing operations	(6,995,000)	(12,695,000)	(16,840,000)	(30,754,000)
Loss from discontinued operations, net of tax	(460,000)	(132,000)	(1,267,000)	(283,000)
Non-controlling interest	0	0	(540,000)	0
Net loss attributable to ShiftPixy, Inc.	(7,455,000)	(12,827,000)	(18,647,000)	(31,037,000)
Preferred stock preferential dividend	0	0	(127,145,000)	0
Deemed dividend from change in fair value from warrants modification	0	0	0	(7,731,000)
Net loss attributable to common stockholders	$ (7,455,000)	$ (12,827,000)	$ (145,792,000)	$ (38,768,000)
Net loss per share attributable, basic and diluted
Continuing operations - basic and diluted	$ (0.70)	$ (33.08)	$ (14.84)	$ (101.72)
Discontinued operations - basic and diluted	(0.05)	(0.34)	(0.13)	(0.75)
Net loss per common share - basic and diluted	$ (0.75)	$ (33.42)	$ (14.97)	$ (102.47)
Weighted average common shares outstanding - basic and diluted	10,057,177	383,726	9,739,578	378,349

XML

Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)	Total	Common Stock Issued	Preferred Stock Issued	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Noncontrolling interest	Total Stockholders' Deficit Shoft Pixy, Inc.
Balance, shares at Aug. 31, 2021		258,631
Balance, amount at Aug. 31, 2021	$ 40,923,000	$ 3,000	$ 0	$ 142,786,000	$ (149,338,000)	$ 47,472,000	$ (6,549,000)
Cumulative effect adjustment for ASC 842 lease accounting adoption	608,000	$ 0	0	0	608,000	0	608,000
Common stock issued for private placement, net of offering cost, shares		28,500
Common stock issued for private placement, net of offering cost, amount	4,183,000	$ 0	0	4,183,000	0	0	4,183,000
Common stock issued on exercised warrants, net of offering costs, shares		96,218
Common stock issued on exercised warrants, net of offering costs, amount	5,410,000	$ 1,000	0	5,409,000	0	0	5,410,000
Prefunded warrants from private placement, net of offering costs	6,861,000	0	0	6,861,000	0	0	6,861,000
Stock-based compensation expense	1,069,000	0	0	1,069,000	0	0	1,069,000
Remeasurement of IHC temporary equity	(13,431,000)	0	0	(13,431,000)	0	0	(13,431,000)
Withdrawal of SPAC registrations under Form S-1	(37,978,000)	0	0	0	0	(37,978,000)	0
Net loss	(31,037,000)	0	0	0	(31,037,000)	0	(31,037,000)
Balance, amount at May. 31, 2022	(23,392,000)	$ 4,000	0	146,877,000	(179,767,000)	9,494,000	(32,886,000)
Balance, shares at May. 31, 2022		383,349
Balance, shares at Feb. 28, 2022		336,616
Balance, amount at Feb. 28, 2022	(10,727,000)	$ 3,000	0	146,716,000	(166,940,000)	9,494,000	(20,221,000)
Common stock issued on exercised warrants, net of offering costs, shares		46,733
Common stock issued on exercised warrants, net of offering costs, amount	1,000	$ 1,000	0		0	0	1,000
Stock-based compensation expense	321,000	0	0	321,000	0	0	321,000
Remeasurement of IHC temporary equity	(160,000)	0	0	(160,000)	0	0	(160,000)
Net loss	(12,827,000)	0	0	0	(12,827,000)	0	(12,827,000)
Balance, amount at May. 31, 2022	(23,392,000)	$ 4,000	$ 0	146,877,000	(179,767,000)	9,494,000	(32,886,000)
Balance, shares at May. 31, 2022		383,349
Balance, shares at Aug. 31, 2022		513,349	8,600,000
Balance, amount at Aug. 31, 2022	(31,494,000)	$ 5,000	$ 1,000	151,731,000	(192,725,000)	9,494,000	(40,988,000)
Stock-based compensation expense	735,000	0	0	735,000	0	0	735,000
Net loss	(18,647,000)	0	0	0	(18,647,000)	0	(18,647,000)
Fair market value increase of preferred stock prior to reverse stock split	127,145,000	0	0	127,145,000	0	0	127,145,000
Preferential dividend of preferred stock	(127,145,000)	$ 0	0	(127,145,000)	0	0	(127,145,000)
Common stock issued on exercised prefunded warrants, shares		124,204
Common stock issued on exercised prefunded warrants, amount	1,000	$ 0	0	1,000	0	0	1,000
Common stock issued for private placement, net of offering costs, shares		416,667
Common stock issued for private placement, net of offering costs, amount	4,387,000	$ 0	$ 0	4,387,000	0	0	4,387,000
Common stock issued on conversion of preferred shares, shares		8,600,000	(8,600,000)
Common stock issued on conversion of preferred shares, amount	0	$ 1,000	$ (1,000)	0	0	0	0
Warrant modification expense	106,000	$ 0	0	106,000	0	0	106,000
Additional shares issued due to reverse stock split, shares		16,976
Additional shares issued due to reverse stock split, amount	0	$ 0	0	0	0	0	0
Net proceeds of ATM, net of offering expenses, shares		439,328
Net proceeds of ATM, net of offering expenses, amount	1,973,000	$ 0	0	1,973,000	0	0	1,973,000
Deconsolidation of VIE	540,000	0	0	10,034,000	0	(9,494,000)	10,034,000
Balance, amount at May. 31, 2023	(42,399,000)	$ 6,000	0	168,967,000	(211,372,000)	0	(42,399,000)
Balance, shares at May. 31, 2023		10,110,524
Balance, shares at Feb. 28, 2023		9,976,536
Balance, amount at Feb. 28, 2023	(35,718,000)	$ 6,000	0	168,193,000	(203,917,000)	9,494,000	(35,718,000)
Stock-based compensation expense	235,000	0	0	235,000	0	0	235,000
Net loss	(7,455,000)	$ 0	0	0	(7,455,000)	0	(7,455,000)
Proceeds of ATM, net of offering expenses, shares		133,988
Proceeds of ATM, net of offering expenses, amount	539,000	$ 0	0	539,000	0	0	539,000
Balance, amount at May. 31, 2023	$ (42,399,000)	$ 6,000	$ 0	$ 168,967,000	$ (211,372,000)	$ 0	$ (42,399,000)
Balance, shares at May. 31, 2023		10,110,524

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	May 31, 2023	May 31, 2022
OPERATING ACTIVITIES
Net loss attributable to ShiftPixy, Inc stockholders	$ (18,647,000)	$ (31,037,000)
Loss from discontinued operations	(1,267,000)	(283,000)
Non-controlling interest	(540,000)	0
Net loss from continuing operations	(16,840,000)	(30,754,000)
Adjustments to reconcile net loss to net cash used in operations
Depreciation and amortization	447,000	386,000
Provision for doubtful accounts	10,000	0
Stock-based compensation	735,000	1,069,000
Stock-based compensation - shares for services accrued to directors	169,000	0
Impaired asset expense	0	4,004,000
Warrant modification expense	106,000	0
Expensed SPAC offering cost	0	515,000
Amortization of operating lease	85,000	727,000
Changes in operating assets and liabilities:
Accounts receivable	(268,000)	146,000
Unbilled accounts receivable	59,000	(729,000)
Prepaid expenses and other current assets	356,000	(146,000)
Deposits - workers' compensation	0	541,000
Deposits and other assets	(79,000)	0
Accounts payable and other accrued liabilities	952,000	4,573,000
Payroll related liabilities	8,324,000	6,583,000
Accrued workers' compensation costs	(448,000)	(295,000)
Total adjustment	10,448,000	17,374,000
Net cash used in continuing operations	(6,392,000)	(13,380,000)
Net cash provided by discontinued operating activities	0	0
Net cash used in operations	(6,392,000)	(13,380,000)
INVESTING ACTIVITIES
Investment of IHC IPO proceeds into Trust Account	0	(116,765,000)
Redemption of Trust Account	117,574,000	0
Investment in private company	(100,000)
Purchase of fixed assets	(343,000)	(500,000)
Net cash provided by (used in) investing activities	117,131,000	(117,265,000)
FINANCING ACTIVITIES
SPAC related offering costs paid	0	(3,663,000)
Proceeds from initial public offering of IHC	0	116,725,000
Payment to IHC shareholders	(117,574,000)	0
Proceeds from exercised warrants. Net of offering costs	1,000	5,410,000
Proceeds from private placement, net of offering costs	4,387,000	4,183,000
Proceeds from At-The-Market Offering, net of offering costs	1,973,000	0
Deferred offering costs		0
Proceeds from private placement prefunded warrants, net of offering costs	0	6,861,000
Net cash (used in) provided by financing activities	(111,213,000)	129,516,000
Net increase in cash	(474,000)	(1,129,000)
Cash - beginning of period	618,000	1,199,000
Cash - end of period	144,000	70,000
Supplemental Disclosure of Cash Flows Information:
Cash paid for interest	102,000	2,000
Non-cash Investing and Financing Activities:
Deconsolidation of VIE	9,494,000	0
Elimination of deferred offering cost of abandoned SPAC's initial public offering	0	37,978,000
Change in fair value due to warrant modification	0	13,728,000
Operating lease assets and liabilities s from adoption of ASC 842	0	8,970,000
Increase in marketable securities in trust account and Class A mandatory redeemable common shares	801,000	0
Transfer of preferred shares to common shares	$ 1,000	$ 0

XML

Nature of Operations

9 Months Ended

May 31, 2023

Nature of Operations

Nature of Operations

Note 1: Nature of Operations

ShiftPixy, Inc. (the “Company”) was incorporated on June 3, 2015, in the State of Wyoming. The Company is a specialized Human Capital service provider that provides solutions for large, contingent, part-time workforce demands, primarily in the restaurant and hospitality service trades. The Company’s historic focus has been on the quick service restaurant industry in Southern California, but the Company has expanded into other geographic areas and industries that employ temporary or part-time labor sources, notably including the healthcare industry.

The Company functions as an employment administrative services (“EAS”) provider primarily through its wholly owned subsidiary, ReThink Human Capital Management, Inc. (“HCM”), as well as a staffing provider through another of its wholly owned subsidiaries, ShiftPixy Staffing, Inc. (“Staffing”). These subsidiaries provide a variety of services to our clients typically as a co-employer through HCM and a direct employer through Staffing, including the following: administrative services, payroll processing, human resources consulting, and workers’ compensation administration and coverage (as permitted and/or required by state law). The Company has built a human resources information systems (“HRIS”) platform to assist in customer acquisition that simplifies the onboarding of new clients into the Company’s closed proprietary operating and processing information system (the “ShiftPixy Ecosystem”). The Company expects this HRIS platform to facilitate additional value-added services in future reporting periods.

In January 2020, the Company sold the assets of Shift Human Capital Management Inc. (“SHCM”), a wholly owned subsidiary of the Company, pursuant to which the Company assigned the majority of the Company’s billable clients at the time of the sale to a third party for cash. The continuing impact of this transaction on the Company’s financial statements is described below in Note 3, Discontinued Operations.

Effective September 1, 2022, the Company filed articles of amendment to the Company’s articles of incorporation to effect a one-for-one hundred (1:100) reverse split of the Company’s issued and outstanding share of common stock. The reverse split became effective on NASDAQ, September 1, 2022. All share related numbers in this Report on Form 10-Q give effect to this reverse split.

XML

Summary of Significant Accounting Policies

9 Months Ended

May 31, 2023

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Note 2: Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) applicable to interim reports of smaller reporting companies. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results of unaudited condensed operations for the three and nine months end May 31, 2023 are not necessarily indicative of the results that may be expected for the full year ending August 31, 2023.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2022 (“Fiscal 2022”), filed with the SEC on December 13, 2022, as amended by Forms 10-K/A, filed with the SEC on December 14, 2022, February 3, 2023 and February 9, 2023, respectively.

Principles of Consolidation

The unaudited condensed consolidated financial statements include the accounts of ShiftPixy, Inc., and its wholly owned subsidiaries. The unaudited condensed consolidated financial statements previously included the accounts of Industrial Human Capital, Inc. (“IHC”), which was a special purpose acquisition company, or “SPAC,” for which our wholly owned subsidiary, ShiftPixy Investments, Inc., served as the financial sponsor (as described below), and which SPAC was deemed to be controlled by us as a result of the Company’s 15% equity ownership stake, the overlap of three of our executive officers for a period of time as executive officers of IHC, and significant influence that the Company exercised over the funding and acquisition of new operations for an initial business combination (“IBC”). (See Note 2, Variable Interest Entity). All intercompany balances have been eliminated in consolidation. As of February 7, 2023, IHC was not a part of the Company’s operations, and consolidation. IHC was dissolved on November 14, 2022, and the Trustee released all the redemption funds from the Trust Account, See Note 4, to IHC shareholders on December 1, 2022, effectively liquidating the Trust. On February 7, 2023, three creditors of IHC filed an involuntary petition for liquidation under Chapter 7 against IHC in the US Bankruptcy Court for the Southern District of Florida. See Note 4, Pursuant to ASC 810-10-15, consolidation is precluded where control does not rest for a non-controlling interest in legal reorganization or bankruptcy. In addition, IHC did not meet the criteria of a Variable Interest Entity (VIE), see Note 4.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include:

· Continuation as a going concern; management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets and liquidation of all liabilities in the normal course of business

· Liability for legal contingencies

· Useful lives of property and equipment

· Deferred income taxes and related valuation allowance

· Projected development of workers’ compensation claims.

These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions are difficult to measure of value.

Management regularly reviews the key factors and assumptions to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such valuation, if deemed appropriate, those estimates are adjusted accordingly.

Liquidity, Capital Resources and Going Concern

Under the existing accounting guidance, management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the condensed consolidated financial statements are issued. This evaluation initially does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented as of the date the unaudited condensed consolidated financial statements are issued. When substantial doubt is determined to exist, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans; however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date the unaudited condensed consolidated financial statements are issued, and (2) it is probable that the plans, when implemented, may mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date the condensed consolidated financial statements are issued. Therefore, management has concluded that there is substantial doubt in the Company’s ability to continue as a going concern for the next twelve months.

As of May 31, 2023, the Company had cash of $0.1 million and a working capital deficit of $41.7 million. During the nine months ended May 31, 2023, the Company used approximately $6.7 million of cash from its continuing operations and incurred recurring losses, resulting in an accumulated deficit of $211.4 million. As of May 31, 2023, the Company is delinquent with respect to remitting payroll tax payments to the IRS. The Company has been in communication with the IRS regarding amounts owing in relation to Employee Retention Tax Credits (“ERTCs”) due. In addition, some clients have filed suits against the Company, demanding that the Company take action to file for additional ERTCs for certain tax periods. Until the matter is concluded, and the taxes are paid, the IRS could, subject to its standard processes and the Company’s right to respond, implement collection actions, including such actions as levying against Company bank accounts, to recover the amounts that it calculates to be due and owing.

Historically, the Company’s principal source of financing has come through the sale of the Company's common stock, including in certain instances, warrants and the issuance of convertible notes.

On January 31, 2023, the Company filed a registration statement on Form S-3 and related prospectus for the sale of up to $100 million of the Company’s equity securities via a “shelf” or "at-the-market” (“ATM”) sales mechanism over a three-year period. The registration statement also included a prospectus supplement providing for the sale of up to $8,187,827 of the Company’s shares of common stock, which the Company proposed to effect pursuant to an ATM Issuance Sales Agreement (“Sales Agreement”) executed with A.G.P./Alliance Global Partners (the “Agent” or “AGP”). Under the Sales Agreement, the Company’s shares of common stock could be sold from time to time and at various prices at the Company’s sole control, subject to the conditions and limitations in the Sales Agreement with AGP. The ATM was scheduled to expire on January 31, 2026. For the nine-months ended May 31, 2023, the Company received $2.4 million in gross proceeds ($2.0 million, net of costs) from the sale of 439,429 shares of the Company’s common stock. On May 22, 2023, the Company terminated the Sales Agreement and concluded the ATM. There is a limitation on the amount of funds that the Company can access under the baby shelf rules which is the value of a company’s public float if less than $75 million, The Company can only raise ⅓ of its float value over the previous 12-month period.

On July 12, 2023, the Company priced a “best efforts” public offering for the sale by the Company of an aggregate of 1,166,667 shares of common stock, 900,000 pre-funded warrants, and 2,066,667 common warrants. The public offering price was $1.50 per share and accompanying common warrant, or $1.4999 per pre-funded warrant and accompanying common warrant. The pre-funded warrants are exercisable immediately, may be exercised at any time until all of the pre-funded warrants are exercised in full, and have an exercise price of $0.0001.  The common warrants are exercisable immediately for a term of five years and have an exercise price of $1.50 per share. 1,100,000 shares, 900,000 pre-funded warrants and 2,000,000 common warrants under the offering were sold pursuant to a securities purchase agreement with an investor. A.G.P./Alliance Global Partners acted as placement agent for the offering and received a fee of 7% of the gross proceeds and reimbursement of $75,000 of expenses. The total estimated offering expenses were approximately $0.6millon and the net proceeds of approximately $2.5 million. The offering closed on July 14, 2023. Effective upon closing of the offering, the exercise price of an aggregate of 1,186,742 outstanding warrants the Company issued to an investor in 2020 and 2022 was reduced to $1.50 per share, subject to further adjustment as provided in the warrants, pursuant to a warrant amendment the Company entered into with the investor.

The Company’s plans and expectations for the next twelve months include raising additional capital to help fund expansion of the Company’s operations and strengthening of the Company’s sales force strategy by focusing on staffing services as the key driver to improve the Company’s margin and the continued support and functionality improvement of the Company’s information technology (“IT”) and HRIS platform. This expanded go-to-market strategy will focus on building a national account portfolio managed by a newly-formed regional team of senior sales executives singularly focused on sustained quarterly revenue growth and gross profit margin expansion. The Company expects to continue to invest in the Company’s HRIS platform, ShiftPixy Labs, and other growth initiatives, all of which have required and will continue to require significant cash expenditures.

The Company expects to raise capital from additional sales of its securities during this fiscal year either through registered public offerings or private placements, the proceeds of which the Company intends to use to fund its operations and growth initiatives. There can be no assurance that we will be able to sell securities on terms that the Company is seeking, or at all. Although management believes that its current cash position, along with its anticipated revenue growth and proceeds from future sales of its securities, when combined with prudent expense management, could alleviate substantial doubt, there is no assurance about its ability to continue as a going concern and to fund its operations for at least one year from the date these financials are available (even with the absence of any funded debt outstanding on its balance sheet). If these sources do not provide the capital necessary to fund the Company’s operations during the next twelve months, it may need to curtail certain aspects of its operations or expansion activities, consider the sale of additional assets, or consider other means of financing. The Company can give no assurance that it will be successful in implementing its business plan and obtaining financing on advantageous terms, or that any such additional financing will be available. If the Company is not successful in obtaining the necessary financing, we do not currently have the cash resources to meet our operating commitments for the next twelve months. Therefore, management has concluded that there is substantial doubt in the Company's ability to continue as a going concern for the next twelve months.

Reclassification

The Company reclassified certain expenses to conform to the current year's presentation.

Revenue and Direct Cost Recognition

The Company’s revenues are primarily disaggregated into fees for providing staffing solutions and EAS/HCM services. The Company enters into contracts with its clients for Staffing or EAS based on a stated rate and price in the contract. Contracts generally have a term of 12 months, however, are cancellable at any time by either party with 30 days’ written notice. The performance obligations in the agreements are generally combined into one performance obligation, as they are considered a series of distinct services, and are satisfied over time because the client simultaneously receives and consumes the benefits provided as the Company performs the services. Payments for the Company’s services are typically made in advance of, or at the time that the services are provided. The Company does not have significant financing components or significant payment terms for its customers and consequently has no material credit losses. The Company uses the output method based on a stated rate and price over the payroll processed to recognize revenue, as the value to the client of the goods or services transferred to date appropriately depicts the Company’s performance towards complete satisfaction of the performance obligation.

Staffing Solutions

The Company records gross billings as revenues for its staffing solutions clients. The Company is primarily responsible for fulfilling the staffing solutions services and has discretion in establishing price. The Company includes the payroll costs in revenues with a corresponding increase to cost of revenues for payroll costs associated with these services. As a result, we are the principal in this arrangement for revenue recognition purposes.

EAS Solutions / HCM

EAS solutions revenue is primarily derived from the Company’s gross billings, which are based on (i) the payroll cost of the Company’s worksite employees (“WSEs”) and (ii) a mark-up computed as a percentage of payroll costs for payroll taxes and workers’ compensation premiums.

Gross billings are invoiced to each EAS client concurrently with each periodic payroll of the Company’s WSEs, which coincides with the services provided and which is typically a fixed percentage of the payroll processed. Revenues, which exclude the payroll cost component of gross billings and therefore consist solely of markup, are recognized ratably over the payroll period as WSEs perform their services at the client worksite. Although the Company assumes responsibility for processing and remitting payroll and payroll related obligations, it does not assume employment-related responsibilities such as determining the amount of the payroll and related payroll obligations. As a result, the Company records revenue on a “net” basis in this arrangement for revenue recognition purposes. Revenues that have been recognized but not invoice are included in unbilled accounts receivable on the Company’s condensed consolidated balance sheets were $2.0 million and $2.1 million, as of May 31, 2023 and August 31, 2022, respectively.

Consistent with the Company’s revenue recognition policy for EAS clients, direct costs do not include the payroll cost of its WSEs. The cost of revenue associated with the Company’s revenue generating activities is primarily comprised of all other costs related to its WSEs, such as the employer portion of payroll-related taxes, employee benefit plan premiums and workers’ compensation insurance costs.

The fees collected from the worksite employers for benefits (i.e. zero-margin benefits pass-through), workers’ compensation and state unemployment taxes are presented in revenues and the associated costs of benefits, workers’ compensation and state unemployment taxes are included in operating expenses for EAS clients, as the Company does retain risk and acts as a principal with respect to this aspect of the arrangement. With respect to these fees, the Company is primarily responsible for fulfilling the service and has discretion in establishing price.

Disaggregation of Revenue

The Company’s primary revenue streams include HCM and staffing services. The Company’s disaggregated revenues for the nine months ended May 31, and May 31, 2022, respectively, were as follows:

	For the Three Months Ended				For the Nine Months Ended
Revenue (in thousands):	May 31, 2023		May 31, 2022		May 31, 2023		May 31, 2022
HCM1	$	111	$	1,734	$	1,521	$	4,052
Staffing		3,877		7,909		12,312		24,969

¹ HCM revenue is presented net, $8.3 million and $30.7 million gross billings less WSE payroll costs of $8.2 million and $29.2 million for the three and nine months ended May 31, 2023, respectively. Gross billings were $13.9 million and $39.4 million less WSE payroll costs of 12.2 million and $35.3 million for the three and nine months ended May 31, 2022, respectively.

For the three and nine months ended May 31, 2023 and May 31, 2022, respectively, the following geographical regions represented more than 10% of total revenues:

	For the Three Months Ended						For the Nine Months Ended
Region:	May 31, 2023			May 31, 2022			May 31, 2023			May 31, 2022
California		33.1	%		49.0	%		42.5	%		52.2	%
Washington		15.5	%		14.9	%		12.8	%		13.7	%
New Mexico		12.9	%		7.6	%		11.9	%		7.4	%

Incremental Cost of Obtaining a Contract

Pursuant to the “practical expedients” provided under Accounting Standards Update “ASC” No 2014-09, the Company expenses sales commissions when incurred because the terms of its contracts are cancellable by either party upon 30 day’' notice. These costs are recorded in commissions in the Company’s unaudited condensed consolidated statements of operations.

Segment Reporting

Prior to August 31, 2021, the Company operated as one reportable segment under Accounting Standards Codification “ASC” 280, Segment Reporting. The chief operating decision maker regularly reviews the financial information of the Company at a consolidated level in deciding how to allocate resources and in assessing performance. Reporting and monitoring activities on a segment basis will allow the chief operating decision maker to evaluate operating performance more effectively. However, the Company is working on its systems to properly allocate to its business segments. However, the CEO is actively involved in the day to day business and is aware of the overall segment information.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased as cash equivalents. The Company had no cash equivalent as of May 31, 2023 and August 31, 2022.

Marketable Securities Held in Trust Account

As of August 31, 2022, substantially all of the assets held in the Trust Account were invested in U.S. Treasury securities with maturities of 180 days or less. These funds are restricted for use and may only be used for purposes of completing an initial business combination ("IB") or redemption of the public common shares of IHC. On December 1, 2022, the Company distributed $117.6 million to the shareholders of IHC. There were no assets held in the Trust Account as of May 31, 2023.

Concentration of Credit Risk

The Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal. As of May 31, 2023 and August 31, 2022, there was $0.0 million and $0.6 million, respectively, of cash on deposit in excess of the amounts insured by the FDIC.

The following represents clients who have ten percent of total accounts receivable as of May 31, 2023 and August 31, 2022, respectively.

	As of
	May 31, 2023			August 31, 2022
Clients:	(Unaudited)
Client 1		57.8	%	—		%
Client 2		21.4	%		41.9	%
Client 3		9.6	%		13.7	%
Client 4		6.3	%		21.9	%
Client 5	—		%		20.7	%

Fixed Assets

Fixed assets are recorded at cost, less accumulated depreciation and amortization. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When fixed assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Leasehold improvements are amortized over the shorter of the useful life or the initial lease term.

Fixed assets are recorded at cost and are depreciated over the estimated useful lives of the related assets using the straight-line method. The estimated useful lives of property and equipment for purposes of computing depreciation are as follows:

Equipment:	5 years
Furniture & Fixtures:	5 – 7 years
Leasehold improvements	Shorter of useful life or the remaining lease term, typically 5 years

Depreciation and amortization expense for the three months ended May 31, 2023 and May 31, 2022 was $0.1 million and $0.1 million, respectively, and included on the unaudited condensed consolidated statements of operations. Depreciation and amortization expense for the nine months ended May 31, 2023 and May 31, 2022 was $0.4 million and $0.4 million, respectively.

Computer Software Development

Software development costs relate primarily to software coding, systems interfaces and testing of the Company’s proprietary employer information systems and are accounted for in accordance with Accounting Standards Codification “ASC” 350-40, Internal Use Software.

Internal software development costs are capitalized from the time the internal use software is considered probable of completion until the software is ready for use. Business analysis, system evaluation and software maintenance costs are expensed as incurred. The capitalized computer software development costs are reported under the section fixed assets, net in the consolidated balance sheets and are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company determined that there was no material capitalized internal software development costs for the nine months ended May 31, 2023 and August 31, 2022. All capitalized software recorded was purchased from third party vendors. Capitalized software development costs are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company incurred research and development costs of $0.2 million and $0.7 million for the three and nine months ended May 31, 2023, respectively. During the three and nine months ended May 31, 2022, the Company incurred research and development costs of approximately $1.1 million and $5 million, respectively. All costs were related to internally developed or externally contracted software and related technology for the Company’s HRIS platform and related mobile application.

Lease Recognition

The Financial Accounting Standards Board "FASB" established Topic 842, Leases, by issuing ASU No. 2016-02 “ASC” 842, which required lessees to recognize leases on the balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The standard established a right-of-use asset model (“ROU”) that required a lessee to recognize an ROU operating lease asset and lease liability on the condensed balance sheets for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the unaudited condensed consolidated statement of operations.

Impairment and Disposal of Long-Lived Assets

The Company periodically evaluates its long-lived assets for impairment in accordance with ASC 360-10, Property, Plant, and Equipment. ASC 360-10 requires that an impairment loss be recognized for assets to be disposed of or held-for-use when the carrying amount of an asset is deemed not to be recoverable. If events or circumstances were to indicate that any of the Company’s long-lived assets might be impaired, the Company would assess recoverability based on the estimated undiscounted future cash flows to be generated from the applicable asset. In addition, the Company may record an impairment loss to the extent that the carrying value of the asset exceeds the fair value of the asset. Fair value is generally determined using an estimate of discounted future net cash flows from operating activities or upon disposal of the asset. The Company assessed impairment for the periods presented and no impairment charges were deemed necessary.

Workers’ Compensation

Everest Program

Until July 2018, a portion of the Company’s workers’ compensation risk was covered by a retrospective rated policy through Everest National Insurance Company, which calculates the final policy premium based on the Company’s loss experience during the term of the policy and the stipulated formula set forth in the policy. The Company funded the policy based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. During the policy term and thereafter, periodic adjustments may involve either a return of previously paid premiums or a payment of additional premiums by the Company or a combination of both. If the Company’s losses under that policy exceed the expected losses under that policy, then the Company could receive a demand for additional premium payments. The Company became engaged in litigation regarding such a demand for additional premium payments; however, the Company has entered into a settlement agreement with Everest and Gallagher Bassett, concluding the litigation. See Note 9, Contingencies, Everest Litigation, below and Note 10 subsequent events. The Company has accrued for this settlement as of May 31, 2023.

Sunz Program

From July 2018 through February 28, 2021, the Company’s workers’ compensation program for its WSEs was provided primarily through an arrangement with United Wisconsin Insurance Company and administered by Sunz Insurance Solutions, LLC (“Sunz”). Under this program, the Company has financial responsibility for the first $0.5 million of claims per occurrence. The Company provides and maintains a loss fund that is earmarked to pay claims and claims related expenses. The workers’ compensation insurance carrier establishes monthly funding requirements comprised of premium costs and funds to be set aside for payment of future claims (“claim loss funds”). The level of claim loss funds is primarily based upon anticipated WSE payroll levels and expected workers’ compensation loss rates, as determined by the insurance carrier. Monies funded into the program for incurred claims expected to be paid within one year were recorded as Deposit - workers’ compensation, a short-term asset, while the remainder of claim funds were included in Deposit - workers’ compensation, a long-term asset in our condensed consolidated balance sheets. The Company is currently engaged in litigation regarding demands by Sunz for additional claims loss funds, which we believe to be without merit, as discussed at Note 9, Contingencies, Sunz Litigation, below.

Under the Everest and Sunz programs, the Company utilized a third party to estimate its loss development rate, which was based primarily upon the nature of WSEs’ job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates.

There were no workers compensation deposits related to these programs as of May 31, 2023, and as of August 31, 2022, respectively.

Current Program

Effective March 1, 2021, the Company migrated its clients to a guaranteed cost program. Under this program, the Company’s financial responsibility is limited to the cost of the workers’ compensation premium. The Company funds the workers’ compensation premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. Any final adjustments to the premiums are based on the final audited exposure multiplied by the applicable rates, classifications, experience modifications and any other associated rating criteria.

With regard to the prior programs, which continue until fully concluded, the Company’s estimate of incurred claim costs expected to be paid within one year is included in short-term liabilities, while its estimate of incurred claim costs expected to be paid beyond one year is included in long-term liabilities on its consolidated balance sheets. As of May 31, 2023 and August 31, 2022, the Company had short term accrued workers’ compensation costs of $0.4 million and $0.6 million, and long-term accrued workers’ compensation costs of $0.9 million and $1.2 million, respectively.

The Company retained workers’ compensation asset reserves and workers’ compensation related liabilities for former WSEs of clients transferred to Shiftable HR Acquisition, LLC, a wholly owned subsidiary of Vensure Employer Services, Inc. (“Vensure”), in connection with the Vensure Asset Sale described in Note 3, Discontinued Operations, below. As of May 31, 2023, the retained workers’ compensation assets and liabilities are presented as a discontinued operation net asset or liability. As of May 31, 2023 and August 31, 2022, the Company had $1.8 million and $1.4 million in short-term liabilities, and $4.1 million and $3.3 million in long-term liabilities, respectively. The Company had no related worker's compensation assets as of May 31, 2023 and as of August 31, 2022, respectively.

Because the Company bears the financial responsibility for claims up to the level noted above, such claims, which are the primary component of its workers’ compensation costs, are recorded in the period incurred. Workers’ compensation insurance includes ongoing health care and indemnity coverage whereby claims are paid over numerous years following the date of injury. Accordingly, the accrual of related incurred costs in each reporting period includes estimates, which take into account the ongoing development of claims and therefore require a significant level of judgment. In estimating ultimate loss rates, the Company utilizes historical loss experience, exposure data, and actuarial judgment, together with a range of inputs that are primarily based upon the WSE’s job responsibilities, their location, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. For each reporting period, changes in the actuarial assumptions resulting from changes in actual claims experience and other trends are incorporated into the Company’s workers’ compensation claims cost estimates. The estimated incurred claims are based upon: (i) the level of claims processed during each quarter; (ii) estimated completion rates based upon recent claim development patterns under the plan; and (iii) the number of participants in the plan.

The Company has had very limited and immaterial COVID-19 related claims between March 2020 through the date of this Quarterly Report, although there is a possibility of additional workers’ compensation claims being made by furloughed WSEs as a result of the employment downturn caused by the pandemic. On May 4, 2020, the State of California indicated that workers who become ill with COVID-19 would have a potential claim against workers’ compensation insurance for their illnesses. There is a possibility that additional workers’ compensation claims could be made by employees required to work by their employers during the COVID-19 pandemic, which could have a material impact on the Company's workers’ compensation liability estimates. While the Company has not seen significant additional expenses as a result of any such potential claims to date, which would include claims for reporting periods after May 31, 2023, we continue to monitor closely all workers’ compensation claims made in relation to the COVID-19 pandemic.

Fair Value of Financial Instruments

Accounting Standard Codification "ASC" 820, Fair Value Measurement, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practical to estimate fair value. ASC 820 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of May 31, 2023 and August 31, 2022, the carrying value of certain financial instruments (cash, accounts receivable and payable) approximated fair value due to the short-term nature of the instruments. Notes Receivable is valued at the Company's estimate of expected collections value as described below, See Note 3, Discontinued Operations.

The Company measures fair value under a framework that utilizes a hierarchy prioritizing the inputs to relevant valuation techniques. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used in measuring fair value are:

· Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

· Level 2: Inputs to the valuation methodology include

· Quoted prices for similar assets or liabilities in active markets

· Quoted prices for identical or similar assets or liabilities in inactive markets

· Inputs other than quoted prices that are observable for the asset or liability

· Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and

· If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability

· Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement

Funds held in Trust Account represent U.S. treasury bills that was restricted for use and may only be used for purposes of completing an IBC or redemption of the public shares of common stock of the SPACs as set forth in their respective trust agreements. The funds held in trust are included within Level 1 of the fair value hierarchy and included in cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheets. The Trustee distributed all the funds in the Trust Account to the shareholders of IHC on December 1, 2022.

When the Company changes its valuation inputs for measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it could be required to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these transfers at the end of the reporting period that the transfers occur. The development and determination of the unobservable inputs for Level 3 fair value measurements and the fair value calculations are the responsibility of the Company’s chief financial officer and are approved by the chief executive officer. There were no transfers out of Level 3 for the nine months ended May 31, 2023 and August 31, 2022.

Advertising Costs

The Company expenses all advertising as incurred. Advertising expense for the three months ended May 31, 2023 and May 31, 2022 was $0.8 million and $0.4 million, respectively. Advertising expense for the nine months end May 31, 2023 and May 31, 2022 was $2.0 million and $1.4 million, respectively.

Income Taxes

The Company accounts for income taxes pursuant to ASC 740, Income Taxes. Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. A full valuation allowance was recorded as of May 31, 2023 and August 31, 2022, respectively,

Income (Loss) Per Share

Basic net income or net (loss) per common share is computed by dividing net income or net (loss) attributable to common shareholders by the weighted-average number of shares of common stock outstanding during the reporting period. Common stock outstanding for purposes of net income or net (loss) per share calculations include options, warrants, shares of common stock to be issued to directors for services provided and Preferred Option. Diluted net income or and net (loss) per share is computed similar to basic income or net (loss) per share except that the denominator is increased to include additional common stock equivalents available upon exercise of stock options, warrants, shares of common stock to be issued to directors for services provided and Preferred Option using the treasury stock method. Dilutive common stock equivalents include the dilutive effect of in-the-money stock equivalents, which are calculated based on the average share price for each period using the treasury stock method, excluding any common stock equivalents if their effect would be anti-dilutive. In periods in which a net loss has been incurred, all potentially dilutive common stock shares are considered anti-dilutive and thus are excluded from the calculation. Securities that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, are:

	Three Months Ended				Nine Months Ended
	May 31, 2023		May 31, 2022		May 31, 2023		May 31, 2022
Options (See Note 5)		10,003		15,498		10,003		15,498
Warrants (See Note 5)		1,252,749		224,402		1,252,749		224,402
Shares of common stock to be issued to directors for services provided, (See Note 7)		59,040		—		59,040		—
Preferred Option (Note 5)		37,570		—		37,570		—
Total potentially dilutive shares		1,359,362		239,900		1,359,362		239,900

For the table above, “Options” represent all options granted under the Company’s 2017 Stock Option/Stock Issuance Plan (the "Plan"), as described in Note 5, Stock Based Compensation, below.

Stock-Based Compensation

The Company has one stock-based compensation plan under which the Company may issue awards, as described in Note 5, Stock Based Compensation, below. The Company accounts for the Plan under the recognition and measurement principles of ASC 718, Compensation-Stock Compensation, which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the unaudited condensed consolidated statements of operations at their fair values.

The grant date fair value is determined using the Black-Scholes-Merton (“Black-Scholes”) pricing model. For all employee stock options, the Company recognizes expense on an accelerated basis over the employee’s requisite service period (generally the vesting period of the equity grant).

The Company’s option pricing model requires the input of highly subjective assumptions, including the expected stock price volatility and expected term. The expected volatility is based on the historical volatility of the Company’s common stock since the Company's initial public offering. Any changes in these highly subjective assumptions significantly impact stock-based compensation expense.

The Company elects to account for forfeitures as they occur. As such, compensation cost previously recognized for an unvested award that is forfeited because of the failure to satisfy a service condition is revised in the period of forfeiture.

The methods and assumptions used in the determination of the fair value of stock-based awards are consistent with those described in the Company's Annual Report on Form 10-K for the year ending August 31, 2022, filed with the SEC on December 13, 2022, and the amendments thereto on Forms 10-K/A filed with the SEC on December 14, 2022, February 3, 2023 and February 9, 2023, respectively, which include a detailed description of the Company's stock-based compensation awards, including information related to vesting terms, service and performance conditions, payout percentages, and process for estimating the fair value of stock options granted.

Recently Adopted Accounting Standards

In June 2016, the Financial Accounting Standards Board "FASB" issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This standard requires an impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces multiple existing impairment models in current. GAAP, which generally requires a loss to be incurred before it is recognized. The new standard applies to trade receivables arising from revenue transactions such as contract assets and accounts receivable. Under ASC 606, revenue is recognized when, among other criteria, it is probable that an entity will collect the consideration it is entitled to when goods or services are transferred to a customer. When trade receivables are recorded, they become subject to the CECL model and estimates of expected credit losses on trade receivables over their contractual life will be required to be recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. For the three months ended May 31, 2023, the Company adopted this guidance, and it was not material to the results of operations.

Variable Interest Entity

The Company has been involved in the formation of various entities considered to be Variable Interest Entities (“VIEs”). The Company evaluates the consolidation of these entities as required pursuant to ASC Topic 810 relating to the consolidation of VIEs. These VIEs are SPACs.

The Company’s determination of whether it is the primary beneficiary of a VIE is based in part on an assessment of whether or not the Company and its related parties are exposed to the majority of the risks and rewards of the entity. Typically, the Company is entitled to substantially all or a portion of the economics of these VIEs. The Company is the primary beneficiary of the VIE entities.

Through November 30, 2022, only one of the four SPAC companies existed, See Note 4 Special Purpose Acquisition Company Sponsorship that has more information regarding the remaining SPAC company. There are no SPAC companies as of February 7, 2022.

In connection with the IPO in October 2021, the Company purchased, through its wholly owned subsidiary, ShiftPixy Investments, Inc. ("Investments" or the "Sponsor"), 4,639,102 private placement warrants ("Placement Warrants") at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102, and the Company currently own 2,110,000 Founder Shares of IHC common stock, representing approximately 15% of the issued and outstanding common stock of IHC. Before the closing of the IPO, the Sponsor transferred 15,000 Founder Shares to IHC's independent directors, reducing its shareholdings from 2,125,000 to 2,110,000. Each Placement Warrant was identical to the warrants sold in the IPO, except as described in the IPO registration statement and prospectus. Following the completion of IHC's IPO, the Company determined that IHC was a VIE in which the Company had a variable interest because IHC did not have enough equity at risk to finance its activities without additional subordinated financial support. The Company had also determined that IHC's public stockholders did not have substantive rights, and their equity interest constitutes temporary equity, outside of permanent equity, in accordance with ASC 480-10-S99-3A, at such time. As such, the Company concluded that they were the primary beneficiary of IHC as a VIE, as the Company had the right to receive benefits or the obligation to absorb losses of the entity, as well as the power to direct a majority of the activities that significantly impact IHC's economic performance. Since the Company was the primary beneficiary, IHC to be consolidated into the Company's unaudited condensed consolidated financial through February 7, 2023. See Note 4, for the dissolution of IHC and entire amount from the Trust Account to IHC shareholders on December 1, 2022. As of December, 1, 2021, the Company determined that IHC was not a VIE. The Company did not have the power to direct the operations of IHC since IHC was dissolved on November 14, 2022 and the assets of the Trust Account was distributed to its shareholders on December 1, 2022. The Company lost its voting rights, and there is no possibility of recouping its investment. As a result, the Company determined that IHC will not be consolidated into the unaudited condensed financial statements as of December 1, 2022 See Note 4 regarding three of IHC creditors forcing them into bankruptcy. As a result of the deconsolidation of the VIE on February 7, 2023, the Company recorded the elimination of $9.4 million of the non-controlling interest to additional paid-in capital as it was originally recorded. The net liabilities of IHC were $0.6 million as of February 7, 2023 that resulted in the Company recorded $0.6 million to other income and $0.5 million to non-controlling or, 85% of its non- ownership interest in IHC.

Subject to Possible Redemption

The Company previously accounts for its common stock holdings in its sponsored SPACs (which were consolidated in the Company's unaudited condensed consolidated financial statements) through February 7, 2023, which was previously subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of common stock were classified as a current liability since the shares were redeemed as of August 31, 2022. Each sponsored SPAC's shares of common stock feature certain redemption rights that are considered to be outside of the SPAC's control and subject to occurrence of uncertain future events. However, since the common stock subject to redemption were paid to IHC shareholders on December 1. 2022, the fair market value as of August 31, 2022 was classified as a current liability. The Company has recorded increases or decreases in the carrying amount of the redeemable common stock are affected by charges against additional paid in-capital and accumulated deficit.

XML

Discontinued Operations

9 Months Ended

May 31, 2023

Discontinued Operations

Discontinued Operations

Note 3: Discontinued Operations

On January 3, 2020, the Company entered into an asset purchase agreement with Shiftable HR Acquisition, LLC, a wholly owned subsidiary of Vensure, pursuant which was the assigned client contracts was significant to its revenues for the three months ended November 30, 2019, including 100% of the Company's existing PEO business. In connection with this transaction, the Company had a Note Receivable to be paid over four years.

For Fiscal 2020, the Company estimated the value of the Note Receivable at fair value as discussed in Note 2, Summary of Significant Accounting Policies, above. The Company recorded the Note Receivable based on the Company's estimate of expected collections which, in turn, was based on additional information obtained through discussions with Vensure and evaluation of the Company's records. On March 12, 2021, the Company received correspondence from Vensure proposing approximately $10.7 million of working capital adjustments under the terms of the Vensure Asset Sale agreement which, if accepted, would have had the effect of eliminating any sums owed to the Company under the Note Receivable. As indicated in the reconciliation table below, the Company has recorded $2.6 million of working capital adjustments, subject to final review and acceptance, and has provided for an additional reserve of $2.9 million for potential claims. By letter dated April 6, 2021, the Company disputed Vensure’s proposed adjustments and maintains that the amount Vensure owes the Company pursuant to the Note Receivable is as much as $9.5 million. The Company assessed the collectability of this note receivable during the reporting of its Fiscal Year End as of August 31, 2022, and determined that it was probable that all contractually required payments will not be collected and recorded a reserve on collectability of approximately $4 million. The disputes between the Company and Vensure regarding working capital adjustments under the Vensure Asset Sale agreement are currently the subject of litigation pending in the Delaware Chancery Court, as discussed at Note 9, Contingencies, Vensure Litigation, below.

The following reconciliation of the gross proceeds to the net proceeds from the Vensure Asset Sale is presented in the condensed consolidated balance sheets as of May 31, 2023 and August 31, 2022.

	As of
	May 31, 2023 (Unaudited)			August 31, 2022
Gross proceeds	$	19,166,000		$	19,166,000
Cash received at closing – asset sale		(9,500,000	)		(9,500,000	)
Cash received at closing – working capital		(166,000	)		(166,000	)
Gross note receivable	$	9,500,000		$	9,500,000
Less:  Transaction reconciliation – estimated working capital adjustments		(2,604,000	)		(2,604,000	)
Adjusted Note Receivable		6,896,000			6,896,000
Reserve for estimated potential claims		(2,892,000	)		(2,892,000	)
Reserve for potential collectability concerns	$	(4,004,000	)	$	(4,004,000	)
Long-term note receivable, estimated net realizable value	$	—		$	—

As of May 31, 2023 and August 31, 2022, as discussed above, the note receivables asset has been impaired to adjust the net realizable value of the long-term note receivable to zero and zero, respectively.

The Vensure Asset Sale generated a gain of $15.6 million for during the fiscal year end August 31, 2020. The Company expected a minimal tax impact from the Vensure Asset Sale as it utilized its net operating losses accumulated since inception to offset the gain resulting from discontinued operations tax provision with a corresponding offset to the valuation allowance.

The Vensure Asset Sale met the criteria of discontinued operations set forth in ASC 205 and as such the Company has reclassified its discontinued operations for all periods presented and has excluded the results of its discontinued operations from continuing operations for all periods presented.

The terms of the Vensure Asset Sale call for adjustments to the Note Receivable either for: (i) working capital adjustments or (ii) in the event that the gross wages of the business transferred is less than the required amount.

(i) Working capital adjustments: Through May 31, 2023,, the Company has identified $2.6 million of likely working capital adjustments, including $88,000 related to lower net assets transferred at closing, and $2.5 million of cash remitted to the Company’s bank accounts, net of cash remitted to Vensure’s bank accounts. Under the terms of the Vensure Asset Sale, a reconciliation of the working capital was to have been completed by April 15, 2020. Due to operational difficulties and quarantined staff caused by the outbreak of COVID-19, Vensure requested a postponement of the working capital reconciliation that was due in Fiscal 2020. Although Vensure provided the Company with its working capital reconciliation on March 12, 2021, it failed to provide adequate documentation to support its calculations. Accordingly, the working capital adjustment recorded as of May 31, 2023, represents the Company’s estimate of the reconciliation adjustment by using Vensure’s claims and the limited supporting information Vensure provided as a starting point, and then making adjustments for amounts in dispute based upon the Company's internal records and best estimates. There is no assurance that the working capital change identified as of May 31, 2023 , represents the final working capital adjustment.

(ii) Gross billings adjustment: Under the terms of the Vensure Asset Sale, the proceeds of the transaction are reduced if the actual gross wages of customers transferred for Calendar 2020 are less than 90% of those customers’ Calendar 2019 gross wages. The Company has prepared an estimate of the Calendar 2020 gross wages based on a combination of factors including reports of actual transferred client billings in early Calendar 2020, actual gross wages of continuing customers of the Company, publicly available unemployment reports for the Southern California markets and the relevant COVID-19 impacts on employment levels, and other information. Based on the information available, the Company estimated that it would receive additional consideration below the required threshold and reduced the contingent consideration by $1.4 million. Vensure has not identified any such adjustments to date. Based on the information available, the Company reclassified the previously recorded gross wages claim to a general potential claims reserve for Fiscal 2021. No additional adjustments were made during the three and nine months ended May 31, 2023 and May 31, 2022.

The carrying amounts of the classes of assets and liabilities from the Vensure Asset Sale included in discontinued operations are as follows:

	As of
	May 31, 2023			August 31, 2022
	(Unaudited)
Deposits – workers’ compensation		—			—
Total current assets		—			—
Deposits – workers’ compensation		—			—
Total assets	$	—		$	—
Accrued workers’ compensation cost		1,765,000			1,362,000
Total current liabilities		1,765,000			1,362,000
Accrued workers’ compensation cost		4,133,000			3,269,000
Total liabilities		5,898,000			4,631,000
Net liability	$	(5,898,000	)	$	(4,631,000	)

Reported results for the discontinued operations by period were as follows:

	For the Three Months Ended						For the Nine Months Ended
	May 31, 2023			May 31, 2022			May 31, 2023			May 31, 2022
Revenues	$	—		$	—		$	—		$	—
Cost of revenues		460,000			132,000			1,267,000			283,000
Gross profit (loss)		(460,000	)		(132,000	)		(1,267,000	)		(283,000	)
Total operating expenses		—			—			—			—
Loss from discontinued operations	$	(460,000	)	$	(132,000	)	$	(1,267,000	)	$	(283,000	)

XML

Special Purpose Acquisition Company (SPAC) Sponsorship

9 Months Ended

May 31, 2023

Special Purpose Acquisition Company (SPAC) Sponsorship

Special Purpose Acquisition Company ("SPAC") Sponsorship

Note 4: Special Purpose Acquisition Company ("SPAC") Sponsorship

IHC closed on its IPO effective October 2021, and its net proceeds of $116.7 million, the funds were placed in a trust account (the “Trust Account”), and was invested in U.S. government securities. The Company owned approximately 15% of its issued and outstanding stock. Furthermore, we anticipated that IHC would operate as a separately managed, publicly traded entity following the completion of its IPO. The operations of IHC have been consolidated in the accompanying unaudited condensed financial statements through November 30, 2022.

On October 14, 2022, the stockholders of IHC approved the proposed action to file an amended and restated certificate of incorporation to extend the date by which the Company has to consummate a Business Combination from October 22, 2022, to April 22, 2023, or a such earlier date as determined by the board of directors. The Company accordingly filed the Amendment with the Secretary of State of Delaware. In connection with the meeting, however, shareholders holding 11,251,347 Public Shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account, leaving 248,653 of the Company’s remaining Public Shares outstanding and the Trust Account substantially below the $5 million minimum net tangible asset amount required by IHC's Amended and Restated Certificate of Incorporation to be available upon consummation of such Business Combination. IHC's efforts to secure the decisions of some shareholders to reverse their redemptions were unsuccessful, and IHC accordingly declined to fund the extension, cancelled the Amendment as filed with the Secretary of State of Delaware, and proceeded to cease operations, dissolve and unwind. The board of directors of IHC accordingly adopted resolutions to liquidate, dissolve and unwind the entity. IHC was dissolved on November 14, 2022, and the Trustee released all the redemption funds from the Trust Account to IHC shareholders on December 1, 2022, effectively liquidating the Trust. The Class A common shares subject to redemption were, however, classified as a current liability as of August 31, 2022 and through November 30, 2022. In view of the actions taken in November and December of 2022, the Company has concluded that as of February 7, 2023, the operations of IHC shall not be included in the Company's consolidation as IHC did not meet the criteria of a VIE. A net liability of $0.6 million was recorded to other income, and $0.5 million was recorded for the non-controlling interest, applicable to the 85% interest that the Company did not own of IHC.

On February 7, 2023, three creditors of IHC filed an involuntary petition for liquidation under Chapter 7 against IHC in the US Bankruptcy Court for the Southern District of Florida. The matter is proceeding, and the Company and its subsidiary, ShiftPixy Investments, Inc., are listed as two significant creditors of IHC. However, there can be no assurance that either the Company or ShiftPixy Investments, Inc. will recover any of the amounts owed to them by IHC from the bankruptcy estate.

XML

Stockholders Deficit

9 Months Ended

May 31, 2023

Stockholders Deficit

Stockholders' Deficit

Note 5: Stockholders’ Deficit

Preferred Stock

In September 2016, the founding shareholders of the Company were granted options to acquire preferred stock of the Company (the “Preferred Options”). The number of Preferred Options granted was based upon the number of shares held at the time of the grant. These Preferred Options are nontransferable and forfeited upon the sale of the related founding shares of common stock held by the option holder. Upon the occurrence of certain specified events, such founding shareholders can exercise each Preferred Option to purchase one share of preferred stock of the Company at an exercise price of $0.0001 per share. The preferred stock underlying the Preferred Options does not include any rights to dividends or preference upon liquidation of the Company and is convertible into shares of the Company’s common stock on a one-for-one basis. Upon consummation of the Vensure Asset Sale in January 2020, a total of 24,634,560 Preferred Options became exercisable and exchangeable into an equal number of shares of the Company's common stock.

On June 4, 2020, Scott W. Absher, the Company’s Chief Executive Officer, exercised 12,500,000 Preferred Options to purchase 12,500,000 shares of the Company's preferred stock for an aggregate purchase price of $1,250 per share, Immediately following the exercise of the Preferred Options, Mr. Absher elected to convert the 12,500,000 shares of preferred stock into 12,500,000 shares of common stock, which were subject to a 24-month lock-up period during which such shares could not be traded. Between July 20, 2020 and November 30, 2020, an additional 294,490 Preferred Options were exercised and converted into 294,490 shares of common stock, which are freely tradable.

On October 22, 2021, the Company’s board of directors canceled 11,790,000 Preferred Options previously issued to its co-founder, J. Stephen Holmes. As noted in Note 9, Contingencies, the trustee of the bankruptcy estate of Mr. Holmes is now asserting rights to these preferred options. Were the trustee to be successful in its claim, the Company would be obligated to issue up to 12,500,000 restricted shares of the Company's common stock to the trustee, which issuance would materially dilute the share ownership of the existing shareholders and could cause a material decline in the price per share of the Company's common stock. A total of 37,570 Preferred Options, in excess of the options claimed by the trustee of the bankruptcy estate of Mr. Holmes and issued pursuant to the September 2016 grant and triggered by the Vensure Asset Sale remain unexercised. The Preferred Options expire on December 31, 2023.

The number of Preferred Options, and the number of shares of preferred stock issuable upon exercise of such options, is based upon the number of shares of common stock held by the option holders at the time the Preferred Options were issued in September 2016. Accordingly, in order to confirm the original intent of the granting of up to 25,000,000 Preferred Options to Mr. Absher, it has always been the Company’s intent to adopt a second grant of an additional 12,500,000 Preferred Options to Mr. Absher, whereby each option permits the holder to acquire one share of the Company’s preferred stock for $0.0001 per share. On August 13, 2021, consistent with this intent, the Company granted 12,500,000 Preferred Options to Mr. Absher to purchase shares of Preferred Stock, par value $0.0001 for consideration of $0.0001 per share. Each Preferred Option is exercisable for a period of twenty-four months upon (i) the acquisition of a Controlling Interest (as defined below) in the Company by any single shareholder or group of shareholders acting in concert (other than Mr. Absher), or (ii) the announcement of (x) any proposed merger, consolidation, or business combination in which the Company’s Common Stock is changed or exchanged, or (y) any sale or distribution of at least 50% of the Company’s assets or earning power, other than through a reincorporation. Each share of Preferred Stock is convertible into Common Stock on a one-for-one basis. “Controlling Interest” means the ownership or control of outstanding voting shares of the Company sufficient to enable the acquiring person, directly or indirectly and individually or in concert with others, to exercise one-fifth or more of all the voting power of the Company in the election of directors or any other business matter on which shareholders have the right to vote under the Wyoming Business Corporation Act.

On July 14, 2022, the Board of the Company approved the issuance to the Company’s founder and principal shareholder, Scott Absher, of 12,500,000 shares of the Company’s Preferred Class A Stock ("Preferred Shares"), par value $0.0001 per share, in exchange for (a) the surrender by Mr. Absher of his options to acquire 12,500,000 Preferred Shares, which Preferred Options provide for exercise upon certain triggering events as described above, and as detailed in the Company's prior filings, and (b) the tender of payment by Mr. Absher of the sum of $5,000, representing four times the par value for such Preferred Shares. The Company evaluated the Preferred Shares on the same date using Level 2 inputs based on the closing market price of the Company’s common stock. The resulting allocated common share price was then discounted for a lack of marketability of shares, which yielded a fair value of $0.2322 per preferred share. The Company used the following assumptions to value the expense related to the Preferred Shares: (i) life of 10 years; (ii) risk free rate of 3.1%; (iii) volatility of 125.7%; (iv) exercise price of $0.0001 per share; and (v) a fair value of $0.3 per share of the Company’s common stock. These were recorded as compensation expense in the general and administrative expenses during the fiscal year August 31, 2022.

On August 12, 2022, the Company entered into an agreement with Mr. Absher whereby he waived claims to certain unpaid compensation due to him through July 31, 2022, totaling $0.82 million, in exchange for an option to receive 4,100,000 shares of the Company's Preferred Class A Stock. The Company evaluated the Preferred Shares on the same date using Level 2 inputs based on the closing market price of the Company’s common stock. The resulting allocated common share price was then discounted for a lack of marketability of shares, which yielded a fair value of $0.2025 per Preferred Share. The Company used the following assumptions to value the expense related to the Preferred Shares: (i) life of 10 years; (ii) risk free rate of 3.0%; (iii) volatility of 125.7%; (iv) exercise price of $0.0001 per share; and (v) a fair value of $0.23 per share of the Company’s common stock. Pursuant to Rule 144, these 4,100,000, when converted into shares of common stock, are subject to a six-month holding period during which they may not be sold in the marketplace. All of the 8,600,000 preferred shares were converted into common stock on September 1, 2022, after the Company's reverse stock split had taken effect. As of November 30, 2022, there were no preferred shares options or preferred shares outstanding. As a result of this transaction, the Company recorded a preferential dividend of $127.1 million based upon the incremental value of the stock that was held prior to the reverse stock split and the date of preferred stock conversion to common stock. In addition, this had no effect on stockholders' deficit.

Prior to the shareholder vote to approve the reverse stock split, the Company on August 2, 2022, amended its Articles of Incorporation to state that only the common stock is affected if the reverse stock split is effectuated with no intention to affect the preferred stock of the company. The reverse stock split was subsequently approved by the shareholders, and effectively the terms and conditions of the preferred stock were “deemed modified” and treated as an extinguishment (in accordance with ASC 470-50 and ASC 260-10-S99-2 for the disproportionate value received (the carrying value compared to the fair value received).

On September 1, 2022, Mr. Absher converted 8,600,000 Preferred Shares to 8,600,000 shares of the Company’s common stock. Pursuant to Rule 144, these 8,600,000 shares of common stock are subject to a six-month holding period during which they may not be sold in the marketplace. All of the 8,600,000 preferred shares were converted into common shares on September 1, 2022, after the Company's reverse stock split had taken effect. Accordingly, no preferred shares are issued and outstanding as of May 31, 2023. As noted in Note 9 Contingencies, however, the trustee of the bankruptcy estate of Mr. Holmes is now asserting rights to preferred options and has attempted to convert preferred options into shares of preferred stock.

Common Stock and Warrants

As reported in our 8-K filed on September 23, 2022, on September 20, 2022, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a large institutional investor (the “Purchaser”) pursuant to which the Company sold to the Purchaser an aggregate of 416,667 shares (the “Shares”) of its common stock together with warrants (the “Warrants”) to purchase up to 833,334 shares of common stock (collectively, the “Offering”). Each share of common stock and two accompanying Warrants were sold together at a combined offering price of $12.00. The Warrants are exercisable for a period of seven years commencing upon issuance at an exercise price of $12.00, subject to adjustment. The private placement closed on September 23, 2022. The net proceeds to the Company from the Offering were $4,378,000.

In connection with the Purchase Agreement, the Company and the Purchaser entered into Amendment No. 1 to Warrants (the “Warrant Amendment”). Pursuant to the Warrant Amendment, the exercise price of (i) 25,233 warrants issued on September 3, 2021, and (ii) 98,969 warrants issued on January 28, 2022, was reduced to $0.01. As a result of the change in exercise price, the Company recorded an expense of $106,000. The incremental change in the fair market values was based upon the Black- Scholes option pricing model with the following inputs. The risk free interest of 3.7%, expected volatility of 149.4%, dividend yield of 0% and expected term of 6.7 to 6.8 years.

A.G.P./Alliance Global Partners (the “Placement Agent” or "AGP") acted as the exclusive placement agent in connection with the Offering pursuant to the terms of a Placement Agent Agreement, dated September 20, 2022, between the Company and the Placement Agent (the “Placement Agent Agreement”). Pursuant to the Placement Agent Agreement, the Company paid the Placement Agent a fee equal to 7.0% of the aggregate gross proceeds from the Offering. In addition to the cash fee, the Company issued to the Placement Agent warrants to purchase up to 20,833 shares of common stock (5% of the number of shares sold in the Offering (the “Placement Agent Warrants”). The Placement Agent Warrants are exercisable for a period commencing six months from issuance, will expire four years from the effectiveness of a registration statement for the resale of the underlying shares, and have an initial exercise price of $13.20 per share.

On January 31, 2023, the Company filed a S-3 registration statement on Form S-3 for $100 million for the sale of up to $100 million of equity securities over a three year period. The SEC declared the S-3 effective on February 2, 2023. There is a limitation on the amount of funds that the Company can access under the baby shelf rules which is the value of a company’s public float if less than $75 million, The Company can only raise ⅓ of its float value over the previous 12-month period.

On January 31, 2023, the Company entered into an ATM Issuance Sales Agreement which was a part of the registration statement on Form S-3 and prospectus supplement. The at the market offering was for up to $8.2 million in shares of its common stock, could be sold from time to time and at various prices at the Company’s sole control, subject to the conditions and limitations in the sales agreement with AGP. For the three and nine months ended May 31, 2023, the Company received net proceeds of $0.5 million and $2.0 million from the sale of 133,988 and 439,328 shares of the Company’s common stock, respectivily. On May 22, 2023, the Company terminated the ATM.

On May 17, 2021, the Company issued warrants to purchase up to an aggregate of 49,484 shares of our common stock, with an exercise price of $242.50 (the "Existing Warrants"). The Existing Warrants were immediately exercisable and expire on June 15, 2026. On January 26, 2022, we entered into a Warrant Exercise Agreement ("the Exercise Agreement") with the holder of the Existing Warrants (the "Exercising Holder"). Pursuant to the Exercise Agreement, the Exercising Holder and the Company agreed that, subject to any applicable beneficial ownership limitations, the Exercising Holder would cash exercise up to 49,484 of its Existing Warrants (the "Investor Warrants") into shares of our common stock underlying such Existing Warrants (the "Exercised Shares"). To induce the Exercising Holder to exercise the Investor Warrants, the Exercise Agreement (i) amended the Investor Warrants to reduce their exercise price per share to $120.00 and (ii) provided for the issuance of a new warrant to purchase up to approximately 98,969 shares of our common stock (the “January 2022 Common Warrant”), with such January 2022 Common Warrant being issued on the basis of two January 2022 Common Warrant shares for each share of the Existing Warrant that was exercised for cash. The January 2022 Common Warrant is exercisable commencing on July 28, 2022, terminates on July 28, 2027, and has an exercise price per share of $155.00. The Exercise Agreement generated aggregate proceeds to the Company of approximately $5.9 million, prior to the deduction of $0.5 million of costs consisting of placement agent commissions and offering expenses payable by the Company. As a result of the warrant modification, which reduced the exercise price of the Existing Warrants, as well as the issuance of the January 2022 Common Warrants, the Company recorded approximately (i) $0.64 million for the increased fair value of the modified warrants; and (ii) $12.6 million as the fair value of the January 2022 Common Warrants on the date of issuance. We recorded approximately $5.5 million as issuance costs that offset the $5.5 million of additional paid-in capital the received for the cash exercise of the existing Warrants at the reduced exercise price, while the remaining $7.7 million was recorded as a deemed dividend on the unaudited condensed consolidated statements of operations, resulting in a reduction of income available to common shareholders in our basic earnings per share calculation.

During the three months ended May 31, 2022, certain prefunded warrant holders exercised their right to purchase 4,673,321 shares of the Company’s Common Stock at an exercise price of $0.0001 totaling $467, all of which was received by the Company in May 2022.

The following table summarizes the changes in the Company’s common stock and prefunded warrants for the period ended May 31, 2023.

	Number of shares			Weighted average remaining life (years)		Weighted average exercise price
Warrants outstanding, August 31, 2022		522,786			7.2		47.99
Issued		854,166			6.3		12.02
Exercised		(124,203	)		—		—
Warrants outstanding and exercisable, May 31, 2023		1,252,749			6.4	$	35.68

The following table summarizes the Company’s warrants outstanding as of May 31, 2023:

	Warrants Outstanding		Weighted Average Life of Outstanding Warrants (In years)		Exercise price
September 2022 Common Warrants (Note 10)		833,334		6.3	$	12.00
September 2022 Underwriter Warrants		20,833		3.9		13.20
July 2022 Common Warrants (Note 10)		348,408		7.1		26.00
Sep 2021Underwriter Warrants		3,762		5.9		175.00
May 2021Underwriter Warrants		2,474		3.0		243.00
October 2020 Common Warrants (1)		23,000		2.4		330.00
October 2020 Underwriter Warrants		2,000		2.4		330.00
May 2020 Common Warrants		12,776		2.0		540.00
May 2020 Underwriter Warrants		1,111		2.0		540.00
March 2020 Exchange Warrants		4,237		2.3		1,017.00
Amended March 2019 Warrants		663		0.8		4,000.00
March 2019 Services Warrants		34		0.8		7,000.00
June 2018 Warrants		63		0.5		9,960.00
June 2018 Services Warrants		54		0.5		9,960.00
		1,252,749		6.4	$	35.68

(1)     See Note 10 Subsequent Events as 5,000 of the 23,000 warrants had change in the exercise price to $1.50 per share.

XML

Stock Based Compensation

9 Months Ended

May 31, 2023

Stock Based Compensation

Stock Based Compensation

Note 6: Stock Based Compensation

Employee Stock Option Plan Increase

In March 2017, the Company adopted its 2017 Stock Option/Stock Issuance Plan (the “Plan”). The Plan provides incentives to eligible employees, officers, directors and consultants in the form of incentive stock options (“ISOs”), non-qualified stock options (“NQs”) (each of which is exercisable into shares of common stock) (collectively, “Options”), or shares of common stock (“Share Grants”). On March 31, 2021, the Shareholders approved an increase in the number of shares of common stock issuable under the Plan from 2,500 to 30,000. On March 6, 2023, the shareholders approved an increase in the number of shares of common stock issuable under the Plan from 30,000 to 750,000. As of May 31, 2023, there are 749,997 shares available under the Plan.

For all options to purchase common stock granted prior to July 1, 2020, each option has a term of service vesting provision over a period of time as follows: 25% vest after a 12-month service period following the award, with the balance vesting in equal monthly installments over the succeeding 36 months. Options granted on or after July 1, 2020 typically vest over four years, with 25% of the grant vesting one year from the grant date, and the remainder in equal quarterly installments over the succeeding 12 quarters. All options granted to purchase common stock have a ten year term.

Stock grants are issued at fair value, considered to be the market price on the grant date. The fair value of option awards is estimated on the grant date using the Black-Scholes stock option pricing model.

Following its adoption of ASU 2016-9, the Company elected to account for forfeitures under the Plan as they occur. Any compensation cost previously recognized for an unvested award that is forfeited because of a failure to satisfy a service condition is reversed in the period of the forfeiture.

Stock-based compensation expense was $0.2 million and $0.7 million for the three and nine months ended May 31, 2023, respectively. Stock-based compensation was approximately $0.3 million and $1.1 million of compensation expense for the three and nine months ended May 31, 2022, respectively.

The following table summarizes option activity for the nine months ended May 31, 2023.

	Options Outstanding and Exercisable
	Number of Options			Weighted Average Remaining Contractual Life		Weighted Average Exercise Price
				(In years)
Balance outstanding as of August 31, 2022		11,753			8.1	$	733.00
Forfeited		(1,750	)		8.3		2.70
Balance outstanding expected to be exercisable as of May 31, 2023		10,003			7.2	$	813.70

As of May 31, 2023, the total unrecognized deferred share-based compensation expected to be recognized over the remaining weighted average vesting periods of 1.5 years for outstanding grants was $918,000. There was no intrinsic value for outstanding as of May 31, 2023.

The following table summarizes the vested options for the nine months ended May 31, 2023.

Options Vested	Number of Options			Weighted Remaining Contractual Life		Weighted Average Exercise Price
				(In years)
Balance, August 31, 2022		5,269			8.1	$	1,146
Vested		2,290			7.7		442
Forfeited		(716	)		8.1		293
Balance, May 31, 2023	6,843				7.4	$	998

The following table summarizes information of all stock options outstanding as of May 31, 2023:

	Options Outstanding						Options Vested
Exercise Prices	Number of Options Exercisable		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number of Options		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price
			(In Years)						(In Years)
$50.00 - 1,000.00		9,641		7.6	$	453	6,483			7.1	$	466
$1,001.00 - $4,000.00		20		6.3		1,895		19		6.0		1,896
$4,001.00 - $8,000.00		121		6.1		5,121		120		5.1		5,120
$8,001.00 - $12,000.00		101		5.2		10,298		101		4.1		10,298
$12,001.00 - $16,000.00		109		4.4		15,584		109		4.0		15,584
$16,001.00 - $39,160.00		11		4.4		39,160		11		4.0		39,160
		10,003		7.6	$	814	6,843			7.4	$	998

XML

Related Parties and Certain Directors and Officers

9 Months Ended

May 31, 2023

Related Parties and Certain Directors and Officers

Related Parties and Certain Directors and Officers

Note 7: Related Parties and Certain Directors and Officers

Director Compensation

Scott Absher

On October 22, 2021, our Board approved raising Mr. Absher’s annual salary to $1M, effective January 1, 2022, and also approved the payment of a $0.5 million bonus to Mr. Absher, 50% of which was payable upon Board approval, and the remainder of which was payable on January 1, 2022. As of August 31, 2022, Mr. Absher received payment of 50% of his bonus, or $0.3 million, in March 2022. Furthermore, as discussed in Note 5, Stockholders' Deficit on August 12, 2022, the Company entered into an agreement with Mr. Absher whereby he waived claims to certain unpaid compensation due to him through July 31, 2022, totaling $0.8 million, in exchange for an option to receive $4.1 million Company Preferred Shares. The agreement settled, the deferred payment of his incremental base salary, his outstanding personal time off or PTO as of July 31, 2022, and the remaining 50% of his approved bonus. As of January 1, 2023, Mr. Absher's salary was adjusted back to the level applicable prior to the time of the adjustment effective January 1, 2022. Mr. Absher salary for the three months and nine months ended May 31, 2023 was $0.2 million and $0.6 million, respectively. Mr. Absher salary for the three months and nine months ended May 31, 2022 was $0.4 million and $0.8 million, respectively. Accrued salary as of May 31, 2023 and August 31, 2022 was $0.3 million and $0.8 million, respectively.

Amanda Murphy

On February 10, 2020, Amanda Murphy was appointed to our Board. Ms. Murphy was our Director of Operations at the time of her appointment. Ms. Murphy received salary compensation of $0.3 million for Fiscal 2022, respectively. On October 22, 2021, our Board approved the promotion of Ms. Murphy to the position of Chief Operating Officer, as well as an increase in her annual salary to $0.5 million, all of which were effective January 1, 2022. As of August 31, 2022, Ms. Murphy has deferred payment related to her salary increase of approximately $0.2 million. The deferred payment salary is recorded in the accrued liabilities on the condensed consolidated balance sheets. As of January 1, 2023, Ms. Murphy's salary was adjusted back to the level applicable prior to the time of the adjustment effective January 1, 2022. Ms. Murphy salary for the three months and nine months ended May 31, 2023 was $66,000 and $0.5 million, respectively. MS Murphy salary for the three months and nine months ended May 31, 2022 was $66,000 and $0.2 million, respectively. Accrued salary as of May 31, 2023 was $0.3 million.

J. Stephen Holmes

J. Stephen Holmes formerly served as a non-employee sales manager, advisor to and significant shareholder of the Company. The Company incurred $0.8 million in professional fees for services provided by Mr. Holmes during Fiscal 2021. On October 22, 2021, the Company severed all ties with Mr. Holmes, effective immediately, and cancelled Preferred Options that had previously been issued to him but had not been exercised. As a result of these actions, the Company no longer has any financial obligation to Mr. Holmes, and believes that he is no longer a significant shareholder of the Company, see Note 5, Stockholders’ Deficit and Note 9, Contingencies.

Related Persons to Scott Absher

Mark Absher, the brother of Scott Absher, was hired by the Company as Deputy General Counsel – Special Projects, for an annual salary of $0.2 million. Mr. Absher's compensation for the three and nine month period ending May 31, 2023, was $60,000 and $0.2 million, respectively. His compensation for the three and nine month period ending May 31, 2022, was $60,000 and $0.1 million, respectively.

David May, a member of our business development team, is the son-in-law of Mr. Absher. Mr. May's compensation for the three month and nine month period ending May 31, 2023, was $38,000 and $0.1 million, respectively. His compensation for the three and nine month period ending May 31, 2022, was $43,000 and $0.1 million, respectively.

Phil Eastvold, the Executive Producer of ShiftPixy Productions, Inc., is the son-in-law of Mr. Absher. Mr. Eastvold received compensation of approximately $56,000 and $0.2 million for the three and nine months ended May 31, 2023, respectively. His compensation remained the same for the three and nine month period ending May 31, 2022.

Jason Absher, a member of the Company's business development team, is the nephew of Scott Absher and the son of Mark Absher. Mr. Absher's compensation for the three month period and nine month period ending May 31, 2023, was $30,000 and $90,000 respectively, His compensation for the three month period and nine month period ending May 31, 2022 remained the same.

Connie Absher, (the spouse of Scott Absher), Elizabeth Eastvold, (the daughter of Scott and Connie Absher and spouse of Mr. Eastvold), and Hannah Woods, (the daughter of Scott and Connie Absher), are also employed by the Company. These individuals, as a group, received compensation for the three and nine month period ending May 31, 2023, of $56,000 and $0.2 million, respectively. Compensation as a group for these individuals for the three month period and nine month period ending May 31, 2022 was $53,000 and $0.2 million, respectively.

The Company has accrued stock-based compensation related to shares of common stock to be issued for services provided by three directors. Stock-based compensation expense for the three months ended May 31, 2023 and May 31, 2022 was $0.2 million and $0.3 million, respectively. Stock-based compensation expense for the nine months ended May 31, 2023 and 2022 was $0.7 million and $1.1 million, respectively. The Company has agreements with three directors to receive shares of common stock was valued at $0.1 million per year. No shares of common stock have been issued as of August 31, 2022 and May 31, 2023, respectively. As of May 31, 2023, there are 59,040 shares of common stock to be issued to directors.

As of May 31, 2023 and August 30, 2022, the Company has accrued $0.7 million and $0.6 million, respectively for stock-compensation related to shares to be issued for services to certain directors.

XML

Commitments

9 Months Ended

May 31, 2023

Commitments and contingencies

Commitments

Note 8: Commitments

Operating Leases & License Agreements

Effective August 13, 2020, the Company entered into a non-cancelable seven-year lease for office space located in Miami, Florida, to house its principal executive offices commencing October 2020, and continuing through September 2027. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. The monthly rent expense under this lease is approximately $57,000. The Company has not made payments under the lease agreement since June 2022, see Note 9 Contingencies related to the legal case with the litigation with the landlord, Courvoisier Centre.

On October 1, 2020, the Company entered into a non-cancelable 64-month lease for industrial space located in Miami, Florida, to house ghost kitchens, production facilities, and certain marketing and technical functions, including those associated with ShiftPixy Labs. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. The monthly rent expense under this lease is approximately $35,000.

On June 7, 2021, the Company entered into a non-cancelable sublease agreement with Verifone, Inc. to sublease premises consisting of approximately 8,000 square feet of office space located in Miami, Florida, that the Company anticipates using for its sales and operations workforce. The lease has a term of three years expiring on May 31, 2024. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the sublease. Monthly rent expense under this lease is approximately $27,000.

On June 21, 2021, the Company entered into a non-cancelable 77-month lease for premises for office space located in Sunrise, Florida, that the Company anticipates using primarily to house its operations personnel and other elements of its workforce. The Company lease had possession date of August 1, 2022. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the lease. Monthly rent expense under this lease is approximately $27,000.

On May 2, 2022, the Company entered into a non-cancelable 60-month operating lease, as constituted in an amendment to a prior lease, commencing on July 1, 2022, for office space in Irvine, California, which the Company anticipates using primarily for its IT, operations personnel, and other elements of its workforce. The base rent is paid monthly and escalates annually according to a schedule outlined in the lease. The monthly rent expense under this lease is approximately $24,000. As an incentive, the landlord provided a rent abatement of 50% of the monthly rent for the first four months, with a right of recapture in the event of default.

On August 31, 2022, the Company decided to formally abandon the leases for its offices in the Courvoisier Center, including a sublease on the second floor with Verifone. The determination was based on its inability to utilize the premises as they were under extensive construction renovation by the landlord, resulting in a significant negative impact on the Company’s ability to conduct business and the health and well-being of the Company’s employees and guests. The Company formally notified the landlord of its intention to vacate the premises and has not been legally released from the Company's primary obligations under the leases. The Company received a formal complaint from the landlord, and the matter is in litigation. The Company intends to vigorously defend the lawsuit and counterclaim for relocation costs, see Note 9, Contingencies. As a result of the abandonment, the Company evaluated the ROU assets for impairment as of August 31, 2022, and recorded an impairment charge of $3.9 million, within the impairment loss line item for the year ended. Furthermore, the Company released the corresponding lease liability and evaluated the need for a loss contingency in accordance with ASC 450, recording a contingent liability of $3.8 million, included within accrued expenses of the consolidated balance sheets as of May 31, 2023 and August 31, 2022, respectively.

The components of lease expense are as follows:

	Three Months  Ended May 31, 2023		Nine Months Ended May 31,  2023
Operating Lease Cost	$	260,000	$	824,000

Future minimum lease and licensing payments under non-cancelable operating leases as of May 31, 2023, are as follows:

	Minimum lease commitments
2024	$	1,047,000
2025		1,081,000
2026		928,000
2027		694,000
2028		403,000
Thereafter		225,000
Total minimum payments		4,378,000
Less: present value discount		508,000
Lease liability		3,870,000
Weighted-average remaining lease term - operating leases (months)		49
Weighted-average discount rate		5.54	%

The current portion of the operating lease liability is included within our accounts payable and other accrued liabilities in our condensed consolidated balance sheets.

Special Purpose Acquisition Company Sponsorship

On April 29, 2021, the Company announced its sponsorship, through a wholly owned subsidiary, of four SPAC IPOs. The Company purchased founder shares in each SPAC (the "Founder Shares"), through its wholly owned subsidiary, for an aggregate purchase price of $25,000 per SPAC. The number of Founder Shares issued was determined based on the expectation that such Founder Shares would represent 15% of the outstanding shares of each SPAC after its IPO (excluding the private placement warrants described below and their underlying securities).

The registration statement and prospectus covering the IPO of IHC, was declared effective by the SEC on October 19, 2021, and IHC units (the “IHC Units”), consisting of one share of common stock and an accompanying warrant to purchase one share of IHC common stock, began trading on the NYSE on October 20, 2021. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million. In connection with the IHC IPO, the Company purchased, through its wholly owned subsidiary, 4,639,102 placement warrants at a price of $1.00 per warrant, for an aggregate purchase price of $4.6 million. Each private placement warrant was exercisable to purchase one whole share of common stock in IHC at $11.50 per share. Inasmuch as IHC was dissolved on November 14, 2022, and the Trust released all the redemption funds to shareholders on December 1, 2022, effectively liquidating the Trust Account, (See Note 4: Special Purpose Acquisition Company ("SPAC") Sponsorship), the private placement warrants have been deemed worthless.

The investment amounts set forth above do not include loans that the Company's subsidiary, ShiftPixy Investments, Inc., has extended to IHC in an amount not to exceed $0.5 million, in its role as sponsor. Nor do they include sums advanced by the Company to IHC to enable it to conduct its activities. As of May 31, 2023, the Company had advanced, through its wholly owned subsidiary, an aggregate of approximately $0.9 million to the SPACs for payment of various expenses in connection with the SPAC IPOs, principally consisting of SEC registration, legal and auditing fees. The Company previously disclosed that it anticipates that the SPAC will repay these advanced expenses from when its IBC is completed. As of May 31, 2023, the Company had an outstanding balance of $0.7 million from advances, which are considered uncollectible with the dissolution of IHC.

XML

Contingencies

9 Months Ended

May 31, 2023

Contingencies

Contingencies

Note 9: Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will be resolved only when one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

During the ordinary course of business, the Company is subject to various claims and litigation. Management believes that after consulting legal counsel the outcome of such claims or litigation will not have a material adverse effect on the Company’s financial position, results of operations or cash flow. Some of the matters are detailed below.

Splond Litigation

On April 8, 2019, claimant, Corey Splond, filed a class action lawsuit, on behalf of himself and other similarly situated individuals in the Eighth Judicial District Court for the State of Nevada, Clark County, naming the Company and its client as defendants, and alleging violations of certain wage and hour laws. The Company denies any liability. Discovery is proceeding in the case, and no trial date has been set. Even if the plaintiff ultimately prevails, the potential damages recoverable will depend substantially upon whether the Court determines in the future that this lawsuit may appropriately be maintained as a class action. Further, in the event that the Court ultimately enters a judgment in favor of the plaintiff, the Company believes that it would be contractually entitled to be indemnified by its client against at least a portion of any damage award.

Everest Litigation

On December 18, 2020, the Company was served with a Complaint filed in the United States District Court for the Central District of California by its former workers’ compensation insurance carrier, Everest National Insurance Company. The Complaint asserts claims for breach of contract, alleging that the Company owes certain premium payments to plaintiff under a retrospective rated policy, and seeks damages of approximately $0.6 million, which demand has since increased to approximately $1.6 million. On February 5, 2021, the Company filed an Answer to Plaintiff’s Complaint denying its claims for relief, and also filed a cross-claim against the third party claims administrator, Gallagher Bassett Services, Inc., for claims sounding in breach of contract and negligence based upon its administration of claims arising under the policy. By order dated April 7, 2021, the Court dismissed the Company’s complaint against Gallagher Bassett without prejudice to re-filing in another forum. On May 17, 2021, the Company refiled its complaint against Gallagher Basset in the Circuit Court of Cook County, Illinois. Everest subsequently filed a complaint against Gallagher Bassett in New Jersey. Discovery proceeded in the cases, and the California Court set a trial date in the Everest case of August 8, 2023, while no trial date has been set in either of the related Illinois or New Jersey cases, which are in preliminary stages. Mediation in the matter was conducted on December 14, 2022, and the matter was kept open until further notice as the parties endeavored to settle the case. As noted below in Note 10: Subsequent Events, on or about June 28, 2023, the Company entered into a confidential settlement agreement with Everest National Insurance Company and Gallagher Bassett, resolving the litigation amongst the parties. The Company accrued for the settlement as of May 31, 2023.

Sunz Litigation

On March 19, 2021, the Company was served with a Complaint filed in the Circuit Court for the 11th Judicial Circuit, Manatee County, Florida, by its former workers’ compensation insurance carrier, Sunz Insurance Solutions, LLC. The Complaint asserts claims for breach of contract, alleging that the Company owes payments for loss reserve funds totaling approximately $10 million, which represents approximately 200% of the amount of incurred and unpaid claims. The Company denies plaintiff’s allegations and is defending the lawsuit vigorously. On May 12, 2021, the Company filed a motion to dismiss the complaint, and Sunz filed an amended complaint in response. Discovery is proceeding in the matter and no trial date has been set. On June 21, 2022, the Court granted Plaintiff’s partial motion for summary judgment, holding that Defendant is liable under the contract, but further finding that the amount of damages, if any, to which Plaintiff is entitled should be determined at trial. We believe that partial summary judgment was improvidently granted, and therefore appealed the Court’s Order by filing a petition for writ of certiorari with the Court of Appeal, which appeal is now pending. On or about November 14, 2022, a court granted Sunz’ motion for summary judgment on a contractual issue—holding that the Company waived claims regarding Sunz’ management of claims to the extent that the Company did not complain about such management within 6 months of the alleged mismanagement of the claims. This ruling may limit the scope of the Company’s counterclaim. Trial in the case has been set for February 2024.

Vensure Litigation

On September 7, 2021, Shiftable HR Acquisition, LLC, a wholly owned subsidiary of Vensure, filed a complaint against the Company in the Court of Chancery of the State of Delaware asserting claims arising from the Asset Purchase Agreement (the “APA”) governing the Vensure Asset Sale described above. The APA provided for Vensure to purchase, through its wholly owned subsidiary, certain of the Company’s assets for total consideration of $19 million in cash, with $9.5 million to be paid at closing, and the remainder to be paid in 48 equal monthly installments (the “Installment Sum”). The Installment Sum was subject to certain adjustments to account for various post-closing payments made by the parties, and the APA provided for the following procedure to determine the final amount of the Installment Sum: (i) Within 90 days of the effective date, Vensure was required to provide the Company with a “Proposed Closing Statement”, which must detail any adjustments; (ii) Within 30 days of its receipt of Vensure’s Proposed Closing Statement, the Company had the right to challenge any of the proposed adjustments contained therein; and (iii) If the Company disputed Vensure’s Proposed Closing Statement, a 30-day period ensued for the parties to attempt to resolve the dispute, with the Company entitled to examine “such Books and Records of [Vensure] as relate to the specific items of dispute.”

Vensure resisted the Company’s repeated efforts to obtain the Proposed Closing Statement for over one year after the closing of the transaction. Finally, on March 12, 2021, under threat of legal action by the Company, Vensure provided its Proposed Closing Statement, in which it contended for the first time that it owes nothing to the Company, and that the Company actually owes Vensure the sum of $1.5 million. By letter dated April 6, 2021, the Company provided Vensure with its objections to the Proposed Closing Statement, which included Vensure’s gross overstatement of payments it purportedly made on the Company’s behalf, as well as its bad faith actions in obstructing the Company’s efforts to make these payments.

From April 2021 through August 2021, Vensure and the Company engaged in the “30-day negotiation period” referred to above, which was extended multiple times at Vensure’s request to provide Vensure an opportunity to provide evidence supporting its assertions. Over the course of these negotiations, Vensure withdrew its claim for approximately $1.5 million from the Company, and acknowledged that Vensure owed ShiftPixy some portion of the Installment Fund. Nevertheless, in early September 2021, without warning and contrary to the dispute resolution provisions of the APA, Vensure filed suit against the Company in Delaware Chancery Court for breach of contract and declaratory judgment, seeking unspecified damages. The Company vigorously disputes and denies each of Vensure’s claims. Accordingly, on November 4, 2021, the Company filed its Answer and Counterclaim to Vensure’s Complaint, in which it not only denied Vensure’s claims, but also asserted counterclaims for breach of contract and tortious interference with contract. The counterclaim seeks damages from Vensure totaling approximately $9.5 million – the full amount due under the APA - plus an award of attorneys’ fees and expenses. The case is proceeding, and no trial date has been set.

Courvoisier Centre Litigation

On August 24, 2022, the landlord of our headquarters offices, Courvoisier Centre, LLC, filed a complaint against the Company in the Eleventh Judicial Circuit Court (Miami-Dade County, Florida) alleging breach of the lease. The Company vacated the offices and ceased payments under the lease in July of 2022, after repeatedly complaining to the landlord regarding the impact of its extensive renovations of the campus and building in which the Company's offices were situated, citing substantial impairments to the Company's ability to conduct business as well as concerns regarding the health and well-being of the Company’s employees and guests, and the Landlord’s inability and refusal to provide any adequate relief. On or about October 10, 2022, the Company filed our answer to the complaint and the Company's counterclaim. The Company intends to vigorously defend the lawsuit and seek recovery for its costs of relocation.

Certified Tire Litigation

On June 29, 2020, the Company was served with a complaint filed by its former client, Certified Tire, in the Superior Court of the State of California, Orange County, naming the Company, two of its officers, and one of its former subsidiaries as defendants. The Complaint asserts multiple causes of action, all of which stem from the former client’s claim that the Company is obligated to reimburse it for sums it paid in settlement of a separate lawsuit brought by one of its employees pursuant to Private Attorney General Act or PAGA. This underlying lawsuit alleged the Company's former client was responsible for multiple violations of the California Labor Code. The Company and the officers named as defendants deny the former client’s allegations, and the Company is defending the lawsuit vigorously based primarily on the Company's belief that the alleged violations that gave rise to the underlying lawsuit were the responsibility of Certified Tire and not the Company. Trial in the matter has been set for September 5, 2023. The Company’s dispositive motion for summary judgment was denied by the court because of its determination that factual disputes exist.

In Re John Stephen Holmes Bankruptcy Litigation

On November 8, 2022, the Chapter 7 trustee of the bankruptcy estate of John Stephen Holmes filed an action against the Company, asserting that the cancellation by the Company of Mr. Holmes' 11,790,000 preferred options on October 22, 2021, violated the automatic stay applicable to Mr. Holmes' Chapter 7 proceedings. After the Company filed a motion to dismiss the trustee's complaint, the trustee endeavored to exercise an option (for 12,500,000 preferred shares) that had been issued in the early stages of the Company but that was later superseded by a modified option that did not provide for convertibility of the preferred shares to common stock and which modified option was in effect at the time that Mr. Holmes filed for bankruptcy. The trustee insists that it has a right to exercise the option for 12,500,000 preferred shares and convert the shares to common stock, notwithstanding (a) the fact that the preferred shares were not convertible to common stock at the time Mr. Holmes filed his bankruptcy petition, (b) the lapse of more than 3 years' time during which the trustee failed to take any action in relation to the option, (c) the connection of the option to Mr. Holmes, who now competes with and is believed to have taken clients from the Company, (d) the intervening 1-for-100 reverse stock split and extensive corporate governance actions, and (e) the negative impact that the issuance of up to 12,500,000 shares would have on the Company and its shareholders. Were the trustee to be successful in its claim, the Company would be obligated to issue up to 12,500,000 restricted shares of the Company's common stock to the trustee, which issuance would materially dilute the share ownership of the existing shareholders and could cause a material decline in the price per share of the Company's common stock. The Company has asserted a number of defenses and intends to vigorously defend itself against the claim.

Employee Retention Tax Credit (“ERTCs”) Claims

The Company has filed various ERTCs claims with the IRS on behalf of its clients that have otherwise failed to obtain the related benefits afforded to them pursuant to the filing of Form 7200—the time for the filing of which has expired. To date, the Company has received ERTCs amounting to $1,152,000, and based on pending claims submissions, it expects to receive an additional $2,985,000, for a total of $4,137,000 in ERTCs submitted to date. In addition, the Company anticipates filing additional ERTCs claims as clients continue to request that the Company complete the submission thereof to the IRS. Because of the Company’s currently existing payroll tax liability, the Company presently receives ERTCs from the IRS in the form of a credit to the Company’s outstanding payroll tax liability. The Company is not presently able to remit the ERTCs to its clients and plans to offer its clients restricted shares of the Company’s common stock in payment of the ERTCs applicable to such clients. If a client rejects the payment of its respective ERTCs in the form of the restricted shares of the Company’s common stock as proposed by ShiftPixy, such client may seek to enforce its rights to recover its ERTCs by filing lawsuits against the Company.

XML

Subsequent Events

9 Months Ended

May 31, 2023

Subsequent Events

Subsequent Events

Note 10: Subsequent Events

On June 5, 2023, the Company received a letter (the “Nasdaq Letter”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), which notifies the Company that it does not presently comply with Nasdaq’s Listing Rule 5550(b)(2), which requires that the Company maintain a Market Value of Listed Securities (“MVLS”) of $35 million, and that the Company does not otherwise satisfy the requirements of Listing Rules 5550(b)(1) or 5550(b)(3). The Staff calculates MVLS based upon the most recent Total Shares Outstanding (TSO), multiplied by the closing bid price. The Nasdaq Letter does not have any immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market, and the Company has 180 calendar days from the date of the Nasdaq Letter (the “Compliance Period”) to regain compliance. If at any time during the Compliance Period the Company’s MVLS closes at $35 million or more for a minimum of ten (10) consecutive business days, Nasdaq will provide the Company with written confirmation of compliance, and this matter will be closed. If the Company does not achieve compliance within the Compliance Period, it will receive written notice from Nasdaq that its securities are subject to delisting, which is a determination that the Company could appeal to the Nasdaq Hearings Panel.

On or about June 28, 2023, the Company entered into a confidential settlement agreement with Everest National Insurance Company and Gallagher Bassett, resolving the litigation amongst the parties, see Note 9: Contingencies. The Company has accrued for this settlement as of May 31, 2023.

On July 12, 2023, the Company priced a “best efforts” public offering for the sale by the Company of an aggregate of 1,166,667 shares of common stock, 900,000 pre-funded warrants, and 2,066,667 common warrants. The public offering price was $1.50 per share and accompanying common warrant, or $1.4999 per pre-funded warrant and accompanying common warrant. The pre-funded warrants are exercisable immediately, may be exercised at any time until all of the pre-funded warrants are exercised in full, and have an exercise price of $0.0001.  The common warrants are exercisable immediately for a term of five years and have an exercise price of $1.50 per share. 1,100,000 shares, 900,000 pre-funded warrants and 2,000,000 common warrants under the offering were sold pursuant to a securities purchase agreement with an investor. A.G.P./Alliance Global Partners acted as placement agent for the offering and received a fee of 7% of the gross proceeds and reimbursement of $75,000 of expenses. The total estimated offering expenses were approximately $0.6millon and net proceeds of approximately $2.5 million. The offering closed on July 14, 2023. Effective upon closing of the offering, the exercise price of outstanding warrants the Company issued to an investor in 2020 and 2022 was reduced to $1.50 per share, subject to further adjustment as provided in the warrants, pursuant to a warrant amendment the Company entered into with the investor. The change in the exercise price will result in a non-cash warrant modification expense for the three months ended August 31, 2023.

Management has evaluated events that have occurred subsequent to the date of these financial statements and has determined that, other than those listed below, no such reportable subsequent events exist through the date the financial statements were issued in accordance with ASC Topic 855, "Subsequent Events."

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

May 31, 2023

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) applicable to interim reports of smaller reporting companies. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results of unaudited condensed operations for the three and nine months end May 31, 2023 are not necessarily indicative of the results that may be expected for the full year ending August 31, 2023.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2022 (“Fiscal 2022”), filed with the SEC on December 13, 2022, as amended by Forms 10-K/A, filed with the SEC on December 14, 2022, February 3, 2023 and February 9, 2023, respectively.

Principles of Consolidation

The unaudited condensed consolidated financial statements include the accounts of ShiftPixy, Inc., and its wholly owned subsidiaries. The unaudited condensed consolidated financial statements previously included the accounts of Industrial Human Capital, Inc. (“IHC”), which was a special purpose acquisition company, or “SPAC,” for which our wholly owned subsidiary, ShiftPixy Investments, Inc., served as the financial sponsor (as described below), and which SPAC was deemed to be controlled by us as a result of the Company’s 15% equity ownership stake, the overlap of three of our executive officers for a period of time as executive officers of IHC, and significant influence that the Company exercised over the funding and acquisition of new operations for an initial business combination (“IBC”). (See Note 2, Variable Interest Entity). All intercompany balances have been eliminated in consolidation. As of February 7, 2023, IHC was not a part of the Company’s operations, and consolidation. IHC was dissolved on November 14, 2022, and the Trustee released all the redemption funds from the Trust Account, See Note 4, to IHC shareholders on December 1, 2022, effectively liquidating the Trust. On February 7, 2023, three creditors of IHC filed an involuntary petition for liquidation under Chapter 7 against IHC in the US Bankruptcy Court for the Southern District of Florida. See Note 4, Pursuant to ASC 810-10-15, consolidation is precluded where control does not rest for a non-controlling interest in legal reorganization or bankruptcy. In addition, IHC did not meet the criteria of a Variable Interest Entity (VIE), see Note 4.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include:

· Continuation as a going concern; management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets and liquidation of all liabilities in the normal course of business

· Liability for legal contingencies

· Useful lives of property and equipment

· Deferred income taxes and related valuation allowance

· Projected development of workers’ compensation claims.

These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions are difficult to measure of value.

Management regularly reviews the key factors and assumptions to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such valuation, if deemed appropriate, those estimates are adjusted accordingly.

Liquidity, Capital Resources and Going Concern

Under the existing accounting guidance, management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the condensed consolidated financial statements are issued. This evaluation initially does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented as of the date the unaudited condensed consolidated financial statements are issued. When substantial doubt is determined to exist, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans; however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date the unaudited condensed consolidated financial statements are issued, and (2) it is probable that the plans, when implemented, may mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date the condensed consolidated financial statements are issued. Therefore, management has concluded that there is substantial doubt in the Company’s ability to continue as a going concern for the next twelve months.

As of May 31, 2023, the Company had cash of $0.1 million and a working capital deficit of $41.7 million. During the nine months ended May 31, 2023, the Company used approximately $6.7 million of cash from its continuing operations and incurred recurring losses, resulting in an accumulated deficit of $211.4 million. As of May 31, 2023, the Company is delinquent with respect to remitting payroll tax payments to the IRS. The Company has been in communication with the IRS regarding amounts owing in relation to Employee Retention Tax Credits (“ERTCs”) due. In addition, some clients have filed suits against the Company, demanding that the Company take action to file for additional ERTCs for certain tax periods. Until the matter is concluded, and the taxes are paid, the IRS could, subject to its standard processes and the Company’s right to respond, implement collection actions, including such actions as levying against Company bank accounts, to recover the amounts that it calculates to be due and owing.

Historically, the Company’s principal source of financing has come through the sale of the Company's common stock, including in certain instances, warrants and the issuance of convertible notes.

On January 31, 2023, the Company filed a registration statement on Form S-3 and related prospectus for the sale of up to $100 million of the Company’s equity securities via a “shelf” or "at-the-market” (“ATM”) sales mechanism over a three-year period. The registration statement also included a prospectus supplement providing for the sale of up to $8,187,827 of the Company’s shares of common stock, which the Company proposed to effect pursuant to an ATM Issuance Sales Agreement (“Sales Agreement”) executed with A.G.P./Alliance Global Partners (the “Agent” or “AGP”). Under the Sales Agreement, the Company’s shares of common stock could be sold from time to time and at various prices at the Company’s sole control, subject to the conditions and limitations in the Sales Agreement with AGP. The ATM was scheduled to expire on January 31, 2026. For the nine-months ended May 31, 2023, the Company received $2.4 million in gross proceeds ($2.0 million, net of costs) from the sale of 439,429 shares of the Company’s common stock. On May 22, 2023, the Company terminated the Sales Agreement and concluded the ATM. There is a limitation on the amount of funds that the Company can access under the baby shelf rules which is the value of a company’s public float if less than $75 million, The Company can only raise ⅓ of its float value over the previous 12-month period.

On July 12, 2023, the Company priced a “best efforts” public offering for the sale by the Company of an aggregate of 1,166,667 shares of common stock, 900,000 pre-funded warrants, and 2,066,667 common warrants. The public offering price was $1.50 per share and accompanying common warrant, or $1.4999 per pre-funded warrant and accompanying common warrant. The pre-funded warrants are exercisable immediately, may be exercised at any time until all of the pre-funded warrants are exercised in full, and have an exercise price of $0.0001.  The common warrants are exercisable immediately for a term of five years and have an exercise price of $1.50 per share. 1,100,000 shares, 900,000 pre-funded warrants and 2,000,000 common warrants under the offering were sold pursuant to a securities purchase agreement with an investor. A.G.P./Alliance Global Partners acted as placement agent for the offering and received a fee of 7% of the gross proceeds and reimbursement of $75,000 of expenses. The total estimated offering expenses were approximately $0.6millon and the net proceeds of approximately $2.5 million. The offering closed on July 14, 2023. Effective upon closing of the offering, the exercise price of an aggregate of 1,186,742 outstanding warrants the Company issued to an investor in 2020 and 2022 was reduced to $1.50 per share, subject to further adjustment as provided in the warrants, pursuant to a warrant amendment the Company entered into with the investor.

The Company’s plans and expectations for the next twelve months include raising additional capital to help fund expansion of the Company’s operations and strengthening of the Company’s sales force strategy by focusing on staffing services as the key driver to improve the Company’s margin and the continued support and functionality improvement of the Company’s information technology (“IT”) and HRIS platform. This expanded go-to-market strategy will focus on building a national account portfolio managed by a newly-formed regional team of senior sales executives singularly focused on sustained quarterly revenue growth and gross profit margin expansion. The Company expects to continue to invest in the Company’s HRIS platform, ShiftPixy Labs, and other growth initiatives, all of which have required and will continue to require significant cash expenditures.

The Company expects to raise capital from additional sales of its securities during this fiscal year either through registered public offerings or private placements, the proceeds of which the Company intends to use to fund its operations and growth initiatives. There can be no assurance that we will be able to sell securities on terms that the Company is seeking, or at all. Although management believes that its current cash position, along with its anticipated revenue growth and proceeds from future sales of its securities, when combined with prudent expense management, could alleviate substantial doubt, there is no assurance about its ability to continue as a going concern and to fund its operations for at least one year from the date these financials are available (even with the absence of any funded debt outstanding on its balance sheet). If these sources do not provide the capital necessary to fund the Company’s operations during the next twelve months, it may need to curtail certain aspects of its operations or expansion activities, consider the sale of additional assets, or consider other means of financing. The Company can give no assurance that it will be successful in implementing its business plan and obtaining financing on advantageous terms, or that any such additional financing will be available. If the Company is not successful in obtaining the necessary financing, we do not currently have the cash resources to meet our operating commitments for the next twelve months. Therefore, management has concluded that there is substantial doubt in the Company's ability to continue as a going concern for the next twelve months.

Reclassification

The Company reclassified certain expenses to conform to the current year's presentation.

Revenue and Direct Cost Recognition

The Company’s revenues are primarily disaggregated into fees for providing staffing solutions and EAS/HCM services. The Company enters into contracts with its clients for Staffing or EAS based on a stated rate and price in the contract. Contracts generally have a term of 12 months, however, are cancellable at any time by either party with 30 days’ written notice. The performance obligations in the agreements are generally combined into one performance obligation, as they are considered a series of distinct services, and are satisfied over time because the client simultaneously receives and consumes the benefits provided as the Company performs the services. Payments for the Company’s services are typically made in advance of, or at the time that the services are provided. The Company does not have significant financing components or significant payment terms for its customers and consequently has no material credit losses. The Company uses the output method based on a stated rate and price over the payroll processed to recognize revenue, as the value to the client of the goods or services transferred to date appropriately depicts the Company’s performance towards complete satisfaction of the performance obligation.

Staffing Solutions

The Company records gross billings as revenues for its staffing solutions clients. The Company is primarily responsible for fulfilling the staffing solutions services and has discretion in establishing price. The Company includes the payroll costs in revenues with a corresponding increase to cost of revenues for payroll costs associated with these services. As a result, we are the principal in this arrangement for revenue recognition purposes.

EAS Solutions / HCM

EAS solutions revenue is primarily derived from the Company’s gross billings, which are based on (i) the payroll cost of the Company’s worksite employees (“WSEs”) and (ii) a mark-up computed as a percentage of payroll costs for payroll taxes and workers’ compensation premiums.

Gross billings are invoiced to each EAS client concurrently with each periodic payroll of the Company’s WSEs, which coincides with the services provided and which is typically a fixed percentage of the payroll processed. Revenues, which exclude the payroll cost component of gross billings and therefore consist solely of markup, are recognized ratably over the payroll period as WSEs perform their services at the client worksite. Although the Company assumes responsibility for processing and remitting payroll and payroll related obligations, it does not assume employment-related responsibilities such as determining the amount of the payroll and related payroll obligations. As a result, the Company records revenue on a “net” basis in this arrangement for revenue recognition purposes. Revenues that have been recognized but not invoice are included in unbilled accounts receivable on the Company’s condensed consolidated balance sheets were $2.0 million and $2.1 million, as of May 31, 2023 and August 31, 2022, respectively.

Consistent with the Company’s revenue recognition policy for EAS clients, direct costs do not include the payroll cost of its WSEs. The cost of revenue associated with the Company’s revenue generating activities is primarily comprised of all other costs related to its WSEs, such as the employer portion of payroll-related taxes, employee benefit plan premiums and workers’ compensation insurance costs.

The fees collected from the worksite employers for benefits (i.e. zero-margin benefits pass-through), workers’ compensation and state unemployment taxes are presented in revenues and the associated costs of benefits, workers’ compensation and state unemployment taxes are included in operating expenses for EAS clients, as the Company does retain risk and acts as a principal with respect to this aspect of the arrangement. With respect to these fees, the Company is primarily responsible for fulfilling the service and has discretion in establishing price.

Disaggregation of Revenue

The Company’s primary revenue streams include HCM and staffing services. The Company’s disaggregated revenues for the nine months ended May 31, and May 31, 2022, respectively, were as follows:

	For the Three Months Ended				For the Nine Months Ended
Revenue (in thousands):	May 31, 2023		May 31, 2022		May 31, 2023		May 31, 2022
HCM1	$	111	$	1,734	$	1,521	$	4,052
Staffing		3,877		7,909		12,312		24,969

¹ HCM revenue is presented net, $8.3 million and $30.7 million gross billings less WSE payroll costs of $8.2 million and $29.2 million for the three and nine months ended May 31, 2023, respectively. Gross billings were $13.9 million and $39.4 million less WSE payroll costs of 12.2 million and $35.3 million for the three and nine months ended May 31, 2022, respectively.

For the three and nine months ended May 31, 2023 and May 31, 2022, respectively, the following geographical regions represented more than 10% of total revenues:

	For the Three Months Ended						For the Nine Months Ended
Region:	May 31, 2023			May 31, 2022			May 31, 2023			May 31, 2022
California		33.1	%		49.0	%		42.5	%		52.2	%
Washington		15.5	%		14.9	%		12.8	%		13.7	%
New Mexico		12.9	%		7.6	%		11.9	%		7.4	%

Incremental Cost of Obtaining a Contract

Pursuant to the “practical expedients” provided under Accounting Standards Update “ASC” No 2014-09, the Company expenses sales commissions when incurred because the terms of its contracts are cancellable by either party upon 30 day’' notice. These costs are recorded in commissions in the Company’s unaudited condensed consolidated statements of operations.

Segment Reporting

Prior to August 31, 2021, the Company operated as one reportable segment under Accounting Standards Codification “ASC” 280, Segment Reporting. The chief operating decision maker regularly reviews the financial information of the Company at a consolidated level in deciding how to allocate resources and in assessing performance. Reporting and monitoring activities on a segment basis will allow the chief operating decision maker to evaluate operating performance more effectively. However, the Company is working on its systems to properly allocate to its business segments. However, the CEO is actively involved in the day to day business and is aware of the overall segment information.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased as cash equivalents. The Company had no cash equivalent as of May 31, 2023 and August 31, 2022.

Marketable Securities Held in Trust Account

As of August 31, 2022, substantially all of the assets held in the Trust Account were invested in U.S. Treasury securities with maturities of 180 days or less. These funds are restricted for use and may only be used for purposes of completing an initial business combination ("IB") or redemption of the public common shares of IHC. On December 1, 2022, the Company distributed $117.6 million to the shareholders of IHC. There were no assets held in the Trust Account as of May 31, 2023.

Concentration of Credit Risk

The Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal. As of May 31, 2023 and August 31, 2022, there was $0.0 million and $0.6 million, respectively, of cash on deposit in excess of the amounts insured by the FDIC.

The following represents clients who have ten percent of total accounts receivable as of May 31, 2023 and August 31, 2022, respectively.

	As of
	May 31, 2023			August 31, 2022
Clients:	(Unaudited)
Client 1		57.8	%	—		%
Client 2		21.4	%		41.9	%
Client 3		9.6	%		13.7	%
Client 4		6.3	%		21.9	%
Client 5	—		%		20.7	%

Fixed Assets

Fixed assets are recorded at cost, less accumulated depreciation and amortization. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When fixed assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Leasehold improvements are amortized over the shorter of the useful life or the initial lease term.

Fixed assets are recorded at cost and are depreciated over the estimated useful lives of the related assets using the straight-line method. The estimated useful lives of property and equipment for purposes of computing depreciation are as follows:

Equipment:	5 years
Furniture & Fixtures:	5 – 7 years
Leasehold improvements	Shorter of useful life or the remaining lease term, typically 5 years

Depreciation and amortization expense for the three months ended May 31, 2023 and May 31, 2022 was $0.1 million and $0.1 million, respectively, and included on the unaudited condensed consolidated statements of operations. Depreciation and amortization expense for the nine months ended May 31, 2023 and May 31, 2022 was $0.4 million and $0.4 million, respectively.

Computer Software Development

Software development costs relate primarily to software coding, systems interfaces and testing of the Company’s proprietary employer information systems and are accounted for in accordance with Accounting Standards Codification “ASC” 350-40, Internal Use Software.

Internal software development costs are capitalized from the time the internal use software is considered probable of completion until the software is ready for use. Business analysis, system evaluation and software maintenance costs are expensed as incurred. The capitalized computer software development costs are reported under the section fixed assets, net in the consolidated balance sheets and are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company determined that there was no material capitalized internal software development costs for the nine months ended May 31, 2023 and August 31, 2022. All capitalized software recorded was purchased from third party vendors. Capitalized software development costs are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company incurred research and development costs of $0.2 million and $0.7 million for the three and nine months ended May 31, 2023, respectively. During the three and nine months ended May 31, 2022, the Company incurred research and development costs of approximately $1.1 million and $5 million, respectively. All costs were related to internally developed or externally contracted software and related technology for the Company’s HRIS platform and related mobile application.

Lease Recognition

The Financial Accounting Standards Board "FASB" established Topic 842, Leases, by issuing ASU No. 2016-02 “ASC” 842, which required lessees to recognize leases on the balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The standard established a right-of-use asset model (“ROU”) that required a lessee to recognize an ROU operating lease asset and lease liability on the condensed balance sheets for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the unaudited condensed consolidated statement of operations.

Impairment and Disposal of Long-Lived Assets

The Company periodically evaluates its long-lived assets for impairment in accordance with ASC 360-10, Property, Plant, and Equipment. ASC 360-10 requires that an impairment loss be recognized for assets to be disposed of or held-for-use when the carrying amount of an asset is deemed not to be recoverable. If events or circumstances were to indicate that any of the Company’s long-lived assets might be impaired, the Company would assess recoverability based on the estimated undiscounted future cash flows to be generated from the applicable asset. In addition, the Company may record an impairment loss to the extent that the carrying value of the asset exceeds the fair value of the asset. Fair value is generally determined using an estimate of discounted future net cash flows from operating activities or upon disposal of the asset. The Company assessed impairment for the periods presented and no impairment charges were deemed necessary.

Workers' Compensation

Everest Program

Until July 2018, a portion of the Company’s workers’ compensation risk was covered by a retrospective rated policy through Everest National Insurance Company, which calculates the final policy premium based on the Company’s loss experience during the term of the policy and the stipulated formula set forth in the policy. The Company funded the policy based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. During the policy term and thereafter, periodic adjustments may involve either a return of previously paid premiums or a payment of additional premiums by the Company or a combination of both. If the Company’s losses under that policy exceed the expected losses under that policy, then the Company could receive a demand for additional premium payments. The Company became engaged in litigation regarding such a demand for additional premium payments; however, the Company has entered into a settlement agreement with Everest and Gallagher Bassett, concluding the litigation. See Note 9, Contingencies, Everest Litigation, below and Note 10 subsequent events. The Company has accrued for this settlement as of May 31, 2023.

Sunz Program

From July 2018 through February 28, 2021, the Company’s workers’ compensation program for its WSEs was provided primarily through an arrangement with United Wisconsin Insurance Company and administered by Sunz Insurance Solutions, LLC (“Sunz”). Under this program, the Company has financial responsibility for the first $0.5 million of claims per occurrence. The Company provides and maintains a loss fund that is earmarked to pay claims and claims related expenses. The workers’ compensation insurance carrier establishes monthly funding requirements comprised of premium costs and funds to be set aside for payment of future claims (“claim loss funds”). The level of claim loss funds is primarily based upon anticipated WSE payroll levels and expected workers’ compensation loss rates, as determined by the insurance carrier. Monies funded into the program for incurred claims expected to be paid within one year were recorded as Deposit - workers’ compensation, a short-term asset, while the remainder of claim funds were included in Deposit - workers’ compensation, a long-term asset in our condensed consolidated balance sheets. The Company is currently engaged in litigation regarding demands by Sunz for additional claims loss funds, which we believe to be without merit, as discussed at Note 9, Contingencies, Sunz Litigation, below.

Under the Everest and Sunz programs, the Company utilized a third party to estimate its loss development rate, which was based primarily upon the nature of WSEs’ job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates.

There were no workers compensation deposits related to these programs as of May 31, 2023, and as of August 31, 2022, respectively.

Current Program

Effective March 1, 2021, the Company migrated its clients to a guaranteed cost program. Under this program, the Company’s financial responsibility is limited to the cost of the workers’ compensation premium. The Company funds the workers’ compensation premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. Any final adjustments to the premiums are based on the final audited exposure multiplied by the applicable rates, classifications, experience modifications and any other associated rating criteria.

With regard to the prior programs, which continue until fully concluded, the Company’s estimate of incurred claim costs expected to be paid within one year is included in short-term liabilities, while its estimate of incurred claim costs expected to be paid beyond one year is included in long-term liabilities on its consolidated balance sheets. As of May 31, 2023 and August 31, 2022, the Company had short term accrued workers’ compensation costs of $0.4 million and $0.6 million, and long-term accrued workers’ compensation costs of $0.9 million and $1.2 million, respectively.

The Company retained workers’ compensation asset reserves and workers’ compensation related liabilities for former WSEs of clients transferred to Shiftable HR Acquisition, LLC, a wholly owned subsidiary of Vensure Employer Services, Inc. (“Vensure”), in connection with the Vensure Asset Sale described in Note 3, Discontinued Operations, below. As of May 31, 2023, the retained workers’ compensation assets and liabilities are presented as a discontinued operation net asset or liability. As of May 31, 2023 and August 31, 2022, the Company had $1.8 million and $1.4 million in short-term liabilities, and $4.1 million and $3.3 million in long-term liabilities, respectively. The Company had no related worker's compensation assets as of May 31, 2023 and as of August 31, 2022, respectively.

Because the Company bears the financial responsibility for claims up to the level noted above, such claims, which are the primary component of its workers’ compensation costs, are recorded in the period incurred. Workers’ compensation insurance includes ongoing health care and indemnity coverage whereby claims are paid over numerous years following the date of injury. Accordingly, the accrual of related incurred costs in each reporting period includes estimates, which take into account the ongoing development of claims and therefore require a significant level of judgment. In estimating ultimate loss rates, the Company utilizes historical loss experience, exposure data, and actuarial judgment, together with a range of inputs that are primarily based upon the WSE’s job responsibilities, their location, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. For each reporting period, changes in the actuarial assumptions resulting from changes in actual claims experience and other trends are incorporated into the Company’s workers’ compensation claims cost estimates. The estimated incurred claims are based upon: (i) the level of claims processed during each quarter; (ii) estimated completion rates based upon recent claim development patterns under the plan; and (iii) the number of participants in the plan.

The Company has had very limited and immaterial COVID-19 related claims between March 2020 through the date of this Quarterly Report, although there is a possibility of additional workers’ compensation claims being made by furloughed WSEs as a result of the employment downturn caused by the pandemic. On May 4, 2020, the State of California indicated that workers who become ill with COVID-19 would have a potential claim against workers’ compensation insurance for their illnesses. There is a possibility that additional workers’ compensation claims could be made by employees required to work by their employers during the COVID-19 pandemic, which could have a material impact on the Company's workers’ compensation liability estimates. While the Company has not seen significant additional expenses as a result of any such potential claims to date, which would include claims for reporting periods after May 31, 2023, we continue to monitor closely all workers’ compensation claims made in relation to the COVID-19 pandemic.

Fair Value of Financial Instruments

Accounting Standard Codification "ASC" 820, Fair Value Measurement, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practical to estimate fair value. ASC 820 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of May 31, 2023 and August 31, 2022, the carrying value of certain financial instruments (cash, accounts receivable and payable) approximated fair value due to the short-term nature of the instruments. Notes Receivable is valued at the Company's estimate of expected collections value as described below, See Note 3, Discontinued Operations.

The Company measures fair value under a framework that utilizes a hierarchy prioritizing the inputs to relevant valuation techniques. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used in measuring fair value are:

· Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

· Level 2: Inputs to the valuation methodology include

· Quoted prices for similar assets or liabilities in active markets

· Quoted prices for identical or similar assets or liabilities in inactive markets

· Inputs other than quoted prices that are observable for the asset or liability

· Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and

· If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability

· Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement

Funds held in Trust Account represent U.S. treasury bills that was restricted for use and may only be used for purposes of completing an IBC or redemption of the public shares of common stock of the SPACs as set forth in their respective trust agreements. The funds held in trust are included within Level 1 of the fair value hierarchy and included in cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheets. The Trustee distributed all the funds in the Trust Account to the shareholders of IHC on December 1, 2022.

When the Company changes its valuation inputs for measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it could be required to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these transfers at the end of the reporting period that the transfers occur. The development and determination of the unobservable inputs for Level 3 fair value measurements and the fair value calculations are the responsibility of the Company’s chief financial officer and are approved by the chief executive officer. There were no transfers out of Level 3 for the nine months ended May 31, 2023 and August 31, 2022.

Advertising Costs

The Company expenses all advertising as incurred. Advertising expense for the three months ended May 31, 2023 and May 31, 2022 was $0.8 million and $0.4 million, respectively. Advertising expense for the nine months end May 31, 2023 and May 31, 2022 was $2.0 million and $1.4 million, respectively.

Income Taxes

The Company accounts for income taxes pursuant to ASC 740, Income Taxes. Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. A full valuation allowance was recorded as of May 31, 2023 and August 31, 2022, respectively,

Income (Loss) Per Share

Basic net income or net (loss) per common share is computed by dividing net income or net (loss) attributable to common shareholders by the weighted-average number of shares of common stock outstanding during the reporting period. Common stock outstanding for purposes of net income or net (loss) per share calculations include options, warrants, shares of common stock to be issued to directors for services provided and Preferred Option. Diluted net income or and net (loss) per share is computed similar to basic income or net (loss) per share except that the denominator is increased to include additional common stock equivalents available upon exercise of stock options, warrants, shares of common stock to be issued to directors for services provided and Preferred Option using the treasury stock method. Dilutive common stock equivalents include the dilutive effect of in-the-money stock equivalents, which are calculated based on the average share price for each period using the treasury stock method, excluding any common stock equivalents if their effect would be anti-dilutive. In periods in which a net loss has been incurred, all potentially dilutive common stock shares are considered anti-dilutive and thus are excluded from the calculation. Securities that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, are:

	Three Months Ended				Nine Months Ended
	May 31, 2023		May 31, 2022		May 31, 2023		May 31, 2022
Options (See Note 5)		10,003		15,498		10,003		15,498
Warrants (See Note 5)		1,252,749		224,402		1,252,749		224,402
Shares of common stock to be issued to directors for services provided, (See Note 7)		59,040		—		59,040		—
Preferred Option (Note 5)		37,570		—		37,570		—
Total potentially dilutive shares		1,359,362		239,900		1,359,362		239,900

For the table above, “Options” represent all options granted under the Company’s 2017 Stock Option/Stock Issuance Plan (the "Plan"), as described in Note 5, Stock Based Compensation, below.

Share-Based Compensation

The Company has one stock-based compensation plan under which the Company may issue awards, as described in Note 5, Stock Based Compensation, below. The Company accounts for the Plan under the recognition and measurement principles of ASC 718, Compensation-Stock Compensation, which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the unaudited condensed consolidated statements of operations at their fair values.

The grant date fair value is determined using the Black-Scholes-Merton (“Black-Scholes”) pricing model. For all employee stock options, the Company recognizes expense on an accelerated basis over the employee’s requisite service period (generally the vesting period of the equity grant).

The Company’s option pricing model requires the input of highly subjective assumptions, including the expected stock price volatility and expected term. The expected volatility is based on the historical volatility of the Company’s common stock since the Company's initial public offering. Any changes in these highly subjective assumptions significantly impact stock-based compensation expense.

The Company elects to account for forfeitures as they occur. As such, compensation cost previously recognized for an unvested award that is forfeited because of the failure to satisfy a service condition is revised in the period of forfeiture.

The methods and assumptions used in the determination of the fair value of stock-based awards are consistent with those described in the Company's Annual Report on Form 10-K for the year ending August 31, 2022, filed with the SEC on December 13, 2022, and the amendments thereto on Forms 10-K/A filed with the SEC on December 14, 2022, February 3, 2023 and February 9, 2023, respectively, which include a detailed description of the Company's stock-based compensation awards, including information related to vesting terms, service and performance conditions, payout percentages, and process for estimating the fair value of stock options granted.

Recently Adopted Accounting Standards

In June 2016, the Financial Accounting Standards Board "FASB" issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This standard requires an impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces multiple existing impairment models in current. GAAP, which generally requires a loss to be incurred before it is recognized. The new standard applies to trade receivables arising from revenue transactions such as contract assets and accounts receivable. Under ASC 606, revenue is recognized when, among other criteria, it is probable that an entity will collect the consideration it is entitled to when goods or services are transferred to a customer. When trade receivables are recorded, they become subject to the CECL model and estimates of expected credit losses on trade receivables over their contractual life will be required to be recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. For the three months ended May 31, 2023, the Company adopted this guidance, and it was not material to the results of operations.

Variable Interest Entity

The Company has been involved in the formation of various entities considered to be Variable Interest Entities (“VIEs”). The Company evaluates the consolidation of these entities as required pursuant to ASC Topic 810 relating to the consolidation of VIEs. These VIEs are SPACs.

The Company’s determination of whether it is the primary beneficiary of a VIE is based in part on an assessment of whether or not the Company and its related parties are exposed to the majority of the risks and rewards of the entity. Typically, the Company is entitled to substantially all or a portion of the economics of these VIEs. The Company is the primary beneficiary of the VIE entities.

Through November 30, 2022, only one of the four SPAC companies existed, See Note 4 Special Purpose Acquisition Company Sponsorship that has more information regarding the remaining SPAC company. There are no SPAC companies as of February 7, 2022.

In connection with the IPO in October 2021, the Company purchased, through its wholly owned subsidiary, ShiftPixy Investments, Inc. ("Investments" or the "Sponsor"), 4,639,102 private placement warrants ("Placement Warrants") at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102, and the Company currently own 2,110,000 Founder Shares of IHC common stock, representing approximately 15% of the issued and outstanding common stock of IHC. Before the closing of the IPO, the Sponsor transferred 15,000 Founder Shares to IHC's independent directors, reducing its shareholdings from 2,125,000 to 2,110,000. Each Placement Warrant was identical to the warrants sold in the IPO, except as described in the IPO registration statement and prospectus. Following the completion of IHC's IPO, the Company determined that IHC was a VIE in which the Company had a variable interest because IHC did not have enough equity at risk to finance its activities without additional subordinated financial support. The Company had also determined that IHC's public stockholders did not have substantive rights, and their equity interest constitutes temporary equity, outside of permanent equity, in accordance with ASC 480-10-S99-3A, at such time. As such, the Company concluded that they were the primary beneficiary of IHC as a VIE, as the Company had the right to receive benefits or the obligation to absorb losses of the entity, as well as the power to direct a majority of the activities that significantly impact IHC's economic performance. Since the Company was the primary beneficiary, IHC to be consolidated into the Company's unaudited condensed consolidated financial through February 7, 2023. See Note 4, for the dissolution of IHC and entire amount from the Trust Account to IHC shareholders on December 1, 2022. As of December, 1, 2021, the Company determined that IHC was not a VIE. The Company did not have the power to direct the operations of IHC since IHC was dissolved on November 14, 2022 and the assets of the Trust Account was distributed to its shareholders on December 1, 2022. The Company lost its voting rights, and there is no possibility of recouping its investment. As a result, the Company determined that IHC will not be consolidated into the unaudited condensed financial statements as of December 1, 2022 See Note 4 regarding three of IHC creditors forcing them into bankruptcy. As a result of the deconsolidation of the VIE on February 7, 2023, the Company recorded the elimination of $9.4 million of the non-controlling interest to additional paid-in capital as it was originally recorded. The net liabilities of IHC were $0.6 million as of February 7, 2023 that resulted in the Company recorded $0.6 million to other income and $0.5 million to non-controlling or, 85% of its non- ownership interest in IHC.

Shares Subject to Possible Redemption

The Company previously accounts for its common stock holdings in its sponsored SPACs (which were consolidated in the Company's unaudited condensed consolidated financial statements) through February 7, 2023, which was previously subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of common stock were classified as a current liability since the shares were redeemed as of August 31, 2022. Each sponsored SPAC's shares of common stock feature certain redemption rights that are considered to be outside of the SPAC's control and subject to occurrence of uncertain future events. However, since the common stock subject to redemption were paid to IHC shareholders on December 1. 2022, the fair market value as of August 31, 2022 was classified as a current liability. The Company has recorded increases or decreases in the carrying amount of the redeemable common stock are affected by charges against additional paid in-capital and accumulated deficit.

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

May 31, 2023

Summary of Significant Accounting Policies

Disaggregation of Revenue

	For the Three Months Ended				For the Nine Months Ended
Revenue (in thousands):	May 31, 2023		May 31, 2022		May 31, 2023		May 31, 2022
HCM1	$	111	$	1,734	$	1,521	$	4,052
Staffing		3,877		7,909		12,312		24,969

Revenue from External Customers by Geographic Areas

	For the Three Months Ended						For the Nine Months Ended
Region:	May 31, 2023			May 31, 2022			May 31, 2023			May 31, 2022
California		33.1	%		49.0	%		42.5	%		52.2	%
Washington		15.5	%		14.9	%		12.8	%		13.7	%
New Mexico		12.9	%		7.6	%		11.9	%		7.4	%

Schedules of Concentration of Risk, by Risk Factor

	As of
	May 31, 2023			August 31, 2022
Clients:	(Unaudited)
Client 1		57.8	%	—		%
Client 2		21.4	%		41.9	%
Client 3		9.6	%		13.7	%
Client 4		6.3	%		21.9	%
Client 5	—		%		20.7	%

Schedule of Estimated Useful Lives of Property and Equipment

Equipment:	5 years
Furniture & Fixtures:	5 – 7 years
Leasehold improvements	Shorter of useful life or the remaining lease term, typically 5 years

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

	Three Months Ended				Nine Months Ended
	May 31, 2023		May 31, 2022		May 31, 2023		May 31, 2022
Options (See Note 5)		10,003		15,498		10,003		15,498
Warrants (See Note 5)		1,252,749		224,402		1,252,749		224,402
Shares of common stock to be issued to directors for services provided, (See Note 7)		59,040		—		59,040		—
Preferred Option (Note 5)		37,570		—		37,570		—
Total potentially dilutive shares		1,359,362		239,900		1,359,362		239,900

XML

Discontinued Operations (Tables)

9 Months Ended

May 31, 2023

Discontinued Operations

Schedule of condensed consolidated balance sheets

	As of
	May 31, 2023 (Unaudited)			August 31, 2022
Gross proceeds	$	19,166,000		$	19,166,000
Cash received at closing – asset sale		(9,500,000	)		(9,500,000	)
Cash received at closing – working capital		(166,000	)		(166,000	)
Gross note receivable	$	9,500,000		$	9,500,000
Less:  Transaction reconciliation – estimated working capital adjustments		(2,604,000	)		(2,604,000	)
Adjusted Note Receivable		6,896,000			6,896,000
Reserve for estimated potential claims		(2,892,000	)		(2,892,000	)
Reserve for potential collectability concerns	$	(4,004,000	)	$	(4,004,000	)
Long-term note receivable, estimated net realizable value	$	—		$	—

Schedule Of classes of assets and liabilities from the Vensure Asset Sale

	As of
	May 31, 2023			August 31, 2022
	(Unaudited)
Deposits – workers’ compensation		—			—
Total current assets		—			—
Deposits – workers’ compensation		—			—
Total assets	$	—		$	—
Accrued workers’ compensation cost		1,765,000			1,362,000
Total current liabilities		1,765,000			1,362,000
Accrued workers’ compensation cost		4,133,000			3,269,000
Total liabilities		5,898,000			4,631,000
Net liability	$	(5,898,000	)	$	(4,631,000	)

Schedule of Disposal Groups Including Discontinued Operations Income Statement

	For the Three Months Ended						For the Nine Months Ended
	May 31, 2023			May 31, 2022			May 31, 2023			May 31, 2022
Revenues	$	—		$	—		$	—		$	—
Cost of revenues		460,000			132,000			1,267,000			283,000
Gross profit (loss)		(460,000	)		(132,000	)		(1,267,000	)		(283,000	)
Total operating expenses		—			—			—			—
Loss from discontinued operations	$	(460,000	)	$	(132,000	)	$	(1,267,000	)	$	(283,000	)

XML

Stockholders Deficit (Tables)

9 Months Ended

May 31, 2023

Stockholders Deficit

Schedule of common stock and prefunded warrants

	Number of shares			Weighted average remaining life (years)		Weighted average exercise price
Warrants outstanding, August 31, 2022		522,786			7.2		47.99
Issued		854,166			6.3		12.02
Exercised		(124,203	)		—		—
Warrants outstanding and exercisable, May 31, 2023		1,252,749			6.4	$	35.68

Schedule of Warrants Outstanding

	Warrants Outstanding		Weighted Average Life of Outstanding Warrants (In years)		Exercise price
September 2022 Common Warrants (Note 10)		833,334		6.3	$	12.00
September 2022 Underwriter Warrants		20,833		3.9		13.20
July 2022 Common Warrants (Note 10)		348,408		7.1		26.00
Sep 2021Underwriter Warrants		3,762		5.9		175.00
May 2021Underwriter Warrants		2,474		3.0		243.00
October 2020 Common Warrants (1)		23,000		2.4		330.00
October 2020 Underwriter Warrants		2,000		2.4		330.00
May 2020 Common Warrants		12,776		2.0		540.00
May 2020 Underwriter Warrants		1,111		2.0		540.00
March 2020 Exchange Warrants		4,237		2.3		1,017.00
Amended March 2019 Warrants		663		0.8		4,000.00
March 2019 Services Warrants		34		0.8		7,000.00
June 2018 Warrants		63		0.5		9,960.00
June 2018 Services Warrants		54		0.5		9,960.00
		1,252,749		6.4	$	35.68

XML

Stock Based Compensation (Tables)

9 Months Ended

May 31, 2023

Stock Based Compensation

Share-based Payment Arrangement, Option, Activity

	Options Outstanding and Exercisable
	Number of Options			Weighted Average Remaining Contractual Life		Weighted Average Exercise Price
				(In years)
Balance outstanding as of August 31, 2022		11,753			8.1	$	733.00
Forfeited		(1,750	)		8.3		2.70
Balance outstanding expected to be exercisable as of May 31, 2023		10,003			7.2	$	813.70

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable

Options Vested	Number of Options			Weighted Remaining Contractual Life		Weighted Average Exercise Price
				(In years)
Balance, August 31, 2022		5,269			8.1	$	1,146
Vested		2,290			7.7		442
Forfeited		(716	)		8.1		293
Balance, May 31, 2023	6,843				7.4	$	998

Summarizes of Stock Options Outstanding

	Options Outstanding						Options Vested
Exercise Prices	Number of Options Exercisable		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number of Options		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price
			(In Years)						(In Years)
$50.00 - 1,000.00		9,641		7.6	$	453	6,483			7.1	$	466
$1,001.00 - $4,000.00		20		6.3		1,895		19		6.0		1,896
$4,001.00 - $8,000.00		121		6.1		5,121		120		5.1		5,120
$8,001.00 - $12,000.00		101		5.2		10,298		101		4.1		10,298
$12,001.00 - $16,000.00		109		4.4		15,584		109		4.0		15,584
$16,001.00 - $39,160.00		11		4.4		39,160		11		4.0		39,160
		10,003		7.6	$	814	6,843			7.4	$	998

XML

Commitments (Tables)

9 Months Ended

May 31, 2023

Commitments and contingencies

Lease, Cost

	Three Months  Ended May 31, 2023		Nine Months Ended May 31,  2023
Operating Lease Cost	$	260,000	$	824,000

Lessee, Operating Lease, Liability, Maturity

	Minimum lease commitments
2024	$	1,047,000
2025		1,081,000
2026		928,000
2027		694,000
2028		403,000
Thereafter		225,000
Total minimum payments		4,378,000
Less: present value discount		508,000
Lease liability		3,870,000
Weighted-average remaining lease term - operating leases (months)		49
Weighted-average discount rate		5.54	%

XML

Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022
HCM
Revenues	$ 111	$ 1,734	$ 1,521	$ 4,052
Staffing
Revenues	$ 3,877	$ 7,909	$ 12,312	$ 24,969

XML

Summary of Significant Accounting Policies (Details 1) - Revenue from Contract with Customer Benchmark - Geographic Concentration Risk	3 Months Ended		9 Months Ended
	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022
Washington
Concentration risk, percentage	15.50%	14.90%	12.80%	13.70%
New Mexico
Concentration risk, percentage	12.90%	7.60%	11.90%	7.40%
California
Concentration risk, percentage	33.10%	49.00%	42.50%	52.20%

XML

Summary of Significant Accounting Policies (Details 2) - Accounts Receivable - Customer Concentration Risk	9 Months Ended	12 Months Ended
	May 31, 2023	Aug. 31, 2022
Client 1
Concentration risk, percentage	57.80%	0.00%
Client 2
Concentration risk, percentage	21.40%	41.90%
Client 3
Concentration risk, percentage	9.60%	13.70%
Client 4
Concentration risk, percentage	6.30%	21.90%
Client 5
Concentration risk, percentage	0.00%	20.70%

XML

Summary of Significant Accounting Policies (Details 3)	9 Months Ended
	May 31, 2023
Equipment:
Property, plant and equipment, useful life	5 years
Furniture & Fixtures: | Minimum
Property, plant and equipment, useful life	5 years
Furniture & Fixtures: | Maximum
Property, plant and equipment, useful life	7 years
Leasehold improvements
Property, plant and equipment, useful life	5 years

XML

Summary of Significant Accounting Policies (Details 4) - shares	3 Months Ended		9 Months Ended
	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022
Total potentially dilutive shares (in shares)	1,359,362	239,900	1,359,362	239,900
Preferred Option
Total potentially dilutive shares (in shares)	37,570	0	37,570	0
Shares of common stock to be issued to the directors for services provided
Total potentially dilutive shares (in shares)	59,040	0	59,040	0
Warrants
Total potentially dilutive shares (in shares)	1,252,749	224,402	1,252,749	224,402
Options
Total potentially dilutive shares (in shares)	10,003	15,498	10,003	15,498

XML

Summary of Significant Accounting Policies (Details Narrative) - USD ($)			1 Months Ended	3 Months Ended		9 Months Ended
	Jul. 12, 2023	Feb. 07, 2023	Oct. 22, 2021	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022	Jan. 31, 2023	Sep. 20, 2022	Aug. 31, 2022	Oct. 31, 2021
Cash				$ 100,000		$ 100,000
Gross billings				8,300,000	$ 13,900,000	30,700,000	$ 39,400,000
Worksite employee payroll cost				8,200,000	12,200,000	29,200,000	35,300,000
Working capital deficit				(41,700,000)		(41,700,000)
Net cash used in operating activities, continuing operations						(6,700,000)
Retained earnings (accumulated deficit)				$ 21,140,000		$ 21,140,000
Exercise price				$ 35.68		$ 35.68			$ 13.20	$ 47.99
Net proceeds from sale				$ 500,000		$ 2,000,000.0
Outstanding warrants				1,252,749		1,252,749				522,786
Sale of stock, number of shares issued in transaction (in shares)				133,988		439,328
Contract with customer, term						12 years
Contract with customer, cancellation period						30 years
Unbilled accounts receivable				$ 2,000,000.0		$ 2,000,000.0				$ 2,100,000
Redemption funds distributed to shareholders						2,000,000.0
Cash, uninsured amount				0.0		0.0				600,000
Depreciation and amortization				100,000	100	400,000	400,000
Research and development expense				200,000	1,100,000	700,000	5,000,000
Workers' compensation, claim responsibility per occurrence				50,000		50,000
Workers' compensation asset, current				400,000		400,000				1,200,000
Workers' compensation asset, noncurrent				900,000		900,000
Workers' compensation liability, current				1,800,000		1,800,000				1,400,000
Workers' compensation liability, noncurrent				4,100,000		4,100,000				$ 3,300,000
Advertising expense				800,000	400,000	2,000,000.0	1,400,000
Redeemable Noncontrolling Interest, Equity, Common, Redemption Funds Distributed To Shareholders						117,574,000	0
Common stock, shares, transferred (in shares)			15,000
Deconsolidation, loss, amount				0	$ 0	$ 540,000	$ 0
Other Income
Deconsolidation, loss, amount		$ 60,000
Noncontrolling interest
Noncontrolling interest, decrease from deconsolidation		940,000
Minimum
Capitalized software development, useful life						three
Maximum
Capitalized software development, useful life						five years
At-The-Market Offering
Sale of stock, aggregate offering amount, maximum								$ 10,000,000
Sale of stock, number of shares issued in transaction (in shares)						439,429
Sale of stock, amount remaining available for sale of shares				$ 2,400,000		$ 2,400,000
Public Offering | Subsequent Event [Member]
Sale of common stock, shares	1,166,667
Sale of pre-funded warrants	900,000
Sale of common warrants	2,066,667
Offering price	$ 1.50
Offering price for pre funded warrants	1.4999
Exercise price	$ 0.0001
Offering fee received	7.00%
Reimbursement expenses	$ 75,000
Offering expenses	600,000
Net proceeds from sale	$ 2,500,000
Outstanding warrants	1,186,742
Exercise price on outstanding stock to investors	$ 1.50
Public Offering | Common Warrants [Member] | Subsequent Event [Member]
Number of common warrants sold	2,000,000
Share sold under securities agreement	1,100,000
Exercise price	$ 1.50
Number of common warrants prefunded	900,000
IHC
Variable interest entity, qualitative or quantitative information, ownership percentage						15.00%
Common stock, shares, owned (in shares)				2,110,000		2,110,000					2,110,000
Variable interest entity, net liabilities		(60,000)
Non-controlling interest		$ 50,000
Variable interest entity, qualitative or quantitative information, non-ownership percentage						85.00%
IHC | IPO | Placement Warrants
Outstanding warrants			4,639,102								4,639,102
Sale of warrants, price per share (in dollars per share)			$ 1.00
Redeemable Noncontrolling Interest, Equity, Common, Redemption Funds Distributed To Shareholders			$ 117,600,000
Aggregate purchase price											$ 4,639,102

XML

Discontinued Operations (Details) - USD ($)	9 Months Ended	12 Months Ended
	May 31, 2023	Aug. 31, 2022
Reserve for potential collectability concerns	$ (4,004,000)	$ (4,004,000)
Disposal by sale | Overall business
Gross proceeds	19,166,000	19,166,000
Cash received at closing - asset sale	(9,500,000)	(9,500,000)
Cash received at closing - working capital	(166,000)	(166,000)
Gross note receivable	9,500,000	9,500,000
Less: Transaction reconciliation - estimated working capital adjustments	(2,604,000)	(2,604,000)
Adjusted Note Receivable	6,896,000	6,896,000
Reserve for estimated potential claims	(2,892,000)	(2,892,000)
Long-term note receivable, estimated net realizable value	$ 0	$ 0

XML

Discontinued Operations (Details 1) - USD ($)	May 31, 2023	Aug. 31, 2022
Deposits - workers' compensation current	$ 0	$ 0
Deposits - workers' compensation	0	0
Total current liabilities	1,765,000	1,362,000
Disposal by sale | Overall business
Total current assets	0	0
Total assets	0	0
Accrued workers' compensation cost current	1,765,000	1,362,000
Accrued workers' compensation cost non current	4,133,000	3,269,000
Total current liabilities	1,765,000	1,362,000
Total liabilities	5,898,000	4,631,000
Net liability	$ (5,898,000)	$ (4,631,000)

XML

Discontinued Operations (Details 2) - Disposal by sale - Overall business - USD ($)	3 Months Ended		9 Months Ended
	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022
Revenues	$ 0	$ 0	$ 0	$ 0
Cost of revenues	460,000	132,000	1,267,000	283,000
Gross profit (loss)	(460,000)	(132,000)	(1,267,000)	(283,000)
Total operating expenses	0	0	0	0
Loss from discontinued operations	$ (460,000)	$ (132,000)	$ (1,267,000)	$ (283,000)

XML

Discontinued Operations (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	May 31, 2023	Aug. 31, 2022	Aug. 31, 2020	Mar. 12, 2021	Jan. 03, 2020
Reserve on potential collectability		$ 4,000,000
Disposal by sale | Overall business
Working capital adjustment	$ 2,600,000			$ 10,700,000
Disposal group, including discontinued operations, additional reserve for estimated potential claims	290,000
Gross note receivable	9,500,000
Discontinued operation, gain (Loss) on disposal of discontinued operation, net of tax			$ 15,600,000
Disposal group, including discontinued operation, consideration receivable, notes receivable, working capital adjustments	2,600,000
Lower net assets transferred at closing	$ 88,000
Disposal group including discontinued operations, estimated lower percentage of gross wages	90.00%
Disposal group including discontinued operations, contingent consideration	$ 140,000
Disposal by sale | PEO business
Percentage of business sold					100.00%

XML

Special Purpose Acquisition Company ("SPAC") Sponsorship (Details Narrative) - USD ($) $ in Thousands		9 Months Ended
	Feb. 07, 2023	May 31, 2023	Oct. 14, 2022	Oct. 22, 2021	Apr. 29, 2021
Temporary equity, carrying amount, attributable to parent				$ 11,670
Other commitments, percentage of outstanding shares, per acquisition company					15.00%
Common stock, shares, outstanding (in shares)			11,251,347
IHC
Assets held-in-trust, net tangible assets threshold			$ 5,000
Variable Interest Entity, Net Assets (Liabilities)	$ 60
Non-controlling interest	$ 50
Variable interest entity, qualitative or quantitative information, non-ownership percentage		85.00%
IHC | Public Shares
Common stock, shares, outstanding (in shares)			248,653

XML

Stockholders Deficit (Details) - $ / shares	9 Months Ended	12 Months Ended
	May 31, 2023	Aug. 31, 2022	Sep. 20, 2022
Number of shares
Number of shares outstanding, beginning balance (in shares)	522,786
Issued (in shares)	854,166
Exercised (in shares)	(124,203)
Number of shares outstanding, ending balance (in shares)	1,252,749	522,786
Weighted average remaining life (years)
Weighted average Life of Outstanding Warrants in years	6 years 4 months 24 days	7 years 2 months 12 days
Issued	6 years 3 months 18 days
Weighted average exercise price
Weighted average exercise price (in dollars per share)	$ 35.68	$ 47.99	$ 13.20
Issued (in dollars per share)	$ 12.02

XML

Stockholders Deficit (Details 1) - $ / shares	9 Months Ended	12 Months Ended
	May 31, 2023	Aug. 31, 2022	Sep. 20, 2022
Class of warrant or right, outstanding (in shares)	1,252,749	522,786
Weighted average Life of Outstanding Warrants in years	6 years 4 months 24 days	7 years 2 months 12 days
Exercise price of warrants (in dollars per share)	$ 35.68	$ 47.99	$ 13.20
September 2022 Common Warrants | Warrants
Class of warrant or right, outstanding (in shares)	833,334
Weighted average Life of Outstanding Warrants in years	6 years 3 months 18 days
Exercise price of warrants (in dollars per share)	$ 12.00
September 2022 Underwriter Warrants | Warrants
Class of warrant or right, outstanding (in shares)	20,833
Weighted average Life of Outstanding Warrants in years	3 years 10 months 24 days
Exercise price of warrants (in dollars per share)	$ 13.20
July 2022 Common Warrants | Warrants
Class of warrant or right, outstanding (in shares)	348,408
Weighted average Life of Outstanding Warrants in years	7 years 1 month 6 days
Exercise price of warrants (in dollars per share)	$ 26.00
Sep 2021Underwriter Warrants | Warrants
Class of warrant or right, outstanding (in shares)	3,762
Weighted average Life of Outstanding Warrants in years	5 years 10 months 24 days
Exercise price of warrants (in dollars per share)	$ 175.00
May 2021Underwriter Warrants | Warrants
Class of warrant or right, outstanding (in shares)	2,474
Weighted average Life of Outstanding Warrants in years	3 years
Exercise price of warrants (in dollars per share)	$ 243.00
October 2020 Common Warrants | Warrants
Class of warrant or right, outstanding (in shares)	23,000
Weighted average Life of Outstanding Warrants in years	2 years 4 months 24 days
Exercise price of warrants (in dollars per share)	$ 330.00
October 2020 Underwriter Warrants | Warrants
Class of warrant or right, outstanding (in shares)	2,000
Weighted average Life of Outstanding Warrants in years	2 years 4 months 24 days
Exercise price of warrants (in dollars per share)	$ 330.00
May 2020 Common Warrants | Warrants
Class of warrant or right, outstanding (in shares)	12,776
Weighted average Life of Outstanding Warrants in years	2 years
Exercise price of warrants (in dollars per share)	$ 540.00
May 2020 Underwriter Warrants | Warrants
Class of warrant or right, outstanding (in shares)	1,111
Weighted average Life of Outstanding Warrants in years	2 years
Exercise price of warrants (in dollars per share)	$ 540.00
March 2020 Exchange Warrants | Warrants
Class of warrant or right, outstanding (in shares)	4,237
Weighted average Life of Outstanding Warrants in years	2 years 3 months 18 days
Exercise price of warrants (in dollars per share)	$ 1,017.00
Amended March 2019 Warrants | Warrants
Class of warrant or right, outstanding (in shares)	663
Weighted average Life of Outstanding Warrants in years	9 months 18 days
Exercise price of warrants (in dollars per share)	$ 4,000.00
March 2019 Services Warrants | Warrants
Class of warrant or right, outstanding (in shares)	34
Weighted average Life of Outstanding Warrants in years	9 months 18 days
Exercise price of warrants (in dollars per share)	$ 7,000.00
June 2018 Warrants | Warrants
Class of warrant or right, outstanding (in shares)	63
Weighted average Life of Outstanding Warrants in years	6 months
Exercise price of warrants (in dollars per share)	$ 9,960.00
June 2018 Services Warrants | Warrants
Class of warrant or right, outstanding (in shares)	54
Weighted average Life of Outstanding Warrants in years	6 months
Exercise price of warrants (in dollars per share)	$ 9,960.00

XML

Stockholders Equity (Deficit) (Details Narrative) - USD ($)					1 Months Ended						3 Months Ended		5 Months Ended		9 Months Ended
	Aug. 12, 2022	Jul. 14, 2022	Aug. 13, 2021	Jun. 05, 2020	Sep. 30, 2022	Sep. 20, 2022	Sep. 02, 2022	Jan. 28, 2022	Jan. 26, 2022	Oct. 22, 2021	May 31, 2023	May 31, 2022	Nov. 30, 2020	Jun. 04, 2020	May 31, 2023	May 31, 2022	Aug. 31, 2022	Oct. 31, 2021	Sep. 03, 2021	Jun. 04, 2021	May 31, 2021	Mar. 31, 2021	Mar. 30, 2021	Oct. 08, 2020
Preferred stock, par or stated value per share (in dollars per share)											$ 0.0001				$ 0.0001		$ 0.0001
Compensation expense					$ 4,673,321						$ 200,000	$ 300,000			$ 700,000	$ 1,100,000
Description of warrant modification											the January 2022 Common Warrants, the Company recorded approximately (i) $0.64 million for the increased fair value of the modified warrants; and (ii) $12.6 million as the fair value of the January 2022 Common Warrants on the date of issuance. We recorded approximately $5.5 million as issuance costs that offset the $5.5 million of additional paid-in capital the received for the cash exercise of the existing Warrants at the reduced exercise price, while the remaining $7.7 million was recorded as a deemed dividend on the unaudited condensed consolidated statements of operations, resulting in a reduction of income available to common shareholders in our basic earnings per share calculation
Expected maturity period								6 years 8 months 12 days
Expected maturity								6 years 9 months 18 days
Share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate								3.70%
Share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate								149.40%
Divident yield								0.00%
Stock options exercised (in shares)						4,378,000
Number of options available for grant to founder shareholders (in shares)																						30,000	2,500
Number of shares cancelled (in shares)							8,600,000								1,750
Options forfeited (in shares)							8,600,000						127,100,000		716
Warrants to acquire shares of common stock (in shares)						20,833
Decrease in employee related liabilities															$ 8,324,000	$ 6,583,000
Exercise price of warrants (in dollars per share)						$ 13.20					$ 35.68				$ 35.68		$ 47.99
Class of warrant or right, outstanding (in shares)											1,252,749				1,252,749		522,786
Sale of stock, placement fee						7.00%
Sale of stock, number of shares issued in transaction (in shares)											133,988				439,328
Net proceeds from sale of stock											$ 500,000				$ 2,000,000.0
Common stock, par or stated value per share (in dollars per share)											$ 0.0001				$ 0.0001		$ 0.0001			$ 0.0001
(Exercised)															(124,203)
Common Share Units
Shares issued upon conversion (in shares)													294,490
Number of shares cancelled (in shares)										11,790,000
Common stock, freely tradeable shares, outstanding											294,490				294,490
Sale of stock, number of shares and warrants issued in transaction (in shares)						416,667
Chief Executive Officer
Shares issued for services rendered (in shares)	4,100,000
Scott W Absher | Chief Executive Officer
Preferred stock, par or stated value per share (in dollars per share)		$ 0.0001	$ 0.0001
Expected maturity period	10 years	10 years	24 months
Share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate	3.00%	3.10%
Share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate	125.70%	125.70%
Fair value exercise price (in dollars per share)	$ 0.0001	$ 0.0001									$ 0.0001				$ 0.0001
Stock options exercised (in shares)		12,500,000												12,500,000
Number of options available for grant to founder shareholders (in shares)			12,500,000								12,500,000			12,500,000	12,500,000
Preferred stock issued		$ 5,000,000												$ 1,250
Number option additionally available for grant to founder shareholders (in shares)				12,500,000
Share-based compensation arrangement by share-based payment award, assets or earning power threshold for option exercise			50.00%
Options forfeited (in shares)		12,500,000
Decrease in employee related liabilities	$ 820,000
Shares issued for services rendered (in shares)	4,100,000
Scott W Absher | Chief Executive Officer | Convertible Preferred Stock
Price per share (in dollars per share)	$ 0.2025	$ 0.2322
Scott W Absher | Chief Executive Officer | Common Share Units
Shares issued upon conversion (in shares)				12,500,000
Private Placement
Proceeds from issuance of private placement											$ 5,900,000
Placement Warrants | IPO | IHC
Class of warrant or right, outstanding (in shares)										4,639,102								4,639,102
Number of preferred stock options										37,570
January 2022 Common Warrants
Number of options available for grant to founder shareholders (in shares)		12,500,000
Warrants to acquire shares of common stock (in shares)									98,969
Class of warrant or right, outstanding (in shares)								98,969											25,233
May 2021 Prefunded Warrants | Private Placement
Warrants to acquire shares of common stock (in shares)																					49,484
Common Stock Warrants | Private Placement
Warrants to acquire shares of common stock (in shares)						833,334
Exercise price of warrants (in dollars per share)						$ 12.00
Sale of stock, stock and warrant price per share (in dollars per share)						$ 12.00
October 2020 Common Warrants | Common Share Units
Number of shares of common stock to be purchased accompanied by common warrant (in shares)																								5
Investor Warrants
(Exercised)									49,484
May 2021 Common Warrants | Private Placement
Shares issued, price per share (in dollars per share)																					$ 242.50
Options
Convertible preferred stock (in shares)											24,634,560				24,634,560
Options | Scott W Abshers [Member]
Number of options available for grant to founder shareholders (in shares)											25,000,000				25,000,000

XML

Stock Based Compensation (Details) - $ / shares	1 Months Ended	9 Months Ended
	Sep. 02, 2022	May 31, 2023
Stock Based Compensation
Beginning balance (in shares)		11,753
Forfeited (in shares)	(8,600,000)	(1,750)
Ending balance (in shares)		10,003
Weighted Average Remaining Contractual Life
Balance, outstanding		8 years 1 month 6 days
Forfeited		8 years 3 months 18 days
Balance, exercisable		7 years 2 months 12 days
Forfeited		$ 2.70
Weighted Average Exercise Price, beginning balance		733.00
Exercisable		$ 813.70

XML

Stock Based Compensation (Details 1) - $ / shares	1 Months Ended	5 Months Ended	9 Months Ended
	Sep. 02, 2022	Nov. 30, 2020	May 31, 2023
Stock Based Compensation
Options vested, beginning balance (in shares)			5,269
Vested (in shares)			2,290
Forfeited (in shares)	(8,600,000)	(127,100,000)	(716)
Options vested, ending balance (in shares)			6,843
Weighted remaining contractual life, beginning			8 years 1 month 6 days
Vested			7 years 8 months 12 days
Forfeited			8 years 1 month 6 days
Weighted remaining contractual life, ending			7 years 4 months 24 days
Weighted average exercise price, beginning			$ 1,146
Vested (in dollars per share)			442
Forfeited (in dollars per share)			293
Weighted average exercise price, ending			$ 998

XML

Stock Based Compensation (Details 2) - $ / shares	9 Months Ended
	May 31, 2023	Aug. 31, 2022
Number of Options Exercisable, Outstanding (in shares)	10,003
Weighted Average Remaining Contractual Life, Outstanding	7 years 7 months 6 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 814	$ 733.00
Number of Options Vested (in shares)	6,843	5,269
Weighted Average Remaining Contractual Life	7 years 4 months 24 days
Weighted Average Exercise Price (in dollars per share)	$ 813.70
Weighted Average Exercise Price (in dollars per share)	998
Exercise Price Range One
Number of Options Exercisable, Outstanding (in shares)	9,641
Weighted Average Remaining Contractual Life, Outstanding	7 years 7 months 6 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 453
Number of Options Vested (in shares)	6,483
Weighted Average Remaining Contractual Life	7 years 1 month 6 days
Weighted Average Exercise Price (in dollars per share)	$ 466
Exercise Price Range Two
Number of Options Exercisable, Outstanding (in shares)	20
Weighted Average Remaining Contractual Life, Outstanding	6 years 3 months 18 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 1,895
Number of Options Vested (in shares)	19
Weighted Average Remaining Contractual Life	6 years
Weighted Average Exercise Price (in dollars per share)	$ 1,896
Exercise Price Range Three
Number of Options Exercisable, Outstanding (in shares)	121
Weighted Average Remaining Contractual Life, Outstanding	6 years 1 month 6 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 5,121
Number of Options Vested (in shares)	120
Weighted Average Remaining Contractual Life	5 years 1 month 6 days
Weighted Average Exercise Price (in dollars per share)	$ 5,120
Exercise Price Range Four
Number of Options Exercisable, Outstanding (in shares)	101
Weighted Average Remaining Contractual Life, Outstanding	5 years 2 months 12 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 10,298
Number of Options Vested (in shares)	101
Weighted Average Remaining Contractual Life	4 years 1 month 6 days
Weighted Average Exercise Price (in dollars per share)	$ 10,298
Exercise Price Range Five
Number of Options Exercisable, Outstanding (in shares)	109
Weighted Average Remaining Contractual Life, Outstanding	4 years 4 months 24 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 15,584
Number of Options Vested (in shares)	109
Weighted Average Remaining Contractual Life	4 years
Weighted Average Exercise Price (in dollars per share)	$ 15,584
Exercise Price Range Six
Number of Options Exercisable, Outstanding (in shares)	11
Weighted Average Remaining Contractual Life, Outstanding	4 years 4 months 24 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 39,160
Number of Options Vested (in shares)	11
Weighted Average Remaining Contractual Life	4 years
Weighted Average Exercise Price (in dollars per share)	$ 39,160
Minimum | Exercise Price Range One
Exercise Prices (in dollars per share)	50
Minimum | Exercise Price Range Two
Exercise Prices (in dollars per share)	1,001
Minimum | Exercise Price Range Three
Exercise Prices (in dollars per share)	4,001
Minimum | Exercise Price Range Four
Exercise Prices (in dollars per share)	8,001
Minimum | Exercise Price Range Five
Exercise Prices (in dollars per share)	12,001
Minimum | Exercise Price Range Six
Exercise Prices (in dollars per share)	16,001
Maximum | Exercise Price Range One
Exercise Prices (in dollars per share)	$ 1,000
Maximum | Exercise Price Range Two
Number of Options Exercisable, Outstanding (in shares)	9,641
Weighted Average Remaining Contractual Life, Outstanding	7 years 7 months 6 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 453
Number of Options Vested (in shares)	6,843
Weighted Average Remaining Contractual Life	7 years 7 months 6 days
Weighted Average Exercise Price (in dollars per share)	$ 466
Maximum | Exercise Price Range Three
Exercise Prices (in dollars per share)	8,000
Maximum | Exercise Price Range Four
Exercise Prices (in dollars per share)	12,000
Maximum | Exercise Price Range Five
Exercise Prices (in dollars per share)	16,000
Maximum | Exercise Price Range Six
Exercise Prices (in dollars per share)	39,160
Maximum | Exercise Price Range Two One
Exercise Prices (in dollars per share)	$ 4,000

XML

Stock Based Compensation (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Sep. 30, 2022	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022	Mar. 06, 2023	Mar. 05, 2023	Mar. 31, 2021	Mar. 30, 2021
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)								30,000	2,500
Share-based compensation arrangement by share-based payment award, number of shares available for grant (in shares)		749,997		749,997
Share-Based Payment Arrangement, Expense	$ 4,673,321	$ 200,000	$ 300,000	$ 700,000	$ 1,100,000
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition				1 year 6 months
Share-based payment arrangement, nonvested award, cost not yet recognized, amount		918,000		$ 918,000
Share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value		$ 0		$ 0
March 6, 2023 [Member]
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)						750,000	30,000
Granted Prior to July 1, 2020 | Share-based payment arrangement, tranche one
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage				25.00%
Share-based compensation arrangement by share-based payment award, award vesting period				12 months
Granted Prior to July 1, 2020 | Share-based payment arrangement, tranche two
Share-based compensation arrangement by share-based payment award, award vesting period				36 months
Options Granted on or After July 1, 2020
Share-based compensation arrangement by share-based payment award, award vesting period				4 years
Options Granted on or After July 1, 2020 | Share-based payment arrangement, tranche one
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage				25.00%
Share-based compensation arrangement by share-based payment award, award vesting period				1 year

XML

Related Parties and Certain Directors and Officers (Details Narrative) - USD ($)		1 Months Ended			3 Months Ended		9 Months Ended		12 Months Ended
	Aug. 12, 2022	Sep. 30, 2022	Mar. 31, 2022	Oct. 22, 2021	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022	Aug. 31, 2022	Aug. 31, 2021	Feb. 28, 2023	Jul. 31, 2022
Decrease in employee related liabilities							$ 8,324,000	$ 6,583,000
Salary					$ 2,621,000	$ 3,254,000	7,477,000	10,796,000
Professional fees					752,000	2,680,000	2,817,000	6,094,000
Stock-based compensation expense		$ 4,673,321			$ 200,000	300,000	$ 700,000	1,100,000
Share-based compensation arrangement by share-based payment award, number of shares available for grant (in shares)					749,997		749,997
Mark Absher [Member]
Payments to employees					$ 60,000	60,000	$ 200,000	100,000
Salaried compensation, amount							200,000
David May [Member]
Payments to employees					38,000	43,000	100,000	100,000
Phil Eastvold [Member]
Payments to employees					56,000		200,000
Jason Absher [Member]
Payments to employees					30,000		90,000
Connie Absher, Elizabeth Eastvold, and Hannah Absher [Member]
Payments to employees					56,000	53,000	200,000	200,000
Scott Absher [Member]
Discretionary bonus, amount				$ 500,000
Employee compensation, discretionary bonus, percent of tranche one				50.00%								50.00%
Employee compensation, discretionary bonus, percent of tranche two				50.00%
Payments of discretionary bonus			$ 300,000
Decrease in employee related liabilities	$ (800,000)
Shares issued for services rendered (in shares)	4,100,000
Accrued salary					300,000		300,000		$ 800,000
Salary					200,000	400,000	600,000	800,000
Directors [Member]
Shares issued for services rendered (in shares)									0
Stock-based compensation expense					200,000	200,000.0	700,000	1,100,000
Number of directors with share-based payment arrangement agreements							300,000
Share-based payment arrangement, value agreed to be issued per year											$ 100,000
Accrued stock-compensation					$ 700,000		$ 700,000		$ 6,000
Share-based compensation arrangement by share-based payment award, number of shares available for grant (in shares)					59,040		59,040
J Stephen Holmes [Member]
Professional fees										$ 800,000
Amanda Murphy [Member]
Received salary compensation									300,000
Increase annual salary									500,000
Accrued liabilities									$ 200,000
Accrued salary					$ 300,000		$ 300,000
Salary					$ 66,000	$ 66,000	$ 500,000	$ 200,000

XML

Commitments Lease Cost (Details) - USD ($)	3 Months Ended	9 Months Ended
	May 31, 2023	May 31, 2023
Commitments and contingencies
Operating Lease Cost	$ 260,000	$ 824,000

XML

Commitments Lessee Operating Lease Liability Maturity (Details) $ in Thousands	9 Months Ended
	May 31, 2023 USD ($)
Commitments and contingencies
2024	$ 1,047,000
2025	1,081,000
2026	928,000
2027	694,000
2028	403,000
Thereafter	225,000
Total minimum payments	4,378,000
Less: present value discount	508,000
Lease liability	$ 3,870,000
Weighted-average remaining lease term - operating leases (months)	49 months
Weighted-average discount rate	5.54%

XML

Commitments Operating Leases License Agreements (Details Narrative)	1 Months Ended		9 Months Ended
	Aug. 31, 2022 USD ($) $ / shares shares	Oct. 22, 2021 USD ($) $ / shares shares	May 31, 2023 USD ($) $ / shares shares	May 31, 2022 USD ($)	Sep. 20, 2022 $ / shares	Oct. 31, 2021 shares	Jun. 07, 2021 ft²	Apr. 29, 2021 USD ($)
ROU asset impairment	$ 3,900,000
Employer contribution plan			$ 700,000
Other commitments, percentage of outstanding shares, per acquisition company								15.00%
Exercise price of warrants (in dollars per share) | $ / shares	$ 47.99		$ 35.68		$ 13.20
Proceeds from issuance initial public offering			$ 0	$ 37,978,000
Class of warrant or right, outstanding (in shares) | shares	522,786		1,252,749
SPAC 2
Other commitment								$ 25,000,000
Irvine Facility
Operating lease, monthly expense			$ 24,000
Miami Office Space Facility
Operating lease, monthly expense			57,000
Miami Verifone Facility
Operating lease, monthly expense			27,000
Area of real estate property | ft²							8,000
Sunrise Facility
Operating lease, monthly expense			$ 27,000
Second Irvine Facility
Operating lease, rent abatement percentage			50.00%
IPO | IHC
Exercise price of warrants (in dollars per share) | $ / shares		$ 1.00
Proceeds from issuance initial public offering		$ 11,500,000
IPO | IHC
Proceeds from issuance initial public offering		$ 4,600,000
Placement Warrants | IPO | IHC
Class of warrant or right, outstanding (in shares) | shares		4,639,102				4,639,102

XML

Contingencies (Details Narrative) - USD ($)				1 Months Ended				5 Months Ended	9 Months Ended
	Nov. 08, 2022	Mar. 12, 2021	Jan. 03, 2020	Sep. 02, 2022	Oct. 22, 2021	Mar. 19, 2021	Dec. 18, 2020	Aug. 31, 2021	May 31, 2023	Aug. 31, 2022	Nov. 04, 2021
Share-based compensation arrangement by share-based payment award, options, forfeitures in period (in shares)				8,600,000					1,750
Received Employee Retention Tax Credit, Amount									$ 1,152,000
Total received employee retention tax credit, Amount									4,137,000
J Stephen Holmes | Founding Shareholder | Preferred Stocks Issued
Share-based compensation arrangement by share-based payment award, options, forfeitures in period (in shares)					11,790,000
Disposal by sale | Overall business
Gross proceeds									19,166,000	$ 19,166,000
Everest Litigaton
Loss contingency, damages sought, value							$ 600,000		$ 1,600,000
Sunz Litigation
Loss contingency, damages sought, value						$ 10,000,000
Loss contingency, damages sought, value as a percentage of incurred and unpaid claims						200.00%
Vensure Litigation
Loss contingency, damages sought, value		$ 1,500,000
Discontinued operation, proposed adjustments period			90 days
Discontinued operation, negotiation period			30 days
Vensure Litigation | Disposal by sale | Overall business
Gross proceeds			$ 19,000,000
Gross note receivable			$ 9,500,000
Period for payment of gross proceeds (in years)			48 months
Vensure Litigation | Withdrawn Claim
Loss contingency, damages sought, value								$ 1,500,000
Vensure Litigation | Pending Litigation
Gain contingency, unrecorded amount											$ 9,500,000
John Stephen Holmes Bankruptcy Litigation
Loss contingency, damages sought (in shares)	12,500,000
Period of time during which trustee failed to take any action (in years)	3 years

XML

Subsequent Events (Details Narrative) - USD ($)			3 Months Ended	9 Months Ended
	Jul. 12, 2023	Jun. 05, 2023	May 31, 2023	May 31, 2023	Sep. 20, 2022	Aug. 31, 2022
Net proceeds from sale			$ 500,000	$ 2,000,000.0
Exercise price of warrants (in dollars per share)			$ 35.68	$ 35.68	$ 13.20	$ 47.99
Class of warrant or right, outstanding (in shares)			1,252,749	1,252,749		522,786
Subsequent Event [Member]
Discription of settlement		If at any time during the Compliance Period the Company’s MVLS closes at $35 million or more for a minimum of ten (10) consecutive business days, Nasdaq will provide the Company with written confirmation of compliance, and this matter will be closed
Market value of listed securities		$ 35,000,000
Subsequent Event [Member] | Public Offering
Net proceeds from sale	$ 2,500,000
Offering expenses	600,000
Reimbursement expenses	$ 75,000
Offering fee received	7.00%
Exercise price of warrants (in dollars per share)	$ 0.0001
Offering price for pre funded warrants	1.4999
Offering price	$ 1.50
Sale of common warrants	2,066,667
Sale of pre-funded warrants	900,000
Exercise price on outstanding stock to investors	$ 1.50
Class of warrant or right, outstanding (in shares)	1,186,742
Sale of common stock, shares	1,166,667
Subsequent Event [Member] | Public Offering | Common Warrants [Member]
Number of common warrants sold	2,000,000
Exercise price of warrants (in dollars per share)	$ 1.50
Number of common warrants prefunded	900,000
Share sold under securities agreement	1,100,000